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SUMMARY 
Titanium (Ti) and its alloys are currently the most widely used orthopedic 
implantable materials. Lack of osseointegration and Ti-associated infection are 
two major problems that result in the failure of Ti-based implants. After 
implantation, the surface of Ti is in direct contact with the host tissue and 
surface properties of Ti play a critical role in modulating bone cell functions. 
In this study, different surface modification approaches were carried out to 
enhance the osteogenesis of osteoblasts and stem cells cultured on Ti. Firstly, 
surface anchors (silane, dopamine and polydopamine) and surface coatings 
(carboxymethyl chitosan (CMCS) and bone morphogenetic protein 2 (BMP-2)) 
were immobilized on Ti. The stability of the surface anchors and surface 
coatings after being subjected to 70% ethanol treatment, autoclaving and 
prolonged immersion in phosphate buffered saline was studied. Next, 
alendronate was immobilized on Ti via two conjugation strategies, and the 
effect of immobilized alendronate on osteoblast functions was compared. 
Thirdly, alkaline phosphatase was covalently bonded on CMCS-modified Ti to 
achieve a bifunctional substrate that enhances osteoblast and stem cell 
functions and reduces the adhesion of Staphylococcus epidermidis. Lastly, 
since recent research has demonstrated that application of electrical 
stimulation (ES) significantly enhanced bone regeneration, nanotubular Ti 
with surface-immobilized BMP-2 was prepared and used in conjunction with 
ES to further enhance the proliferation and differentiation of osteoblasts.  
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Figure 7-2 XPS wide scan spectra of (a) TiNT (b) PPYC-TiNT. 
Figure 7-3 FESEM images of (a) PPYC-TiNT and (b) BMP-PPYC-
TiNT. Scale bar = 400 nm. 
Figure 7-4 Osteoblast proliferation on Pristine-Ti in (a) horizontal and 
(b) vertical assembly and subjected to DC stimulation for 4 
h/day over 7 days. Suffix of CA or AN refers to osteoblasts 
cultured on Pristine-Ti cathode or anode in the vertical 
assembly, respectively (* denotes significant difference 
(P<0.05) as compared with Pristine-Ti without ES (0 µA) 
at the same time point, # denotes significant difference 
(P<0.05) as compared with 100 µA on Day 7). 
Figure 7-5 Osteoblast proliferation on (a) Pristine-Ti and (b) TiNT 
subjected to different current and duration of ES (200 µA) 
in horizontal and vertical assemblies after 7 days. The type 
of ES and substrate used are as indicated in the suffix and 
bracket, respectively. 0 h/day refers to cell culture without 
ES (*, #, & and + denote significant difference (P<0.05) as 
compared with 0, 1, 2 and 4 h/day cultured in the same 
assembly and subjected to the same type of ES, @, ^ and 
$ denote significant difference (P<0.05) as compared with 
Horizontal-DC, Horizontal-BEC, and Vertical-DC 
subjected to the same duration of ES and on the same type 
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of substrate). 
Figure 7-6 (a) Osteoblast proliferation after 7 days (b) ALP activity of 
osteoblasts over 14 days and (c) calcium deposition of 
osteoblasts after 21 days in vertical assembly with and 
without ES. ES refers to BEC stimulation of 200 µA for 4 
h/day (* denotes significant difference (P<0.05) comparing 
substrate subjected to ES with the corresponding substrate 
without ES at the same time point). 
Figure 7-7 (a) Osteoblast proliferation after 7 days (b) ALP activity of 
osteoblasts over 14 days and (c) calcium deposition by 
osteoblasts after 21 days in the vertical assembly with and 
without ES. ES refers to BEC stimulation of 200 µA for 4 
h/day (* denotes significant difference (P<0.05) comparing 
substrate subjected to ES with the corresponding substrate 
without ES, # and & denote significant difference (P<0.05) 
comparing substrate with Pristine-Ti or TiNT, all in the 
absence of ES, ^ and @ denote significant difference 
(P<0.05) comparing substrate with Pristine-Ti or TiNT, all 
subjected to ES. Comparison was made between substrates 
at the same time point). 
Figure 7-8 Optical microscopy images of Alizarin Red-stained 
osteoblasts cultured on pristine and functionalized Ti 
substrates in the vertical assembly without ES ((a), (c), (e) 
and (g)) with ES (BEC stimulation of 200 µA for 4 h/day) 
((b), (d), (f) and (h)) after 21 days. Scale bar = 200 μm. 
Figure 8-1 Proposed friction test for assessment of stability of 
nanotubular Ti functionalized with BMP-2. 
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1.1 Background 
The reconstruction of bone defects resulting from trauma, degenerative disease, 
cancer or congenital disorders frequently requires bone reparation and 
replacement. Orthopedic implants are used routinely worldwide for 
musculoskeletal applications to repair or replace the failing bone tissue, such 
as for fixation of long bone fractures and replacement of arthritic joints (Carter 
et al., 1998). Among the metallic, ceramic, and polymeric materials, Ti and its 
alloys are the most prevalent due to their excellent mechanical properties, 
stable chemical properties and biocompatibility with the human tissues (Long 
and Rack, 1998). However, Ti-based implants may fail to achieve complete 
tissue integration with the host tissue and result in ultimate failure of the 
implant, which requires revision surgery, causing pain and morbidity to the 
patients. The major reasons for implant failure are aseptic loosening due to 
incomplete osseointegration (Abu-Amer et al., 2007) and implant-associated 
infection (Campoccia et al., 2013, Zhao et al., 2009).  
 
The osseointegration of the implant and the bone tissue occurs in two stages: 
initial fixation of the implant by mechanical engagement with bone, and long 
term rigid fixation of the loaded implant with bone through bone remodeling 
(Parithimarkalaignan and Padmanabhan, 2013). The former can be achieved 
by physical means such as use of screws. On the other hand, the latter strongly 
relies on the ability of the implant to support the adhesion and growth of bone 
cells (osteoconduction) and to induce the osteogenesis of bone cells 
(osteoinduction) (Albrektsson and Johansson, 2001).  
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Clinical studies have identified the presence of implant as one of the most 
significant risk factors for developing surgical site infection, as the surface of 
the implant is susceptible to bacterial adhesion and colonization (ter Boo et al., 
2015). Implant-associated infections may result in severe complications, 
which may lead to osteomyelitis with destructive effects on bone and 
surrounding tissue (Montanaro et al., 2011). Moreover, once an implant-
associated infection develops to chronic infection, it no longer responds to 
debridement or systemic delivery of antibiotics. The only effective way to 
eradicate the infection is through the substitution of the implant. However, the 
risk of relapse remains high (Arciola et al., 2012). 
 
The behavior of bone cells and microorganisms can be modulated by the 
surface properties of the implant (Bazaka et al., 2012, Tejero et al., 2014). 
Surface modification can thus be a promising approach to endow the implant 
with osteoconductive, osteoinductive and antibacterial properties to enhance 
osseointegration and reduce infection. Besides cell-surface interactions, bone 
cells can also be regulated by biochemical and biophysical stimuli to recreate 
the bone tissue microenvironment at the implant site (Balint et al., 2013, Polo-
Corrales et al., 2014). Since the discovery of piezoelectric current in 
mechanically loaded bone, electrical stimulation (ES) has been widely used to 
promote bone healing and bone regeneration in clinical applications (Ebrahim 
et al., 2014, Fukada and Yasuda, 1957). In this thesis, it is hypothesized that 
proper modification of surface chemistry and/or surface topography of Ti may 
result in enhanced bone cell functions. When surface modification of Ti is 
applied in combination with ES, the functions of bone cells may be further 
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enhanced. Thus, in vitro experiments were carried out to assess improvements 
in bone cell functions in terms of increased proliferation and enhanced 
differentiation of osteoblasts and stem cells.  
 
1.2 Research Objectives and Scope 
The main objective of this thesis is to develop different surface modification 
strategies to enhance the osteogenesis of osteoblasts and stem cells cultured on 
Ti substrates. This thesis consists of eight chapters. Chapter 1 presents a 
general introduction and the research objectives and scope. Chapter 2 provides 
a detailed literature review in the field of the study. In Chapter 3, surface 
anchors (silane, dopamine (DA) and polydopamine (PDA)) and surface 
coatings of carboxymethyl chitosan (CMCS) and bone morphogenetic protein 
2 (BMP-2) were immobilized on Ti. The stability of surface anchors and 
surface coatings after being subjected to 70% ethanol, autoclaving and 
prolonged immersion in phosphate buffered saline (PBS) was evaluated using 
bacterial and osteoblast response assays. The stability of the surface anchors 
and surface coatings after these treatment procedures suggests that these 
molecules are suitable for surface modification of Ti. Chapter 4 describes two 
strategies for immobilizing alendronate on the surface of Ti to enhance 
osteoblast and/or stem cell functions. Alendronate was immobilized on Ti with 
hydroxyl groups, or on Ti with silane anchors. The conjugation strategies were 
compared by evaluation of surface property and stability, as well as osteoblast 
responses on these substrates. The second conjugation strategy resulted in 
higher surface density and higher stability of alendronate, and these 
alendronate-modified substrates enhanced the functions of osteoblasts and 
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stem cells. In Chapter 5, alkaline phosphatase (ALP) was covalently bonded to 
a CMCS coating on PDA-modified Ti. The substrate enhanced the osteogenic 
differentiation of osteoblasts and stem cells while inhibiting the bacterial 
adhesion of Staphylococcus epidermidis (S. epidermidis). The thermal stability 
of the surface-immobilized ALP was greatly improved compared to free ALP. 
In Chapter 6, the surface properties of Ti were modified with nanotubes (NTs) 
and the molecules studied in the previous chapters (i.e. BMP-2, alendronate or 
ALP) were introduced on the surface. The effects of modifications of surface 
topography and surface chemistry of Ti on osteoblast functions were 
investigated and compared. The substrate with BMP-2 immobilized on Ti with 
NT features (TiNT) was found to be the most effective in enhancing osteoblast 
functions. In Chapter 7, the BMP-2-functionalized TiNT substrates were used 
in conjunction with ES, and the proliferation, ALP activity and calcium 
deposition of osteoblasts were further enhanced. Lastly, Chapter 8 provides 
the overall conclusion of the study with some recommendations for future 
work. The flow chart on the next page shows a summary of the investigations 
carried out in this thesis. 
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2.1 Introduction 
Bone is a remarkable organ which plays key roles in human physiology. Its 
importance becomes clear in cases of disorders or diseases when bone does 
not function properly, along with traumatic injury and orthopedic surgeries, 
which lead to or induce bone defects. When injured or diseased bone is unable 
to repair itself, orthopedic implants are often required to help restore the bone 
functions (Porter et al., 2009). 
 
Bone defects affect hundreds of millions of people worldwide and the 
economic impact of orthopedic implants is tremendous. For instance, in UK, 
National Joint Registry recorded >200,000 hip, knee, ankle, shoulder and 
elbow replacement procedures in 2013 (National Joint Registry 11
th
 Annual 
Report, 2014). According to American Joint Replacement Registry, >43,000 
hip and knee replacement procedures were reported in 123 hospitals in the 
same year in US (Annual Report on Hip and Knee Arthroplasty Data, 2013). 
In Australia, the number of hip and knee procedures has increased by 40.9% 
and 69.1% from 2003 to 2013, respectively (Australian Orthopaedic 
Association National Joint Replacement Registry Annual Report, 2013). It is 
also estimated that there will be a demand for > 3.5 million primary hip and 
knee arthroplasties by 2030 (Kurtz et al., 2007). In addition, the value of the 
global market for orthopedic implants was estimated to be over US$ 30.5 
billion in 2012 and is projected to reach US$ 46.5 billion by 2017 (Industry 
Experts, 2011). 
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After an orthopedic implant is implanted, it may fail and revision surgery will 
be needed. Statistical analysis of the outcome after joint replacement in UK 
between 2003 and 2013 suggests about 2% of patients require at least one 
revision operation related to primary hip or knee replacement in 10 years 
(National Joint Registry 11
th
 Annual Report, 2014). With the estimated 
number of bone reparation and replacement procedures trending upwards, the 
need for revision surgeries is also increasing. It is estimated that total hip and 
total knee revisions will grow by 137% and 601% from 2005 to 2030, 
respectively (Kurtz et al., 2007). Some possible causes for revision surgeries 
are: lack of integration of implant with surrounding tissue, inflammation, wear 
or corrosion of the implant and failure of implant due to low fatigue strength 
(Geetha et al., 2009). For example, between 8% and 12% of the annually 
performed joint replacement procedures in Australia are revision arthroplasties 
due to implant failure. The main reasons are aseptic loosening (28-29%) and 
implant infection (15-20%) (Zhang et al., 2014). 
 
With the development of medical technology, the longevity of people 
increases. Therefore, the lifespan of orthopedic implant is now expected to be 
much longer, and the development of appropriate prosthetic materials to 
reduce implant failure and revision surgeries is crucial (Geetha et al., 2009). 
An ideal orthopedic implant should be mechanically strong, stable and 
biocompatible with bone. It is highly desirable for the material to also be 
osteoconductive to facilitate the adhesion and growth of bone cells, and 
osteoinductive to induce osteogenic differentiation of bone cells (Albrektsson 
and Johansson, 2001). Another desired property for the orthopedic implant is 
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antibacterial property to minimize the risk of infection. Currently, there is no 
commercial implant that meets all these criteria, which highlights the need for 
research and development in this field (Zhang et al., 2014). 
 
2.2 Bone Physiology 
In order to design orthopedic implants for bone healing and regeneration, it is 
essential to understand bone physiology, which is given below. 
 
2.2.1 Bone Structure 
The major functions of bone include the protection and support of internal 
organs, homeostasis, mineral storage, production of blood cells, housing of 
multiple progenitor cells, and control and regulation of blood pH (Lee et al., 
2007). As a composite material, bone is made up of 33-43% minerals, 32-44% 
organics, and 15-25% water on a volumetric basis. The organics consist about 
90% of Type I collagen and 10% of non-collagenous proteins such as growth 
factors, osteopontin, sialoprotein, osteonectin and osteocalcin (Olszta et al., 
2007). The hierarchical structure of bone from macroscopic to molecular scale 
provides bone with balances of stiffness and flexibility, strength and lightness, 
compactness and porosity (Tejero et al., 2014). Figure 2-1 shows the 
hierarchical structure of human bone.  
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Figure 2-1 Hierarchical structural organization of bone (Rho et al., 1998).  
 
The outmost layer of bone (cortical bone) is smooth, rigid and most compact, 
whereas the inner part of bone (cancellous bone) is spongy, porous and softer 
(Price, 2004). The microstructure and sub-microstructure of cortical bone 
include osteons (200-250 µm in diameter) and Haversian canals. Osteons are 
formed by sheets of mineralized collagen fibers (lamellae) wrapping in 
concentric layer around Haversian canals (Rho et al., 1998). The osteons are 
crucial for bone tissue to resist bending or compression, while Haversian 
canals contain nerves and blood vessels to nourish osteocytes (Tejero et al., 
2014). The fibers that build lamellae contain fibrils. At nanostructural and sub-
nanostructural level, they are a composite of bone crystals (platelet-shaped 
hydroxyapatite (HA), 50 nm × 25 nm × 3 nm) and collagen molecules. The 
crystals grow in the orientation that is roughly parallel to the long axes of 
collagen fibrils, in the hole and groove regions that lay between the staggered 
arrangements of the collagen molecules (Bauer et al., 2013, Landis, 1995, 
Tejero et al., 2014).  
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2.2.2 Bone Cells and Mesenchymal Stem Cells 
Three types of bone cells are involved in bone metabolism: osteoblasts, 
osteocytes and osteoclasts. Osteoblasts and osteocytes are bone-forming cells 
that differentiate from pluripotent mesenchymal progenitor cells (also referred 
to as mesenchymal stem cells (MSCs)) (Caplan, 2007, Yamaguchi et al., 
2000). Osteoblasts synthesize extracellular matrix (ECM) proteins such as 
collagen and non-collagenous proteins, and regulate the local concentrations 
of calcium and phosphate to promote the formation of HA (Ducy et al., 1996). 
ECM proteins are secreted by osteoblasts to form non-mineralized bone matrix 
during cell proliferation, followed by cross-linking of the proteins for matrix 
maturation. The cross-linked collagen fibrils then become templates for 
mineral deposition to form the mineralized bone matrix (Polo-Corrales et al., 
2014). The osteoblasts may become embedded in the newly formed bone 
matrix after matrix mineralization, and these mature and embedded osteoblasts 
are called osteocytes. The osteocytes secrete growth factors to modulate the 
differentiation of osteoblasts (Manolagas, 2000). On the other hand, 
osteoclasts are bone-resorbing cells that secrete acid and collagenase to induce 
bone resorption (Salgado et al., 2004).  
 
MSCs constitute a small population of cells that mainly originate from the 
stem cell niches in bone marrow located in the cancellous bone tissue. 
However, MSCs are also found in other sources including adipose tissue and 
umbilical cord blood, which display variations in terms of differentiation 
potential and cell phenotype (Baksh et al., 2007, Kern et al., 2006, Meirelles 
et al., 2006, Tejero et al., 2014). MSCs possess high proliferation capacity and 
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ability to differentiate into different cell lineages such as osteoblasts, 
adipocytes and chondrocytes under appropriate conditions, both in vitro and in 
vivo (Deng et al., 2008, Vats et al., 2005). Important transcription factors in 
the osteogenic differentiation of MSCs include runt-related transcription factor 
2 (RUNX2), osterix (OSX), osteopontin (OPN) and osteocalcin (OC) (Deng et 
al., 2008, Graneli et al., 2014, Heino and Hentunen, 2008). Due to their ability 
to self-replicate and to differentiate to osteoblasts, MSCs are also frequently 
utilized in bone healing and regeneration applications (Bruder et al., 1994, 
Keller, 2005, Salgado et al., 2004, Vats et al., 2005, Weissman et al., 2001).  
 
2.2.3 Cell-Surface Interactions 
When an implant is introduced to in vitro cell culture condition or in vivo 
animal model, proteins in the culture medium or bodily fluid adsorb on the 
surface of the implant within 1 s. Protein adsorption and conformation of the 
adsorbed proteins are affected by several factors, such as surface chemistry, 
surface wettability, surface roughness, surface charge, and surface topography 
(Brammer et al., 2012). The types of adsorbed proteins are also shown to 
direct the subsequent cell adhesion and spreading. For instance, the absence of 
vitronectin in cell culture medium results in 73-83% reduction in attachment 
and spreading of bone-derived cells on stainless steel (SS), Ti and alumina 
surfaces (Howlett et al., 1994). The adhesion of cells on the protein-adsorbed 
implant is achieved via focal adhesion between receptors in the cell membrane 
(integrins) and the specific peptide sequence present in the surface-adsorbed 
proteins (Minagar et al., 2012). Some examples of ECM proteins containing 
the specific peptide sequence (such as arginine-glycine-aspartic acid (RGD) 
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peptide sequence) are vitronectin, fibronectin, and laminin (Xu and Mosher, 
2011). Through focal adhesion, the cytoskeletal reorganization of the cells 
results in formation of extensions such as filopodia (finger-like protrusions) 
and lamellipodia (membrane veils rich in actin). These extensions enable the 
cells to change shape, crawl and progressively spread over the surface of the 
implant (Variola et al., 2011). 
  
2.2.4 Cell-Microenvironment Interactions 
Bone tissue microenvironment is responsible for regulating cell functions. 
Essential to the microenvironment are stimulating factors which include 
biochemical and biophysical stimuli (Polo-Corrales et al., 2014). Molecules 
such as growth factors are recognized as biochemical stimuli as they direct 
osteogenesis. Growth factors initiate cellular signaling cascade by binding to 
specific integrins which results in signal transduction into cell nucleus where 
transcription factors are activated, affecting gene expressions and thus cell 
functions (Polo-Corrales et al., 2014). Prominent growth factors are 
transforming growth factor-beta (TGF-β), bone morphogenetic proteins 
(BMPs), fibroblast growth factor, platelet-derived growth factor, and insulin-
like growth factor (Wiesmann et al., 2004). 
 
Exogenous biophysical stimuli also affect the microenvironment, such as 
mechanical stimulation and ES. Mechanical stimulation is believed to be 
converted to biochemical signals via mechanotransduction, during which 
osteocytes sense the shear stress and produce signaling molecules that regulate 
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activities of osteoclasts and osteoblasts. However, the exact signaling pathway 
has not been elucidated (Huang and Ogawa, 2010).  
 
The discovery of piezoelectric potential in mechanically loaded bone leads to 
the identification of biopotentials as natural electric properties that control the 
growth and development of bone tissue (Fukada and Yasuda, 1957, Gittens et 
al., 2011). Since endogenous electric fields modulate bone cell activities, it is 
assumed that exogenous biophysical stimulus such as ES could be used to 
promote bone growth (Gan and Glazer, 2006). ES is shown to result in 
improved cell proliferation, altered pattern of gene expression, enhanced ECM 
synthesis and elevated intracellular and extracellular calcium in osteoblasts 
and MSCs (Wiesmann et al., 2004). However, similar to mechanical 
stimulation, the exact molecular mechanisms underlying the response of cells 
to ES are complex and not entirely known. When there are bone defects or 
when an implant is inserted to the body, the microenvironment at the implant 
site is changed and injury potential is generated. This causes the injury site to 
be electronegative compared to the surrounding microenvironment, and 
disrupts the normal biopotential for bone growth and development (Gittens et 
al., 2011). Thus it may be beneficial to help restore the microenvironment by 
incorporating ES in the bone healing process. 
 
2.2.5 Bone Remodeling 
Bone constantly undergoes a dynamic process of remodeling, which is 
mediated by osteoclasts and osteoblasts arranged within temporary anatomical 
structures known as basic multicellular units (BMUs). There are five distinct 
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and sequential phases in the bone remodeling process. Firstly, osteoclasts are 
activated by complex pathways due to apoptosis of osteocytes in the impaired 
bone or sensing of microcracks by osteocytes in the normal bone. Next, the 
mature osteoclasts anchor on the surface of the bone and create an isolated 
microenvironment beneath the cell, where dissolution of mineralized matrix 
occurs. Following osteoclast-mediated bone resorption, reversal cells from 
osteoblast lineage remove the matrix debris, receive or produce signals to 
initiate the transition from bone resorption to bone formation within BMUs. 
Then, MSCs or early osteoblast progenitors differentiate into mature 
osteoblasts, which ultimately form mineralized bone. After equal quantity of 
resorbed bone is replaced with new mechanically stronger bone, the 
remodeling cycle is ceased (Raggatt and Partridge, 2010). In cases when an 
implant is inserted, the bone remodeling around the implant site helps the bone 
to adapt to the change in the physical stress in the local environment. The bone 
remodeling also improves the fixation of the implant with bone for 
osseointegration. Therefore, it is of great significance that the properties of the 
implant do not interrupt or cause adverse effects during the bone remodeling 
process. 
 
2.3 Requirements for Implants 
As orthopedic implants are in direct contact with human body, they should 
meet certain mechanical, chemical and biological requirements.  
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2.3.1 Mechanical Aspects 
To repair or replace bone, which is satisfactorily strong and tough, an implant 
should match the mechanical parameters such as Young’s modulus and tensile 
strength with those of bone (Chen and Thouas, 2015). The composite nature of 
bone structure results in anisotropic behavior of bone, with Young’s modulus 
ranging between 10 and 30 GPa and tensile strength ranging between 90 and 
140 MPa (Long and Rack, 1998). An orthopedic implant should possess 
comparable Young’s modulus as that of bone, because changes in distribution 
and transmission of the load within the bone due to the presence of an implant 
affect bone metabolism (Bauer and Schils, 1999). For instance, when an 
implant with higher Young’s modulus than that of bone is inserted, the needed 
stress to be transferred to adjacent bone is prevented due to the stiffer implant 
(stress-shielding effect). This results in bone resorption around the site of the 
implant, and leads to implant loosening (Geetha et al., 2009). 
 
Another mechanical requirement of an implant is its resistance to wear. Wear 
occurs with loss of implant material and generation of debris particles due to 
relative motion (such as abrasion, fatigue cracking and bending) between bone 
and surface of the implant (Schmalzried and Callaghan, 1999). Wear of an 
implant may have detrimental effects such as aseptic loosening, bone 
resorption and/or inflammation at the implant site. The type of material, bulk 
and surface property of material, design and geometry are important factors 
that may affect the wear resistance of an implant (Bauer and Schils, 1999, 
Dowson, 2001). 
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2.3.2 Chemical Aspects 
Implants of metallic nature should resist corrosion due to electrochemical 
dissolution under physiological condition. Corrosion decreases the structural 
integrity of an implant, and the release of degradation products may exert an 
adverse biological effect such as allergic or toxic reaction. Moreover, 
corrosion and wear may interact, causing premature structural failure and 
accelerated release of non-compatible metal particles and ions (Geetha et al., 
2009, Hallab et al., 2001, Jacobs et al., 1998). Most metallic implants rely on 
the passive oxide film formed on the implant surface as a barrier against 
corrosion. Thus, properties of surface oxide film such as porosity, coverage 
and atomic defects are of great importance in minimizing corrosion (Jacobs et 
al., 1998). 
 
2.3.3 Biological Aspects 
As described in Section 2.2.3, when an implant is inserted to the body, the 
initial cell-surface interactions take place at molecular level. These effects 
propagate efficiently throughout the entire cell, and in turn generate a cascade 
of cellular responses (Variola et al., 2011). Therefore, it is crucial that the 
implant supports protein adsorption, and adhesion and growth of osteoblasts. 
The requirements of biocompatibility imply the implant should not cause 
inflammatory, allergic or toxic reactions. In addition to initial cell-surface 
interactions, long term osseointegration should also be achieved through bone 
remodeling at the implant site. Hence, it is highly desirable for the implant to 
be osteoinductive to recruit osteoblasts and MSCs from adjacent tissue and 
induce osteogenesis.  
Chapter 2  
19 
 
2.4 Ti and Its Alloys as Implants 
In recent years, great progress has been made in designing implants using 
metals, ceramics and polymers. Comparing these three types of materials, the 
excellent mechanical properties of metals make them the first choice as 
orthopedic implants to restore the load bearing functions of the bone tissue. 
On the other hand, ceramics or polymers are frequently used as parts in an 
integrated orthopedic implant system, such as bearing balls in artificial joints, 
or coatings on the surface of metallic implants (Bauer et al., 2013, Hench, 
1991). Among the metallic implants, the routinely used implant materials are 
Ti and its alloys, Type 316 SS and cobalt-chromium (Co-Cr) alloys (Chen and 
Thouas, 2015). A brief comparison of some properties of these three types of 
materials is summarized in Table 2-1. 
 
Table 2-1 Some properties of metallic implant materials (Chen and Thouas, 
2015, Long and Rack, 1998). 
 
 Ti and its alloys Type 316 SS Co-Cr alloys 
Principal alloying 
elements (wt%) 
Ti (bal.*) 
Al (6) 
V(4) 
Nb(7) 
Fe (bal.*) 
Cr (17-20) 
Ni (12-14) 
Mo (2-4) 
Co (bal.*) 
Cr (19-30) 
Mo (0-10) 
Ni (0-37) 
Density (g/cm
3
) ~4.5 ~8 ~8.3 
Young’s modulus (GPa) 105-125 200-210 220-230 
Tensile strength (MPa) 600-1100 500-1350 900-1800 
Fatigue Strength  
(at 10
7
 cycles, MPa) 
500-600 (air) 
400-600 
(solution) 
300-350 (air) 
100-200 
(solution) 
600-900 (air) 
200-300 
(solution) 
Corrosion resistance Excellent Poor Excellent 
Biocompatibility Best Acceptable Good 
*bal. indicates the balance of the composition of the alloy 
 
From Table 2-1, the major disadvantage of Type 316 SS and Co-Cr alloys is 
their high Young’s modulus as compared to that of bone, which may result in 
stress-shielding effect (as described in Section 2.3.1). Another disadvantage is 
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the potential wear and/or corrosion of Type 316 SS and Co-Cr alloys, which 
may lead to release of Ni and Cr, which are toxic to human (Hayes, 1997). For 
Ti and its alloys, their Young’s modulus is much lower than that of the other 
two types of alloys. The tensile strength of Ti alloys is comparable to that of 
Type 316 SS and Co-Cr alloys. Moreover, the fatigue strengths of Ti alloys 
are more consistent under different testing conditions. As the fatigue strength 
of Ti alloys is much higher than the maximal strength for legs and arms in 
human (~200 MPa), they are considered safe as long term or permanent 
implants (Chen and Thouas, 2015). The spontaneously formed oxide layer on 
Ti alloys is stable and contains fewer atomic defects than that on Type 316 SS 
and Co-Cr alloys. This results in higher corrosion resistance (Ratner et al., 
2013).  
 
Despite their excellent biocompatibility, a current problem associated with Ti 
alloys is that they are not bioactive materials and lack osteoinductive and 
antibacterial properties (Bauer et al., 2013, Geetha et al., 2009, Tejero et al., 
2014). Since osseointegration and infection occur on the surface of the implant, 
surface modification of Ti not only retains the desired bulk properties of Ti, 
but also enhances the biological responses of the implant. As highlighted in 
Section 2.2, the initial adhesion and spreading of bone cells are affected by 
surface chemistry, surface wettability, surface roughness, surface charge, and 
surface topography of an implant. The proliferation and differentiation of bone 
cells are affected by the biochemical and biophysical stimuli in the local 
microenvironment of an implant. Thus, these properties should be properly 
tailored during the surface modification in order to enhance the functions of 
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osteoblasts and stem cells. The modification of surface chemistry can alter the 
surface wettability and surface charge in addition to the surface chemistry 
(Alghamdi and Jansen, 2013, Bauer et al., 2013). On the other hand, the 
modification of surface topography, as a biophysical cue, can also change the 
surface wettability and surface roughness (Das et al., 2009, Gittens et al., 
2013). In the following sections (Section 2.5 and Section 2.6), modifications 
of Ti’s surface chemistry and surface topography to enhance osseointegration 
and reduce infection are discussed. 
 
2.5 Surface Modification of Ti to Enhance Osseointegration 
2.5.1 Surface Chemistry 
As described in Section 2.2.3, surface properties of Ti determine the initial 
protein adsorption, and subsequent cell adhesion, cell-surface interactions and 
cell functions. A straightforward approach to modify the surface chemistry of 
Ti is to introduce non-therapeutic or therapeutic molecules on it (Alghamdi 
and Jansen, 2013). The non-therapeutic molecules are usually inorganic. One 
example is the use of calcium phosphate on Ti, due to its compositional 
similarity to the mineral phase of the bone (Goodman et al., 2013). Calcium 
phosphate-coated Ti has been applied to improve the implant-bone fixation in 
clinical applications since 1980s (de Groot et al., 1998). However, there are 
limitations with such coating. For instance, the thickness of calcium phosphate 
on Ti (when >50 µm) may lead to low adhesive strength of the coating and 
increase the risk of coating delamination (Hulshoff et al., 1997). Furthermore, 
while the calcium phosphate-coated Ti is osteoconductive, it is not 
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osteoinductive, and only interacts with the bone via direct bone-bonding at the 
implant site (Alghamdi and Jansen, 2013).  
 
Surface modification of Ti with therapeutic molecules can enhance 
osseointegration by providing biomimetic surfaces and acting like localized 
biochemical stimuli (Goodman et al., 2013). These molecules are expected to 
alter the surface property of Ti to recreate the cell microenvironment at the 
implant site (Morra, 2006, Tejero et al., 2014). For instance, ECM 
components such as collagen and growth factors regulate osteoblast functions 
during bone formation. They are good candidates for surface modification of 
Ti to induce specific intrinsic osteogenesis directly at the bone-implant 
interface (de Jonge et al., 2008). 
 
2.5.1.1 BMP-2, ALP and BPs in Bone Formation 
In this section, three types of molecules, namely, BMP-2, ALP and BPs are 
discussed as potential therapeutic molecules for surface modification of Ti. 
BMPs are multi-functional growth factors that belong to the TGF-β 
superfamily, which are the non-collagenous proteins in ECM (Hogan, 1996). 
BMPs bind to Type I and II BMP receptors in the membrane of osteoblasts 
and form a heterotetrameric-activated receptor complex. Smad proteins of 
Type I BMP receptor substrates are responsible for relaying the BMP signal to 
target genes in the nucleus. After phosphorylation by BMP receptors, Smad1, 
5 and 8 are released and associate with Smad4 to translocate into the nucleus 
and participate in gene transcriptions, such as the transcription of RUNX2 in 
osteoblasts (Chen et al., 2004). The osteoinductive potential of BMP-2 has 
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been well demonstrated in osteoblasts and MSCs in vitro. The bone forming 
and healing capacity of BMP-2 are also reported in many animal models 
including rats, rabbits, dogs, sheep and non-human primates with critical-sized 
defects (Chen et al., 2004, Diefenderfer et al., 2003, Hogan, 1996, Murakami 
et al., 2002, Osyczka et al., 2004, Tsuchida et al., 2003). In addition, BMP-2 
and BMP-7 have been approved by US Food and Drug Administration (FDA) 
for clinical applications (Kanakaris et al., 2009). 
 
ALP is a membrane-bound enzyme that is expressed in several tissues. ALP 
present in osteoblasts participates actively in the mineralization process (Lian 
and Stein, 1992, Quarles et al., 1992). The initial mineralization in bone takes 
place within the matrix vesicles which originate in specific regions of the outer 
plasma membrane of osteoblasts. Ca
2+
 and PO4
3-
 ions are accumulated within 
the matrix vesicles and precipitate to form needle-like HA crystals, which will 
later be released from the matrix vesicles and exposed to extracellular fluid for 
crystal growth. During this process, ALP is responsible for all crystal 
nucleation processes occurring inside the matrix vesicles (Anderson, 1995). 
ALP catalyzes the hydrolysis of organic phosphate monoesters (ROP). This 
catalytic reaction results in the formation of a serine phosphate at the active 
site of ALP, which reacts with water at alkaline pH to release inorganic 
phosphate (Pi) from the enzyme (Coleman, 1992). Moreover, ALP also 
hydrolyzes the local pyrophosphate (PPi) to yield two molecules of 
orthophosphate. PPi is a physiological regulator of calcification and bone 
resorption, and is known as an inhibitor of HA crystal formation (Ezra and 
Golomb, 2000, Fleisch, 1997). The hydrolysis of PPi promotes mineralization 
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of matrix vesicles (Anderson, 1995, de Jonge et al., 2009). Lastly, the 
phosphotransferase activity of ALP may translocate phosphate groups from 
ROP molecules from extracellular fluid to the nearby substrates. For example, 
phosphate groups from ROP can be translocated to phospholipids of the 
matrix vesicle membranes and create phosphate-enriched regions that could 
serve as a nidus for the nucleation of HA (Anderson, 1995, Coleman, 1992, de 
Jonge et al., 2009). Figure 2-2 shows the summary of catalytic reactions of 
ALP.  
 
Figure 2-2 Catalytic actions of ALP increase the Pi concentration for the 
nucleation of HA by hydrolysis of ROP and PPi.(de Jonge et al., 2009) 
 
Besides intracellular proteins, certain drugs are also ideal candidates as 
therapeutic molecules for surface modification of Ti. The bisphosphonates 
(BPs) family constitutes a class of drugs with long history in treatment of bone 
diseases such as Paget’s disease and osteoporosis, by promoting bone 
mineralization and inhibiting bone resorption (Balena et al., 1993, Cattalini et 
al., 2012). BPs are analogous in structure to PPi. With the replacement of P-O-
P bonds in PPi with P-C-P bonds, BPs are more stable than PPi due to their 
resistance to chemical and enzymatic hydrolysis. Figure 2-3 shows the general 
chemical structure of BPs, where the R1 and R2 side chains are responsible for 
different biological and therapeutic mechanisms as observed among this 
family of drugs (Cattalini et al., 2012). 
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Figure 2-3 Chemical structure of BPs, where R1 and R2 indicate the different 
side chains. 
 
BPs can be classified into two groups, namely, nitrogen-containing BPs (N-
BPs) and non-nitrogen-containing BPs (non-N-BPs), depending on the 
structure and different mechanism of action of the drugs. The potent N-BPs, 
such as alendronate, ibandronate, residronate, pamidronate and zoledronic acid, 
are reported to act by competition, binding to the natural substrate-binding site 
of the enzyme farnesyl pyrophosphate synthase. The N-BPs thereby inhibit 
and interrupt the intracellular mevalonate pathway, which results in the 
impairment of osteoclast function and induction of osteoclast apoptosis 
(Dominguez et al., 2011, Reszka and Rodan, 2004). The less potent non-N-
BPs, such as clodronate and etidronate, cause apoptosis of osteoclasts by 
metabolizing to a cytotoxic adenosine triphosphate (ATP) analog. The toxic 
ATP analog thus inhibits the ATP-dependent intracellular enzymes and in turn 
suppresses the bone resorption (Cattalini et al., 2012, Frith et al., 2001, Frith 
et al., 1997).  
 
Recent research also suggests that BPs are capable of preventing the apoptosis 
of osteoblasts, and enhancing osteoblast and stem cell proliferation and 
osteogenic differentiation (Boanini et al., 2008, Fromigue and Body, 2002, 
Garcia-Moreno et al., 1998, Plotkin et al., 1999, von Knoch et al., 2005). It 
has been shown that BPs prevent apoptosis and stimulate proliferation of 
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osteoblasts by binding to certain catalytic domain of phosphatases and 
inhibiting the activity of tyrosine phosphatases in osteoblasts. This results in 
increased cellular tyrosine phosphorylation levels, which trigger the activation 
of intracellular signaling pathways and lead to biological response such as 
increased proliferation. However, the exact molecular mechanism and signal 
transduction pathway activated by BPs are still far from known (Lezcano et al., 
2014). N-BPs have also been reported to possess better osteogenic potency in 
stimulating the differentiation of osteoblasts than non-N-BPs in vitro (Koch et 
al., 2011). Considering the dynamics of osteoblasts and osteoclasts during 
bone metabolism as previously reviewed, delivery of BPs should be designed 
to achieve a reduction in osteoclast activity and enhancement of osteoblast 
functions. A successful delivery of BPs would shift the balance between 
formation and resorption of the bone towards an increase in net bone 
formation. 
 
2.5.1.2 Surface Modification of Ti with BMP-2, ALP or BPs 
The methods for surface modification of Ti with BMP-2, ALP or BP include 
adsorption, covalent immobilization and affinity-based immobilization. 
Adsorption of molecules on Ti can be achieved by simple dip-coating or 
soaking the substrate in a solution that contains the desired therapeutic 
molecule (Morra, 2006). For instance, Ti implants after immersion in BMP-2 
solution significantly improve the implant-bone contact and bone formation in 
minipig, dog and sheep models. (Epstein et al., 2001, Liu et al., 2007, Wikesjo 
et al., 2008). The adsorption of ALP on Ti using an electrospray deposition 
device has been reported. The adsorbed ALP retained its enzymatic activity 
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for inducing HA mineralization in cell culture medium in vitro, and 
significantly improved implant-bone contact in a mouse model in vivo. (de 
Jonge et al., 2009, Schouten et al., 2009). 
 
Pretreatment of Ti surface to introduce surface anchors or reactive leaving 
groups is typically carried out prior to the conjugation of the desired 
therapeutic molecule on the surface. The surface anchors can be conventional 
anchors such as organosilane or phosphonate acid, or biomimetic anchors such 
as dopamine or PDA (Bauer et al., 2013, Liu et al., 2014). These anchors 
provide reactive functional groups such as carboxyl, amino, catechol or 
quinone groups on the Ti surface. The anchors will be directly linked to the 
therapeutic molecule, or linked to the molecule via coupling agents such as 
glutaraldehyde and carbodiimide. Ti can also be functionalized with reactive 
leaving groups which will be replaced by nucleophiles such as amino or thiol 
groups in the therapeutic molecule in a subsequent reaction. This results in the 
direct immobilization of the molecule on Ti without spacers (no anchors or 
coupling agents) (Bauer et al., 2013, Hayakawa et al., 2003). For instance, 
ALP can be conjugated on Ti by replacing the tresyl chloride leaving groups 
on tresyl chloride-activated Ti. The immobilized ALP is able to induce HA 
formation in simulated body fluid (Ferraris et al., 2011).  
 
Affinity-based immobilization utilizes the strong affinity between molecules, 
such as (1) antibody-antigen affinity, (2) growth factor-heparin affinity, and (3) 
BPs-calcium phosphate affinity. For instance, BMP-2 has been immobilized 
on heparin-coated Ti via the growth factor-heparin specific affinity, and the 
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modified surface significantly enhances osteogenic differentiation of human 
osteosarcoma cell line, MG63 cells (Kim et al., 2011). A variety of BPs can be 
immobilized on HA-coated Ti implant, and this leads to improved bone 
formation and better bone-contact in a rat model (Gao et al., 2009).  
 
Among the three types of surface modification strategies, adsorption and 
affinity-based immobilization are quick and simple. However, they generally 
require a large amount of reagent during the coating process. Furthermore, 
unavoidable release of therapeutic molecules from the Ti surface may reduce 
the osteoinductive efficacy of the Ti implant over time. Covalent 
immobilization may require a number of reactions for conjugation, thus the 
surface modification process may be complex. Nevertheless, molecules 
immobilized via covalent bonding exhibit high stability under physiological 
conditions over long term (Morra, 2006). More importantly, covalent 
immobilization of molecules enables the conjugated moieties to obtain a more 
specific and rapid physiological response by exposing and aligning the 
appropriate active sites at the tissue interface (Lee et al., 2009, Nanci et al., 
1998). 
 
2.5.2 Surface Topography 
It has been well acknowledged that the surface topography of Ti at micrometer 
and nanometer level can affect its integration with the host tissue (Gittens et 
al., 2013, Mendonca et al., 2008, Shalabi et al., 2006, Wennerberg and 
Albrektsson, 2009). A review of surface modification of Ti with micrometer 
and nanometer-scaled structure is given below. To introduce microtopography 
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on Ti, irregular microfeatures such as microphases, micropits and micropores 
can be created using blasting, acid etching and anodization. On the other hand, 
ordered microfeatures such as microgrooves can be created using 
photolithography (Nikkhah et al., 2012). The microstructures on Ti enhance 
osteoblast functions in terms of adhesion, alignment, proliferation, 
differentiation and/or mineralization in vitro (Cei et al., 2011, Lu and Leng, 
2003, Park et al., 2010, Park et al., 2013). In vivo, the microstructures direct 
the development of proper interlocking of Ti with bone tissue, leading to 
improved bone-implant contact (Cochran, 1999, Shalabi et al., 2006). 
Experiment driven results from in vitro and in vivo investigations have 
concluded that microtopographies in the range of 1-10 μm is optimal for 
orthopedic implants to maximize the physical interlocking to the host bone 
tissue (Bauer et al., 2013). One limitation of the microstructures is that they 
are usually irregular features, and the dimension of the features cannot be 
easily tuned or optimized by changing reagents, or changing reaction or 
microfabrication conditions.  
 
Osteoblasts have been reported to exhibit better adhesion, differentiation and 
mineralization on Ti with nanostructures than on Ti with microstructures or 
sub-microstructures (Colon et al., 2006, Webster and Ejiofor, 2004, Yao and 
Webster, 2006). Moreover, Ti with combined microstructures and 
nanostructures has also been shown to further enhance multiple functions of 
osteoblasts (Landolt et al., 2003, Zinger et al., 2004). These studies imply that 
nanostructures on Ti may have dual effects of both providing strong physical 
interlocking and influencing cell-surface interactions. The fact that bone 
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tissues exist in the nanometer scale (as described in Section 2.2.1) suggests 
that bone cells are intrinsically adapted to nanoscale surfaces. Modification of 
Ti with nanostructures alters the chemical reactivity of Ti, and hence affects 
the ionic or biomolecular interactions at the interface (Zhang et al., 2013, 
Zhao et al., 2010). Since cell-surface interactions are based on integrins which 
also have nanostructures (8-12 nm), it can be predicted that cell-surface 
interactions will be affected by the nanostructures of Ti (Cavalcanti-Adam et 
al., 2006, Minagar et al., 2012). Recently, different nanostructures such as 
nanopits, nanopores, nanophases, NTs, nanopillars and nanodots have been 
created on Ti to enhance osteoblast and MSC functions (Hong et al., 2014, 
Lavenus et al., 2011, Oh et al., 2009, Sjostrom et al., 2009, Variola et al., 
2008, Yu et al., 2010).  
 
NTs are one of the most established and characterized nanostructures. Highly 
self-ordered tubular features can be formed on Ti surface with dimensions 
which can be tuned by reagents and reaction conditions (Regonini et al., 2013). 
TiNTs can be prepared by anodization, where Ti is used as anode and an inert 
metal (usually gold or platinum) is used as cathode in an electrolyte under 
constant voltage. Different morphologies of NTs on Ti can be achieved by 
controlling the experimental factors. These factors include type of electrolyte, 
concentration of electrolyte, pH, reaction temperature, voltage applied, inter-
electrode spacing, duration of anodization, and post reaction annealing 
(Minagar et al., 2012, Roy et al., 2011). Numerous studies have reported NTs 
with diameter below 100 nm on Ti significantly improve osteoblast and MSC 
functions, although there is no conclusive result on the optimal dimension of 
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the NTs on cell functions (Oh et al., 2009, Park et al., 2009, Yu et al., 2010). 
For instance, Jin’s group reported that NTs with diameters of 70-100 nm on Ti 
enhanced the differentiation of mouse osteoblasts significantly more than 
those with smaller diameters (20-50 nm) in vitro (Brammer et al., 2009). The 
group also reported that NTs with diameter of 80 nm on Ti improved the bone 
bonding tensile strength compared with grit-blasted Ti in vivo in a rabbit tibia 
model (Bjursten et al., 2010). For human MSCs (hMSCs), smaller diameter 
NTs (~30 nm) on Ti were reported to promote adhesion but not differentiation, 
while larger diameter NTs (~70-100 nm) on Ti induced osteogenic 
differentiation of hMSCs (Oh et al., 2009). On the other hand, Schumki’s 
group demonstrated that adhesion, proliferation and differentiation of rat 
MSCs and human osteoblasts were maximally induced on NTs with diameter 
of 15 nm on Ti. However, larger diameter (~100 nm) NTs impaired cell 
functions on the TiNT substrate (Park et al., 2009, Park et al., 2007). The 
TiNT can be further modified with non-therapeutic or therapeutic molecules to 
achieve a combined surface modification. For instance, BMP-2 has been 
immobilized on the PDA-coated TiNT, and this results in further enhanced 
osteogenic differentiation of hMSCs compared to those on TiNT in vitro. (Lai 
et al., 2011).  
 
2.6 Surface Modification of Ti to Reduce Infections 
Most infectious complications at the implant site result from entry of bacteria 
at the surgical site post surgery, and the infections significantly delay bone 
healing and regeneration. Clinical studies have identified several risk factors 
for development of surgical site infections, which may be classified as patient-
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related factors and operation-related factors. One of the highest risk factors is 
the presence of an implant (ter Boo et al., 2015). It is believed to be due to the 
intrinsic susceptibility of the implanted material (ter Boo et al., 2015). The 
causes of implant-associated infections are mainly due to opportunistic 
pathogens found within the microflora of human skin, with Staphylococci 
being responsible for the majority of the cases (Del Pozo and Patel, 2009). In 
fact, Staphylococcus aureus (S. aureus) and S. epidermidis account for more 
than 50% of infections related to fracture fixation devices and up to 65% of 
prosthetic joint infections (AlBuhairan et al., 2008, Esposito and Leone, 2008, 
ter Boo et al., 2015, Trampuz and Zimmerli, 2006). 
 
S. aureus and S. epidermidis contain receptorial adhesins that bind to specific 
adsorbed ECM proteins (such as fibronectin and vitronectin) on the implant 
and thus adhere on the surface of implant and form stable anchorage (Mack, 
1999, Mack et al., 2004, Montanaro et al., 2011). The initial bacterial 
adhesion is followed by colonization and accumulation of multiple bacterial 
cell layers, which leads to formation of mature biofilm. Detachment of 
bacterial cells from the mature biofilm will initiate a new cycle of biofilm 
formation somewhere else (Costerton et al., 1999, Mack et al., 2004). The 
production of exopolysaccharide matrix in the biofilm also protects the biofilm 
from the body’s immune response and systemically delivered antibiotics (Mah 
and O'Toole, 2001, Montanaro et al., 2011). Therefore, it would be 
advantageous if the surface of the implant can be modified to reduce implant-
associated infection. Two surface modification strategies are possible. Firstly, 
the surface can be made anti-adhesive to inhibit the initial bacterial adhesion 
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to reduce possibilities of subsequent events. Secondly, the surface can be 
made bactericidal to kill the bacteria to reduce possibilities of biofilm 
formation. The next two Sections (Section 2.6.1 and Section 2.6.2) provide 
some discussion on the modification of the surface chemistry and surface 
topography of Ti to reduce infection. 
 
2.6.1 Surface Chemistry 
Bacterial adhesion is dependent on material hydrophobicity and electrostatic 
charge (Campoccia et al., 2013). The initial adhesion of S. aureus and S. 
epidermidis is promoted on hydrophobic surfaces, and both bacteria carry 
negative charges at the cell membrane (Legeay et al., 2006). Thus, a highly 
hydrophilic surface and/or a negatively charged surface may resist the 
adhesion of S. aureus and S. epidermidis. Surface chemistry of Ti can be 
altered by self-assembled monolayers and polymer brush coatings to modulate 
the kinetics of microbial adhesion (Campoccia et al., 2013). For instance, 
polyethylene glycol and poly(methacrylic acid) have been immobilized on Ti 
to form hydrophilic surfaces to inhibit the adhesion of S. aureus and S. 
epidermidis (Harris et al., 2004, Khalil et al., 2014, Maddikeri et al., 2008, 
Subbiahdoss et al., 2010, Zhang et al., 2008). However, such polymeric 
coatings also inhibit osteoblast attachment on the substrates, which 
compromises their applicability in orthopedic applications. In order to counter 
the anti-adhesiveness of coatings towards osteoblasts, RGD peptide and silk 
sericin have been co-immobilized with polyethylene glycol and 
poly(methacrylic acid), respectively. Both of these biomolecules improved the 
osteoblast adhesion and functions on the modified Ti surfaces without 
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significantly affecting the polymeric coatings’ ability to resist bacterial 
adhesion (Subbiahdoss et al., 2010, Zhang et al., 2008).  
 
As a result of electrostatic interactions, polyanionic-functionalized Ti can 
exert a repulsion effect on S. aureus and S. epidermidis. Poly(sodium styrene 
sulfonate) and hyaluronic acid, which contain a large number of sulfonate and 
carboxylate groups, respectively, have been immobilized on Ti. The 
poly(sodium styrene sulfonate)- and hyaluronic acid-modified surfaces 
resulted in 75% and 46% reduction in S. aureus adhesion, compared to that on 
pristine Ti, respectively (Alcheikh et al., 2013, Hu et al., 2010). However, 
hyaluronic acid-coated Ti is shown to inhibit the growth of osteoblasts 
compared to pristine Ti. The osteoblast adhesion and functions are improved 
by co-immobilization of hyaluronic acid and vascular endothelial growth 
factor (VEGF) on Ti without affecting the anti-adhesive property of 
hyaluronic acid (Hu et al., 2010). On the other hand, poly(sodium styrene 
sulfonate)-coated Ti supports the growth of osteoblasts and enhanced the 
differentiation of osteoblasts compared to that on pristine Ti (Alcheikh et al., 
2013).  
 
Besides using anti-adhesive agents, bactericidal coatings can also be adopted 
to reduce infection. Silver has long been used as a bactericidal agent in 
biomedical applications. Dissolved silver cations are biochemically active and 
interfere with the membrane permeability and cellular metabolism of bacterial 
cells (Gallo et al., 2014). Silver can be introduced on Ti surface by different 
techniques such as sputtering and chemical deposition (Song et al., 2011, 
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Tarquinio et al., 2010). However, toxicity of silver is a concern, as silver may 
adversely affect surrounding cells and lead to potentially harmful 
accumulation in the human body (Mijnendonckx et al., 2013).  
 
Antibiotics are another group of bactericidal agents. For instance, gentamicin 
has been loaded to Ti surfaces to reduce infection (Lee et al., 2012). The 
surface modification of Ti with antibiotics enables local delivery of the drug 
specifically at the implant site for prolonged period. At the same time, the 
local delivery of antibiotics eliminates the potential side effects experienced 
by the patient from systemic administration of the antibiotics. However, a 
potential problem associated with such antibiotics coating is that bacteria may 
develop resistance to the antibiotics over time, and the bactericidal efficacies 
of the surface may be reduced (Montanaro et al., 2011).  
 
Biopolymers can also be applied on Ti surfaces to exert bactericidal actions. 
Chitosan is a biopolymer with bactericidal effects against a wide spectrum of 
Gram-negative and Gram-positive bacteria. Chitosan with low molecular 
weight acts by penetrating the bacterial cell wall and reacting with 
deoxyribonucleic acid (DNA) to inhibit messenger ribonucleic acid (mRNA) 
synthesis and DNA transcription of the bacteria. Chitosan with high molecular 
weight acts by altering the permeability of bacterial cell wall or forming an 
impermeable layer outside the bacterial cell to hinder nutrient transport into 
the bacterial cell (Kim et al., 2008, Kong et al., 2010). Chitosan is non-toxic 
and biocompatible, making it a good candidate for antibacterial coating (Dash 
et al., 2011, Renoud et al., 2012). Chitosan and its derivatives have been 
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coated on Ti via adsorption or covalent bonding (Krajewska, 2004, Shi et al., 
2009). Furthermore, the amino groups in chitosan and other functional groups 
in its derivatives allow further modifications of the chitosan-coated surface via 
introduction of other biofunctional molecules (Kim et al., 2008, Renoud et al., 
2012).  
 
2.6.2 Surface Topography 
As mentioned in Section 2.5.2, the formation of NTs on Ti results in different 
surface chemistry and surface reactivity, and thus resulting in different 
interactions with bacterial cells. However, unlike the consistent reports on the 
improvement in osteoblast functions, the anti-adhesive and bactericidal effects 
from nanostructured Ti are not conclusive. It has been reported that NTs with 
controlled dimensions on Ti significantly inhibit the growth of S. epidermidis 
and S. aureus compared to pristine Ti. Smaller diameter (20 nm) NTs are 
better in reducing bacterial growth compared to larger diameter (80 nm) ones 
(Kummer et al., 2013). Another work showed inhibited growth of S. aureus on 
smaller diameter NTs (~23-30 nm) compared to pristine Ti, but larger 
diameter ones (~38-88 nm) did not have anti-biofilm formation effect on S. 
aureus (Lewandowska et al., 2015). On the other hand, it was also reported 
that a higher degree of adhesion of S. epidermidis, S. aureus and Pseudomonas 
aeruginosa was found on TiNT (diameter of NTs ~60-70 nm) compared to 
pristine Ti (Puckett et al., 2010). The possible reason for the discrepancies 
could be due to the different dimensions and properties of the TiNTs. Small 
changes in reaction chemistry may lead to a high degree of change in 
chemistry, morphology, crystallinity and reactivity of the TiNTs in the 
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nanoscale regime (Lewandowska et al., 2015, Minagar et al., 2012, Puckett et 
al., 2010, Regonini et al., 2013). Further investigations are still needed in 
characterizing TiNTs and understanding the molecular mechanism of the anti-
adhesive and/or bactericidal effects of TiNTs.  
 
2.7 Sterilization of Ti Implants 
It is necessary to sterilize all medical implants after fabrication and prior to 
their surgical placement to reduce the risk of infections and associated 
complications. Sterilization is defined as a process that eliminates or kills all 
forms of life, including transmissible agents (such as fungi, bacteria, viruses, 
spore forms, etc) present in a specified region (Athanasiou et al., 1996). There 
are various sterilization techniques in biomedical and clinical applications. 
Sterilization can be categorized as irradiation (non-ionizing and ionizing 
irradiation), heat treatment (steam autoclaving and dry heat), and chemical 
treatment (ethylene oxide, peracetic acid and hydrogen peroxide) (Crow, 1992, 
Favero, 2007, Mendes et al., 2007, Rutala and Weber, 1998, 2004). Table 2-2 
provides a brief summary of the effects of different sterilization techniques 
applied to Ti-based substrates. 
 
The sterilization procedure may affect the physical and chemical properties of 
the implant and hence the subsequent biological responses of cells cultured on 
it. For instance, it is clearly noticeable from Table 2-2 that sterilization by heat 
alters the wettability of the surface due to hydrocarbon contamination and 
results in compromised biological responses. Currently, studies on effects of 
sterilization procedures on Ti focus on two aspects: surface property of Ti and 
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biological response of bone cells cultured on Ti. In terms of surface property, 
materials characterization techniques were utilized to investigate the effects of 
sterilization procedures on bare Ti. Atomic force microscopy, Auger electron 
microscopy, scanning electron microscopy (SEM), differential scanning 
calorimetry and X-ray photoelectron spectroscopy (XPS) have been used to 
characterize the Ti substrates (Alexandrou et al., 2006, Degatica et al., 1993, 
Kilpadi et al., 1998, Pegueroles et al., 2008, Thierry et al., 2000). In terms of 
biological response of bone cells cultured on Ti surfaces after being subjected 
to sterilization procedures, osteoblast adhesion, proliferation, differentiation 
and gene marker expressions have been studied (Oh et al., 2011, Park et al., 
2012, Serro and Saramago, 2003, Stanford et al., 1994). The sterilization 
treatments shown in Table 2-2 were performed on bare Ti substrates. For 
surface-functionalized Ti, the bioactivity and/or structural integrity of the 
surface functional groups or surface topographies after sterilization have to be 
considered. 
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Table 2-2 Effects of sterilization procedures on bare Ti substrates. 
 
Category  Sterilization 
techniques 
Related research works 
 Substrate Effects 
Irradiation  Ultraviolet light 
(UV) irradiation 
(Non-ionizing 
irradiation) 
cpTi UV exposure of 254 nm, 300 µW/cm
2
 
for 1, 5 and 10 cycles did not adversely 
affect cell attachment and spreading 
(Vezeau et al., 1996). 
  Ti6Al4V UV exposure of 254.6 nm, 15 mW/cm
2
 
from 5 to 30 min did not alter the 
composition of the surface or property 
of oxide layer (Degatica et al., 1993). 
 Gamma 
irradiation 
(Ionizing 
irradiation) 
Ti Gamma irradiation of Ti at 25 kGy for 
overnight improved the wettability and 
did not affect osteoblast functions 
(Park et al., 2012).  
  cpTi Gamma irradiation of cpTi at 30 kGy 
resulted in more hydrophobic surface 
due to increased carbon contamination 
(Serro and Saramago, 2003). 
Heat Steam 
(Autoclaving) 
cpTi Autoclaved surface was contaminated 
with various ion species with lower 
surface energy and increased water 
contact angle (Doundoulakis, 1987) 
  cpTi Autoclaving at 132 °C, 2.1 bar for 3 
min caused surface decoloration and 
particulate contamination, resulting in 
lower cell attachment and spreading 
(Vezeau et al., 1996). 
 Dry heat Unalloyed 
Ti 
Dry heat sterilization at 205°C for 3 h 
did not affect most surface roughness 
parameters, but resulted in higher solid 
surface tension and increase in surface 
energy (Kilpadi et al., 1998). 
Chemical Ethylene oxide cpTi Exposure to ethylene oxide gas at 
130 °C for 240 min at 70 MPa did not 
significantly change the expressions of 
collagen and OC by osteoblast-like 
cells (Stanford et al., 1994). 
 Peracetic acid NiTi alloy Exposure to 0.2% peracetic acid at 
11 °C for 12 min did not affect the 
wettability, surface composition and 
oxide layer thickness (Thierry et al., 
2000). 
 Hydrogen 
peroxide 
NiTi alloy One cycle of hydrogen peroxide 
plasma sterilization (~28 min) did not 
affect the corrosion resistance of NiTi 
alloy (Thierry et al., 2000).  
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2.8 Electrical Stimulation (ES) 
Besides the modifications of surface topography and surface chemistry of Ti, 
osseointegration can also be enhanced through microenvironmental 
stimulation such as application of ES to the implant site (Gittens et al., 2011, 
Isaacson and Bloebaum, 2010). There are three methods to apply ES, direct 
current (DC), capacitive coupling (CC), and induced coupling (IC). Table 2-3 
shows some commercially available ES devices that are approved by US FDA. 
 
Table 2-3 Some commercial ES devices that have been approved by US FDA 
(Griffin and Bayat, 2011). 
 
Company Device name ES mode Usage of device 
Bioelectron SpinalPak® CC For primary lumbar fusion surgery 
for one to two levels 
 OrthoPak® CC For non-union acquired secondary 
to trauma 
Biomet OsteoGen®, 
OsteoGen®-M 
DC Implanted for non-union; or as an 
adjunct to internal/ external fixation 
and autograft 
 SpF® DC As an adjunct to posterolateral 
lumbar spine fusions 
DJO Global CMF OL1000™  IC(CMF) For non-union acquired secondary 
to trauma,  
 SpinaLogic®  IC(CMF) For primary lumbar fusion surgery 
for one or two levels 
Orthofix Spinal-Stim® IC(PEMF) For spinal fusion 
 Physio-Stim® IC(PEMF) For non-union acquired secondary 
to trauma,  
 Cervical-Stim® IC(PEMF) For cervical fusion surgery 
 
ES using DC is an invasive procedure, which requires surgical implantation of 
electrodes at the fracture site with either an internal current generator in an 
intramuscular or subcutaneous space or an external current generator. The 
implanted current generator will be removed in a second surgical procedure 
after bone healing, but the electrodes may or may not be removed. Figure 2-
4(a) shows a typical method of applying DC stimulation. As electrodes are 
Chapter 2  
41 
 
implanted, DC treatment increases the compliance of the patient with constant 
ES at the implanted site and optimized positioning of the electrodes. However, 
drawbacks associated with DC stimulation include surgical procedures for 
insertion and removal, which raises the possibility of infection, pain and 
electrode dislocation (Griffin and Bayat, 2011).  
 
Figure 2-4 Methods of application of ES (a) DC stimulation: a cathode is 
implanted at the treatment site which is attached to either an internal or an 
external power source (figure illustrates the case of an internal power source). 
(b) CC stimulation: two capacitive coupled electrodes are placed on the skin 
on either side of the treatment site. An external power source is attached to the 
electrodes. (c) IC stimulation: an electromagnetic current carrying coil is 
placed on the skin overlying the treatment site, which is attached to an external 
power source (Griffin and Bayat, 2011). 
 
DC stimulation is shown to give rise to upregulation of osteoinductive factors 
in osteoblasts. The Faradic reactions at the cathode of a DC stimulation set-up 
lower the local concentration of oxygen, increase pH, and produce hydrogen 
peroxide. The lower oxygen level with increased pH is reported to enhance 
osteoblast functions and decrease osteoclast functions (Bushinsky, 1996). The 
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generation of hydrogen peroxide could stimulate the release of VEGF which is 
an angiogenic factor crucial for bone healing (Cho et al., 2001, Gan and 
Glazer, 2006). However, the exact molecular pathways associated with DC 
stimulation have not yet been elucidated.  
 
CC and IC stimulations are non-invasive. ES using CC involves electrodes 
placed on the skin on either side of the treatment site. Figure 2-4(b) illustrates 
a typical set up for CC stimulation. Although portable and non-invasive, 
patient compliance during CC stimulation is required for better outcome. The 
high voltages or frequency of alternating current in CC stimulation may cause 
irritation (Gan and Glazer, 2006). CC stimulation is reported to activate the 
voltage-gated calcium channels in osteoblasts, and lead to increased cytosolic 
calcium concentration via transmembrane calcium translocation (Lorich et al., 
1998). The elevated concentration of cytosolic calcium in turn activates 
calmodulin, which induces increased mRNA expression of TGF-β 1 in 
osteoblasts via calcium-calmodulin pathway, which results in enhanced cell 
functions (Lorich et al., 1998, Zhuang et al., 1997). 
 
IC stimulation is delivered via a treatment coil placed directly on the skin 
overlying the treatment site as shown in Figure 2-4(c). In IC stimulation, either 
pulsed electromagnetic field (PEMF) or combined electromagnetic field (CMF) 
may be utilized (Griffin and Bayat, 2011, Isaacson and Bloebaum, 2010). 
Similar to CC stimulation, patient compliance is also needed for IC 
stimulation. IC stimulation also results in release of calcium ions, but the 
source of calcium is from intracellular stores in osteoblasts. The increased 
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concentration of cytosolic calcium activates calmodulin, which enhances the 
osteoblast functions via the calcium-calmodulin pathway, similar to that with 
CC stimulation. Although the initial signal transduction in CC and IC 
stimulation is different, a common final pathway of increased cytosolic 
calcium and activated calmodulin is achieved with these two types of ES 
(Brighton et al., 2001, Gan and Glazer, 2006). The non-localized application 
of IC stimulation may affect multiple cells and tissues besides osteoblasts at 
the treatment site. For instance, PEMF stimulation is shown to promote 
angiogenesis by increasing tubulization and proliferation of endothelial cells 
in vitro (Tepper et al., 2004). 
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CHAPTER 3 ASSESSMENT OF STABILITY OF 
SURFACE ANCHORS FOR ANTIBACTERIAL 
COATINGS AND IMMOBILIZED GROWTH 
FACTORS ON TITANIUM 
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3.1 Introduction 
As mentioned in Chapter 2, surface chemistry of Ti can be tailored to improve 
osteoblast functions. Due to the multiple advantages of covalent 
immobilization, this strategy has been adopted by many researchers. It is of 
great significance to ensure the functionalities anchored on Ti remain stable 
and bioactive after being subjected to physiological conditions, disinfections 
and sterilization procedures. Currently, there is very limited information on the 
stability of surface anchors and surface coatings immobilized on Ti. This 
Chapter thus aims to address this issue. Surface functionalization of Ti with 
CMCS and BMP-2 has been reported to inhibit bacterial colonization and 
enhance osteoblast functions (Shi et al., 2009). This surface modification 
strategy was utilized to investigate the stability of three types of anchoring 
molecules (Silane, DA and PDA) and two immobilized biomolecules (CMCS 
and BMP-2) on Ti. Herein, Silane, DA and PDA were used for immobilizing 
CMCS on Ti. The CMCS-modified surfaces were then subjected to 70% 
ethanol treatment, autoclaving and prolonged immersion in PBS. After the 
treatment procedures, the ability of the CMCS-modified substrates to inhibit 
colonization by S. epidermidis was assessed to evaluate the stability of the 
immobilized CMCS. As the DA and PDA anchors were found to possess 
higher stability compared to the silane anchor, the CMCS-DA- and CMCS-
PDA-modified Ti substrates were functionalized with BMP-2, and used to 
support osteoblast growth. Evaluation of ALP activity and calcium deposition 
from osteoblasts cultured on these substrates which have been treated with 
70% ethanol or subjected to autoclaving and prolonged immersion in PBS 
were used to assess the stability of the surface conjugated BMP-2.  
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3.2 Materials and Methods 
3.2.1 Materials 
Ti foils were purchased from Goodfellow Inc (Cambridge, UK). Dopamine 
hydrochloride, chitosan (deacetylation degree ≥75%), (3-
aminopropyl)triethoxysilane (APTES), 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC), N-hydroxysuccinimide (NHS) and 2-(N-morpholino)-
ethanesulfonic acid (MES sodium salt) were purchased from Sigma Aldrich 
(St. Louis, US). Recombinant human BMP-2 was purchased from US 
Biological Inc. (Swampscott, US). S. epidermidis (ATCC 35984) and mouse 
osteoblast cell line (MC3T3-E1) were obtained from American Type Culture 
Collection (ATCC) (Manassas, US). All other chemicals, unless specified, 
were purchased from Sigma Aldrich. 
 
3.2.2 Synthesis of CMCS 
CMCS was synthesized according to a previously reported method (Hu et al., 
2010). In short, 20 g of chitosan was added to 200 mL of isopropanol with 
agitation, and 50.4 mL of 10 M NaOH was added in six equal parts over 20 
min. The slurry was stirred for another 45 min before 24 g of 
monochloroacetic acid was added. The mixture was then heated at 60 °C for 3 
h. 17 mL of cold distilled water was added and pH of the reaction mixture was 
adjusted to 7.0 using glacial acetic acid. The mixture was filtered and rinsed 
with 70% and 99% ethanol, and the solid product (denoted as CMCS) was 
dried overnight in an oven at 60 °C under reduced pressure. 
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3.2.3 Grafting of CMCS on Ti via Silane Anchor 
Ti foils were cut into 1 cm×1 cm pieces and sonicated twice with acetone, 
isopropanol and distilled water for 20 min each time. The Ti substrates were 
etched using Kroll’s reagent (7.2% HNO3, 4% HF and 88.8% H2O acidic 
aqueous solution), sonicated with copious amount of distilled water, dried 
under reduced pressure, autoclaved and stored in a sterile environment prior to 
surface modification (denoted as Pristine-Ti). CMCS was grafted on the Ti 
surface using the technique reported in an earlier work (Nanci et al., 1998). 
The Pristine-Ti substrates were immersed in 2% APTES in toluene solution at 
70 °C for 6 h with stirring. The substrates were then sonicated in toluene for 
15 min, washed with toluene, isopropanol and distilled water for 15 min each 
(denoted as Silane-Ti). The Silane-Ti substrates were treated with CMCS (1 
mg/mL), NHS (50 mM) and EDC (100 mM) in 0.1 M MES buffer (pH=6.0) 
for 4 h followed by washing with copious amount of distilled water (denoted 
as CMCS-Silane-Ti). The surface modification steps are summarized in Figure 
3-1(a). 
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Figure 3-1 Schematic diagram illustrating the grafting of CMCS on Ti 
surfaces via (a) Silane, (b) DA and (c) PDA anchors. 
 
3.2.4 Grafting of CMCS on Ti via DA Anchor and Subsequent BMP-2 
Immobilization 
The Pristine-Ti substrates were prepared as described above, and then 
immersed in aqueous dopamine solution (1 mg/mL) overnight, protected from 
light at room temperature (denoted as DA-Ti). The amount of dopamine 
immobilized on DA-Ti was determined using 2,4,6-trinitrobenzene sulfonic 
acid (TNBSA) assay (Hermanson, 2013). Briefly, seven DA-Ti substrates 
were immersed in 250 µL of TNBSA (0.01% w/v) in 0.1 M sodium 
bicarbonate buffer (pH=7.4) and 500 µL of distilled water, and incubated at 
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37 °C for 2 h. The reaction was stopped by addition of 250 µL of 10% sodium 
dodecyl sulfate and 125 µL of 1 M HCl. The amine groups present on the DA-
Ti substrates reacted with TNBSA and formed a highly chromogenic 
derivative (orange-yellow colored solution). The amount of amine groups 
present on DA-Ti substrates, which is proportional to the amount of the 
surface-immobilized dopamine, was quantified by measuring the absorbance 
of the solution mixture at 335 nm using a microplate reader. A calibration 
curve was generated using dopamine solution of known concentrations. 
CMCS was grafted onto the DA-Ti substrates using NHS/EDC as described 
above (denoted as CMCS-DA-Ti) (Figure 3-1(b)). To conjugate BMP-2 on the 
CMCS-DA-Ti substrates, the substrates were first immersed in NHS (313 mM) 
and EDC (125 mM) in 0.1 M MES buffered solution (pH=6.0) for 1 h, rinsed 
with MES and then incubated in 50 ng of BMP-2 in 0.05 mL of MES buffered 
solution overnight at room temperature. The resultant substrates were rinsed 
with PBS and left to air-dry in a sterile environment (denoted as BMP-CMCS-
DA-Ti). The amount of BMP-2 remaining in the buffered solution was 
measured using an enzyme-linked immunosorbent assay kit (ELISA, R&D 
System, Minneapolis, US) according to the manufacturer’s instructions and 
the surface density of immobilized BMP-2 was calculated from the difference 
between the initial and the remaining BMP-2 in the MES buffer. 
 
3.2.5 Grafting of CMCS on Ti via PDA Anchor and Subsequent BMP-2 
Immobilization 
The Pristine-Ti substrates were prepared as described above, and then 
immersed in 10 mM Tris buffered (pH=8.5) solution containing 2 mg/mL 
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dopamine at room temperature for 4 h with continuous shaking. The substrates 
were rinsed with copious amount of distilled water to remove the loosely 
adsorbed polydopamine (denoted as PDA-Ti). CMCS and BMP-2 were 
sequentially grafted onto the PDA-Ti substrates in a similar manner as on the 
DA-Ti substrate (denoted as CMCS-PDA-Ti (Figure 3-1(c)) and BMP-CMCS-
PDA-Ti). 
 
3.2.6 Stability Tests 
The surface-modified Ti substrates were subjected to three types of stability 
tests: immersion in 70% ethanol solution for 1 h (samples denoted with ET 
suffix), or autoclaving (using a Hirayama HVE50 autoclave, Japan) at 121 °C 
for 20 min (samples denoted with AC suffix), or immersion in sterile 1 × PBS 
solution (pH=7.4) for 14 days (samples denoted with PBS suffix). After these 
treatment procedures, the CMCS-modified substrates were rinsed with sterile 
distilled water, while the BMP-modified substrates were rinsed with sterile 
PBS. Bacterial or cell assays were carried out with the substrates as described 
below. 
 
3.2.7 Characterization 
The surface chemical compositions of the substrates were analyzed by XPS on 
an AXIS Ultra DLD spectrometer (Kratos Analytical Ltd, Wharfside, UK) 
with a monochromatic Al Kα X-ray source (1486.6 eV photons). All binding 
energies (BEs) were referenced to the C 1s hydrocarbon peak at 284.6 eV. 
Contact angles of the substrates were measured at 20 °C and 60% relative 
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humidity by sessile drop method, using a 3 μL water droplet in a telescopic 
goniometer (Rame-Hart, Succasunna, US). 
 
3.2.8 Bacterial Adhesion 
S. epidermidis was cultured in tryptic soy broth (TSB) overnight at 37 °C. The 
bacterial solution was centrifuged at 2700 rpm for 10 min. The supernatant 
was removed and the bacterial pellet was resuspended in PBS at a 
concentration of 1×10
7
 cells/mL. The substrates were placed in a 24-well 
microplate, and 1 mL of the bacterial suspension was added to each well and 
incubated for 4 h at 37 °C. After incubation, the substrates were washed three 
times with PBS to rinse off loosely adhered bacterial cells. The viability of the 
adhered bacteria on substrates was investigated using fluorescence microscopy. 
The bacterial cells on each substrate were stained by a combination dye 
(LIVE/DEAD Baclight bacteria viability kits, Molecular Probes, L13152) as 
per the manufacturer’s instructions, and observed under a Leica DMLM 
microscope with a 100W Hg lamp. Viable bacterial cells would be stained 
green while membrane-compromised cells would be stained red. 
Quantification of the viable adhered bacterial cells was carried out using the 
spread plate method. After rinsing three times with PBS, the substrates were 
taken out of the microplate and transferred to individual centrifuge tubes. 2 
mL of PBS was added into each tube and the substrates were sonicated for 7 
min and vortexed for another 30 s to detach the adhered bacterial cells. The 
resulting bacterial solution was serially diluted, spread on the prepared agar 
plate, and cultured overnight at 37 °C for viable bacterial cells quantification. 
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The number of the bacterial cells on each substrate was expressed relative to 
the surface area of the substrate (number of bacterial cells/cm
2
). 
 
3.2.9 Osteoblast Culture and Cell Attachment Assay 
In this study, mouse osteoblast cells MC3T3-E1 Subclone 14 from ATCC 
(referred to as osteoblasts in the later context) was used. Osteoblasts were 
cultured in α-minimum essential medium (Gibco, Carlsbad, US) supplemented 
with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL 
streptomycin in 5% CO2 and 95% air at 37 °C. The growth medium was 
changed every 2 to 3 days. The cells used in this study were in passage 12-15. 
The substrates were placed into a 24-well microplate. To avoid cell adhesion 
on the microplate well during cell seeding, 0.05 mL of cell suspension was 
first carefully added to cover each substrate. After 6 h, another 0.95 mL of 
medium was added to each well. 
 
3.2.10 ALP Activity and Calcium Deposition Assay 
For ALP activity assay, the osteoblasts were seeded onto the substrates at 
~30,000 cells/cm
2
 and cultured in the growth medium supplemented with 50 
μg/mL ascorbic acid and 10 mM sodium glycerophosphate. At Day 7 and Day 
14 of culture, the substrates were washed with PBS and the attached cells on 
the substrates were lysed in water by four quick freeze-thaw cycles of 45 min 
at -20 °C in a freezer and 45 min at 20 °C. The cell lysate was then collected 
for the analysis of ALP activity and total protein level. For the ALP activity 
analysis, 100 μL of p-nitrophenyl phosphate solution (Sigma) was added to 
100 μL of cell lysate, and incubated at 37 °C for 30 min. The reaction was 
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stopped by adding 50 μL of 1 M NaOH and the optical absorbance of the 
resultant solution was measured at 405 nm with a microplate reader (calibrated 
with known concentrations of p-nitrophenol) to quantify the amount of p-
nitrophenol produced. The protein concentration was determined using micro 
BCA protein assay kit (Pierce Chemical, Waltham, US) with bovine serum 
albumin as a standard. The ALP activity was expressed as the rate of release 
of p-nitrophenol from p-nitrophenyl phosphate normalized with respect to the 
total protein content in the same cell lysate (μmol of p-nitrophenol formed per 
minute per milligram of total proteins). The amount of calcium deposited on 
the substrates by the osteoblasts after 21 days was also measured. Briefly, the 
substrates with attached cells were rinsed with distilled water and immersed in 
concentrated nitric acid (65%) overnight with shaking to dissolve the calcium 
minerals deposited by the cells. The calcium content was determined by 
inductively coupled plasma-mass spectroscopy (ICP-MS, Agilent 
Technologies, Santa Clara, US). 
 
3.2.11 Statistical Analysis 
At least three samples per time point per experimental condition were tested. 
The results were reported as mean ± SD and were assessed statistically using 
one-way analysis of variance (ANOVA) post-hoc Tukey test. Statistical 
significance was accepted at P < 0.05. 
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3.3 Results and Discussion 
3.3.1 Surface Characterization 
The grafting of CMCS on Silane-Ti and DA-Ti was carried out via reaction 
between the -COOH groups of CMCS and the -NH2 groups of the Silane or 
DA anchor. The surface-immobilized dopamine on DA-Ti available for 
conjugation was determined to be 4.24 ± 0.15 nmol/cm
2
. With the PDA 
anchor, the reaction occurred between the amino groups of CMCS and the 
catechol or quinone groups in PDA by Michael addition and Schiff-base 
reaction (Lee et al., 2007). The CMCS-functionalized substrates were 
analyzed by XPS and contact angle measurements. The XPS wide scan spectra 
for DA-based, Silane-based and PDA-based surface-modified Ti are shown in 
Figure 3-2, Figure 3-3 and Figure 3-4, respectively. In Figure 3-2, the 
predominant peaks for Pristine-Ti are C 1s (284.6 eV), Ti 2p (~460 eV) and O 
1s (~530 eV). The carbon present on Pristine-Ti results from unavoidable 
hydrocarbon contamination and is used as an internal reference. The presence 
of N is likely due to surface contamination and impurity of the Ti substrates, 
while O is mainly due to the oxide layer on the Pristine-Ti surface. With 
sequential treatment of the Pristine-Ti with DA, CMCS and BMP-2, there is a 
progressive increase in the intensity of the N 1s and C 1s peaks, indicative of 
the increasing surface density of these N- and C-containing molecules. After 
BMP-2 was grafted on the CMCS-DA-Ti, the Ti 2p peak is hardly discernible, 
indicating that the thickness of the BMP-CMCS-DA coating is approaching 
the XPS sampling depth. The corresponding results obtained with Silane and 
PDA as the surface anchor (Figure 3-3 and Figure 3-4) show a similar trend of 
increasing intensity of the N 1s and C 1s peaks and decreasing intensity of the 
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Ti peaks with progressive modifications of the Ti substrates with anchoring 
molecule and CMCS. By comparing the intensity of the Ti peaks in Figure 3-2 
and Figure 3-3, it can be concluded that the thickness of the immobilized 
CMCS layer on DA-Ti is greater than that on Saline-Ti. PDA is known to 
form a relatively thick and complex polymeric layer on surfaces (Lee et al., 
2007), and it is evident from the XPS results (comparing Figure 3-4 with 
Figure 3-2 and Figure 3-3) that the thickness of the PDA layer itself, without 
the overlying CMCS layer, is already greater than the XPS sampling depth. 
 
Figure 3-2 XPS wide scan spectra of (a) Pristine-Ti, (b) DA-Ti, (c) CMCS-
DA-Ti and (d) BMP-CMCS-DA-Ti. 
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Figure 3-3 XPS wide scan spectra of (a) Pristine-Ti, (b) Silane-Ti and (c) 
CMCS-Silane-Ti. 
 
 
Figure 3-4 XPS wide scan spectra of (a) Pristine-Ti, (b) PDA-Ti, (c) CMCS-
PDA-Ti and (d) BMP-CMCS-PDA-Ti. 
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The water contact angle of Pristine-Ti was measured to be 68°, and the 
immobilization of DA resulted in a slight increase in surface hydrophilicity 
(contact angle decreased to 54°) whereas the Silane and PDA anchors did not 
significantly alter the surface hydrophilicity (contact angles of 64° and 63°, 
respectively) After the immobilization of CMCS on Ti with the Silane, DA 
and PDA anchors, all three surfaces became very hydrophilic with contact 
angle of 27°, <10° and <10°, respectively. The water contact angle of different 
CMCS-modified substrates subjected to various treatment procedures are 
summarized in Table 3-1.  
 
Table 3-1 Water contact angle of CMCS-functionalized substrates before and 
after 70% ethanol treatment, autoclaving and prolonged immersion in PBS. 
 
Substrate Before 
Treatment 
Ethanol 
Treatment
1
 
Autoclaved
2
 Immersion in 
PBS
3
 
CMCS-Silane-Ti 27° ± 3° 24° ± 2° 35° ± 3° 32° ± 4° 
CMCS-DA-Ti <10°
*
 <10°
*
 24° ± 3° <10°
*
 
CMCS-PDA-Ti <10°
*
 <10°
*
 10°
 
± 3° <10°
*
 
1
Samples with ET suffix 
2
Samples with AC suffix 
3
Samples with PBS suffix 
*
Due to the highly hydrophilic surface, it was very difficult to get an accurate 
measurement of the contact angle. 
 
For CMCS-Silane-Ti, ethanol treatment did not alter the surface hydrophilicity, 
whereas autoclaving and prolonged immersion of the substrates in PBS 
resulted in an increase of the water contact angle of the substrates. For CMCS-
DA-Ti and CMCS-PDA-Ti, both ethanol treatment and prolonged immersion 
of the substrates in PBS did not affect the surface hydrophilicity. Autoclaving 
resulted in a significant increase in the water contact angle for CMCS-DA-Ti 
substrates, and a smaller but significant change in the hydrophilicity of the 
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CMCS-PDA-Ti substrates. Since the hydrophilicity of CMCS-based substrates 
is mainly due to the hydrophilic immobilized CMCS layer, the change in the 
surface water contact angles implies that there may be some loss of the 
immobilized CMCS. This will be verified with the bacterial adhesion assay 
results below.  
 
3.3.2 Bacterial Adhesion Assay 
Figure 3-5, Figure 3-6 and Figure 3-7 show the fluorescence microscopy 
images of adherent viable bacterial cells on DA-, Silane- and PDA-based 
substrates after incubation in S. epidermidis suspension of 1×10
7
 cells/mL for 
4 h, respectively. It can be seen from Figure 3-5, that there are comparable 
numbers of adherent bacterial cells on the Pristine-Ti (Figure 3-5(a)) and DA-
Ti (Figure 3-5(b)). Similar results were found for Silane-Ti (Figure 3-6(b)) and 
PDA-Ti (Figure 3-7(b)). This indicates that the anchoring molecule (DA, 
Silane and PDA) does not inhibit bacterial colonization. On the other hand, 
Figure 3-5(c) shows that there is a drastic decrease in viable adherent bacterial 
cells on CMCS-DA-Ti as compared to DA-Ti (Figure 3-5(b)). The ability of 
CMCS to inhibit bacterial colonization may be due to its anti-adhesive effect 
as well as its bactericidal property. The bactericidal property of CMCS can be 
seen from the fluorescence microscopy images of the bacterial cells in contact 
with CMCS. An increase in the number of membrane-compromised bacterial 
cells (stained red) on CMCS-DA-Ti (Figure 3-8(c)) as compared to Pristine-Ti 
(Figure 3-8(a)) and DA-Ti (Figure 3-8(b)) substrates can be observed. The 
ability of CMCS to inhibit bacterial colonization is consistent with the results 
reported earlier (Hu et al., 2010, Shi et al., 2009). Since the Silane, DA and 
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PDA anchors do not have such anti-adhesive or bactericidal effect, the 
efficacy of the CMCS-functionalized substrates in inhibiting bacterial 
colonization can be used as an indirect tool to evaluate whether there is a loss 
of the CMCS coating after the substrates were subjected to 70% ethanol 
treatment, autoclaving and prolonged immersion in PBS. After 70% ethanol 
treatment of CMCS-DA-Ti, the number of adherent bacterial cells on the 
substrate (CMCS-DA-Ti-ET, Figure 3-5(d)) appeared comparable to that 
before treatment (Figure 3-5(c)). However, after the CMCS-DA-Ti substrate 
was subjected to autoclaving (CMCS-DA-Ti-AC, Figure 3-5(e)) and extended 
immersion in PBS (CMCS-DA-Ti-PBS, Figure 3-5(f)), a slight increase in the 
number of adherent bacterial cells was observed, although this number is still 
much lower than that on the Pristine-Ti. The results obtained with CMCS-
Silane-Ti and CMCS-PDA-Ti substrates (Figure 3-6 and Figure 3-7) also 
show that these substrates after ethanol treatment, autoclaving and prolonged 
immersion in PBS still possess significant ability to inhibit bacterial 
colonization, although the number of the adherent bacterial cells on CMCS-
Silane-Ti-AC (Figure 3-6(e)) and CMCS-Silane-Ti-PBS (Figure 3-6(f)) 
appears to be more than that on CMCS-Silane-Ti. 
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Figure 3-5 Fluorescence microscopy images of (a) Pristine-Ti, (b) DA-Ti, (c) 
CMCS-DA-Ti, (d) CMCS-DA-Ti-ET, (e) CMCS-DA-Ti-AC and (f) CMCS-
DA-Ti-PBS surfaces after exposure to a PBS suspension of S. epidermidis of 
1×10
7
 cells/mL for 4 h. (a)-(f) were viewed under a green filter. Scale bar = 
50µm. 
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Figure 3-6 Fluorescence microscopy images of (a) Pristine-Ti, (b) Silane-Ti, 
(c) CMCS-Silane-Ti, (d) CMCS-Silane-Ti-ET, (e) CMCS-Silane-Ti-AC and (f) 
CMCS-Silane-Ti-PBS surfaces after exposure to a PBS suspension of S. 
epidermidis of 1×10
7
 cells/mL for 4 h. (a)-(f) were viewed under a green filter. 
Scale bar = 50µm. 
 
Chapter 3  
62 
 
 
Figure 3-7 Fluorescence microscopy images of (a) Pristine-Ti, (b) PDA-Ti, (c) 
CMCS-PDA-Ti, (d) CMCS-PDA-Ti-ET, (e) CMCS-PDA-Ti-AC and (f) 
CMCS-PDA-Ti-PBS surfaces after exposure to a PBS suspension of S. 
epidermidis of 1×10
7
 cells/mL for 4 h. (a)-(f) were viewed under a green filter 
Scale bar = 50µm. 
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Figure 3-8 Fluorescence microscopy images of (a) Pristine-Ti, (b) DA-Ti and 
(c) CMCS-DA-Ti surfaces after exposure to a PBS suspension of S. 
epidermidis of 1×10
7
 cells/mL for 4 h. (a)-(c) were viewed under a red filter 
Scale bar = 50µm. 
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Since fluorescence microscopy images only provide qualitative information on 
bacterial adhesion on the substrates, quantification of adherent viable bacterial 
cells was carried out using the spread plate method, and the results are shown 
in Figure 3-9. Figure 3-9(a) confirms that the Silane, DA and PDA anchors are 
not able to inhibit bacterial colonization on Ti. Regardless of the type of 
anchor, the CMCS coating results in ~75 to 85% reduction in adherent 
bacteria compared with Pristine-Ti. The number of adherent bacterial cells on 
CMCS-Silane-Ti-ET is not significantly different from that on CMCS-Silane-
Ti (Figure 3-9(b)), indicating that the CMCS coating was not affected by the 
treatment with 70% ethanol. However, there is a significant increase in the 
number of adherent bacterial cells on CMCS-Silane-Ti-AC and CMCS-Silane-
Ti-PBS. Nevertheless, the number of adherent viable bacterial cells on these 
substrates is reduced by ~63% and 68% as compared to Pristine-Ti. Since it 
has been reported that autoclaving does not change the physical-chemical 
properties of CMCS powder (Daroz et al., 2008), it is likely that bond 
cleavage involving the silane anchor has occurred. This is consistent with the 
increase in the water contact angle of the CMCS-Silane-Ti (Table 3-1) after 
autoclaving and prolonged immersion in PBS. The stability of Silane-modified 
substrates upon heat or long term immersion in aqueous buffered solution has 
been reported to depend on a number of factors such as substrate, method of 
Silane synthesis and pH of the testing solution (Etienne and Walcarius, 2003, 
Shlyakhtenko et al., 2003, Ulman, 1996, Yakovleva et al., 2002). The 
corresponding results for the CMCS-DA-Ti and the CMCS-PDA-Ti substrates 
are given in Figure 3-9(c) and Figure 3-9(d), respectively. Although Figure 3-
9(c) shows that there is an increase in the number of adherent bacterial cells on 
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CMCS-DA-Ti-AC as compared to that on CMCS-DA-Ti, this increase in 
adherent bacterial cells was not significant (P=0.133). As mentioned above, 
the increase in the water contact angle of CMCS-DA-Ti after autoclaving 
(Table 3-1) may indicate some loss of CMCS, but this loss is probably not 
extensive enough to adversely affect the surface’s ability to resist bacterial 
colonization. Thus, it can be concluded that both the DA anchor and the 
immobilized CMCS show a high degree of stability after 70% ethanol 
treatment, autoclaving and prolonged immersion in PBS. In the case of the 
CMCS-PDA-Ti substrate (Figure 3-9(d)), 70% ethanol and PBS treatment of 
the substrate also did not affect the efficacy of CMCS in inhibiting bacterial 
colonization. A small but significant increase in adherent bacterial cell count 
was observed with the autoclaved substrate, consistent with the fluorescence 
microscopy results (Figure 3-7(e)). Nevertheless, the CMCS-PDA-Ti after 
autoclaving still retains a substantial level of anti-adhesive and bactericidal 
efficacy (~74% reduction in adherent bacterial cells compared to Pristine-Ti) 
close to those of as-prepared CMCS-DA-Ti and CMCS-Silane-Ti substrates 
(~74% and ~81%). Thus, similar to CMCS-DA-Ti, it is possible that some 
loss of CMCS occurred after autoclaving the CMCS-PDA-Ti substrate, 
probably as a result of bond cleavage between CMCS and PDA and/or within 
the PDA layer itself. 
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Figure 3-9 Number of adherent S. epidermidis per cm
2
 on the different 
substrates after exposure to bacterial suspension in PBS (1×10
7
 cells/mL) for 4 
h (* denotes significant differences (P<0.05) compared with Pristine-Ti in (a), 
# denotes significant differences (P<0.05) compared with CMCS-Silane-Ti or 
CMCS-PDA-Ti in (b) and (d), respectively). 
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3.3.3 Assessment of Osteoblast Functions on BMP-2-Functionalized 
Substrates 
Based on the above results, it is clear that CMCS-DA-Ti and CMCS-PDA-Ti 
are more stable than CMCS-Silane-Ti. Thus, the DA- and PDA-based 
substrates were selected for the conjugation of BMP-2 to the CMCS layer. The 
amount of BMP-2 immobilized on the CMCS-DA-Ti and CMCS-PDA-Ti 
surfaces was determined to be 46.4 ± 1.3 ng/cm
2
 and 46.9 ± 0.3 ng/cm
2
, 
respectively, when a BMP-2 loading solution of 50 ng/cm
2
 was used. The 
biological response of osteoblasts cultured on these substrates before and after 
the stability tests were determined, and the results are discussed below. 
 
ALP activity is widely used as a marker for the early differentiation of 
osteoblast-like cells, and surface-immobilized BMP-2 has been reported to 
enhance the ALP activity of osteoblasts (Shi et al., 2009, Vo et al., 2012). 
Figure 3-10 shows the ALP activity of osteoblasts cultured on the different 
substrates over 14 days. From Figure 3-10(a), it can be seen that the ALP 
activity of osteoblasts cultured on CMCS-DA-Ti is comparable to that on 
Pristine-Ti, whereas the ALP activity of osteoblasts cultured on BMP-CMCS-
DA-Ti is almost doubled that on Pristine-Ti after 14 days. Thus, the evaluation 
of the ALP activity of osteoblasts cultured on the BMP-modified Ti substrates 
which have been subjected to the sterilization procedures and prolonged 
immersion in PBS would provide an indication of the stability of the 
immobilized BMP-2. Figure 3-10(a) shows that the BMP-CMCS-DA-Ti 
substrates after these treatment procedures are as effective as the as-prepared 
substrate (i.e. before being subjected to the stability tests) in supporting 
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osteoblast growth and functions. Similar results are observed in Figure 3-10(b) 
for the PDA-based substrates. Therefore, the BMP-CMCS-DA-Ti and BMP-
CMCS-PDA-Ti substrates retain their bioactivity upon 70% ethanol treatment, 
autoclaving and prolonged immersion in PBS. 
 
Figure 3-10 ALP activity of osteoblasts cultured on Pristine-Ti and BMP-2-
functionalized (a) DA- and (b) PDA-based Ti substrates over 14 days (* 
denotes significant differences (P<0.05) compared with Pristine-Ti at 
respective time point). 
 
Calcium deposition is a phenotypic expression by osteoblast cells in late stage 
differentiation (van den Beucken et al., 2006). The amount of calcium 
deposited by the osteoblasts after 21 days of culture on the DA- and PDA-
based substrates is shown in Figure 3-11. On both types of substrates, the 
surface-immobilized BMP-2 enhances calcium deposition by the osteoblasts, 
and this enhancement is also apparent on the substrates which have been 
treated with ethanol, autoclaving and prolonged immersion in PBS, consistent 
with the results in Figure 3-10. The results shown in Figure 3-10 and Figure 3-
11 are interesting since many proteins lose their bioactivity under harsh 
sterilization conditions such as autoclaving and gamma irradiation (Harding, 
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2010, Kempner, 2001). BMP-2 was reported to be a fairly heat-tolerant protein, 
and crude human BMP-2 extracted from human bones preserves its 
osteoinductive bioactivity after being heated at 60 °C for 10 hours (Izawa et 
al., 2001). However, BMP-2 in its free form loses its bioactivity under harsh 
autoclaving conditions (121 °C, 15 min) (Yano et al., 2009). In the present 
study, immobilization of the BMP-2 on the CMCS layer was achieved via 
covalent bonding between the -COOH groups of CMCS and -NH2 groups of 
BMP-2. This may have resulted in a more heat-stable orientation for the 
immobilized BMP-2 than the free BMP-2. Other in vitro studies have shown 
that the bioactivity of BMP-2 adsorbed on Ti was enhanced upon heating at 
100 °C for 30 min, due to the generation of a largely insoluble bioactive layer 
of protein (Wiemann et al., 2002, Winkler et al., 2006). It has been reported 
BMP-2 protein has multiple binding sites which enable binding with cellular 
membrane receptors and not all peptide segments in the BMP-2 protein 
participate in the BMP-2 transcription and signaling pathway (Miyazono et al., 
2010, Mueller and Nickel, 2012, Nickel et al., 2009). Thus, it is possible that 
even if some parts of the immobilized BMP-2 were rendered inactive upon 
heating, some other active binding sites may not be affected. It is known that 
70% ethanol denatures the free proteins in solution by weakening the tertiary 
hydrophobic interactions inside the protein, and at the same time stabilizes its 
secondary structure (Buck, 1998, Hirota et al., 1998, Uversky et al., 1997). 
The covalent conjugation of BMP-2 with the CMCS coating may restrain the 
protein from undergoing conformation changes upon treatment with 70% 
ethanol or prolonged immersion in PBS, hence preserving the bioactivity of 
the BMP-2.  
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Figure 3-11 Calcium mineral deposition of osteoblasts cultured on Pristine-Ti 
and BMP-2-functionalized (a) DA-based and (b) PDA-based Ti substrates 
over 21 days (* denotes significant differences (P<0.05) compared with 
Pristine-Ti). 
 
Even though the BMP-CMCS-DA-Ti and BMP-CMCS-PDA-Ti substrates 
retain their bioactivity after the sterilization procedures or prolonged 
immersion in PBS, there is a possibility that there may be some denaturation 
or loss of the growth factor but the extent of loss/denaturation is not sufficient 
to adversely affect the bioactivity of the BMP-2-functionalized substrates 
(Figure 3-10 and Figure 3-11). Since the enhancement of the osteoblast 
functions induced by free and adsorbed BMP-2 has been reported to be dose-
dependent (Lecanda et al., 1997, Yano et al., 2009), we prepared substrates 
with different BMP-2 surface density to establish how this would affect 
osteoblast functions. The BMP-2 surface density of the BMP-CMCS-DA-Ti 
substrate is about 46 ng/cm
2
 and this resulted in 106% increase in ALP 
activity of osteoblasts over those on the Pristine-Ti surface on Day 14 (Figure 
3-10(a)). When the immobilized BMP-2 surface density is decreased to 36 
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ng/cm
2
, the results were similar to that obtained with 46 ng/cm
2
. With a 
further decrease in BMP-2 surface density to 26 ng/cm
2
, the increase in ALP 
activity over that of the Pristine-Ti surface decreased to 31%. A BMP-2 
surface density of less than 14 ng/cm
2
 is no longer effective in enhancing the 
ALP activity of the osteoblasts. Thus, we can conclude from these results and 
Figure 3-10(a) that at least 78% of the immobilized BMP-2 remained active on 
the BMP-CMCS-DA-Ti substrate after 70% ethanol treatment, autoclaving or 
prolonged immersion in PBS. Similar results were obtained with the BMP-
CMCS-PDA-Ti substrates. 
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3.4 Conclusion 
In this Chapter, the stability of CMCS and BMP-2 immobilized on Ti surfaces 
after treatment with 70% ethanol or subjected to autoclaving and prolonged 
immersion in PBS was evaluated. CMCS’s ability to inhibit bacterial 
colonization and BMP-2’s bioactivity were used to assess the retention of 
these functionalities on the Ti surface. Of the three different types of anchors 
used for immobilization of the CMCS layer, the DA and PDA anchors were 
found to be more stable than the silane anchor. On the DA- and PDA-based 
substrates, the CMCS and BMP-2 retained a high level of its respective 
bioactivity after the substrates were subjected to 70% ethanol treatment, 
autoclaving, and prolonged immersion in PBS. The stability of the 
immobilized BMP-2 is attributed to the covalent bonds formed with the 
CMCS layer which resulted in a more stable protein conformation. Our study 
shows that the use of DA and PDA anchors for attaching bioactive 
functionalities such as CMCS and BMP-2 on biomaterials has good potential 
for future clinical applications. Therefore, other surface modification strategies 
based on these stable surface anchors and biomolecules were developed and 
these are discussed in the following chapters.  
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CHAPTER 4 IMMOBILIZATION OF 
ALENDRONATE ON TITANIUM VIA ITS 
DIFFERENT FUNCTIONAL GROUPS AND THE 
SUBSEQUENT EFFECTS ON CELL FUNCTIONS  
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4.1 Introduction 
As highlighted in Chapter 2, BPs promote bone mineralization and inhibit 
bone resorption. Thus, this family of drugs was chosen as the therapeutic 
molecules for surface modification of Ti in this Chapter. Current strategies for 
delivery of BPs include systemic delivery (oral administration or intravenous 
injection) and local delivery (adsorption or covalent immobilization of BPs on 
implants). A disadvantage associated with systemic delivery of BPs is its 
adverse side effects. Osteonecrosis of the jaw, which is caused by over-
suppression of bone metabolism, is closely associated with the intravenous 
and oral administration of BPs (Patel et al., 2011, Pazianas and Abrahamsen, 
2011). Local delivery of BPs via adsorption or covalent binding on implants 
requires a comparatively smaller dose of BPs (Cattalini et al., 2012), and the 
specificity for local biological responses minimizes the probability of adverse 
side effects arising from systemic administration of BPs. In vivo studies have 
shown that local delivery of BPs by adsorption on Ti or stainless steel 
implants results in better implant fixation than systemic delivery of BPs in rat 
models (Abtahi et al., 2013, Linderback et al., 2010).  
 
Although the adsorption of BPs on the implant is a simple procedure, it suffers 
from unavoidable release of BPs over long term. On the other hand, formation 
of chemical bonds between BPs and the implant via covalent immobilization 
enables specific physiological response by exposing appropriate functional 
groups of BPs at the tissue-implant interface (Nanci et al., 1998). Thus, the 
covalent immobilization method was adopted for surface modification of Ti 
with BP in this Chapter.  
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Alendronate, a FDA approved drug from the BPs family, was used to modify 
the surface of Ti in this Chapter. Alendronate has phosphate and amine 
functional groups which can be used for conjugating with the surface of the 
substrate. For instance, alendronate has been conjugated via its amine group 
by carbodiimide reaction to fibrinogen-functionalized Ti screws to improve 
mechanical fixation in rat tibia (Wermelin et al., 2008). The immobilization of 
alendronate on silanized poly(ε-caprolactone) surface at different 
concentration gradients via glutaraldehyde linker promotes the differentiation 
of rat bone marrow stem cells (Zhu et al., 2013). The strong affinity between 
the phosphate groups in alendronate and hydroxyapatite also enables 
alendronate to be immobilized on hydroxyapatite-modified Ti surface, 
hydroxyapatite ceramics or calcium phosphate bone cements (Bosco et al., 
2015, Kim et al., 2013, Panzavolta et al., 2010, Schuessele et al., 2009). These 
alendronate-modified substrates inhibit osteoclast functions (Bosco et al., 
2015) and enhance osteoblast and stem cell functions (Kim et al., 2013, 
Panzavolta et al., 2010, Schuessele et al., 2009). However, the functionality 
within the surface-immobilized alendronate that is responsible for modulating 
cell functions has not been identified and the corresponding molecular 
mechanism has not been elucidated.  
 
It is not known whether alendronate immobilized on surfaces via its different 
functional groups would achieve the desired functions on osteoblasts 
differently. In this Chapter, alendronate was immobilized on Ti via two 
different methods, and the response of osteoblasts on the alendronate-
functionalized surfaces was investigated. In Method 1, the phosphate groups 
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of alendronate were conjugated to surface hydroxyl groups of Ti, leaving the 
amine groups of the alendronate free to interact with the cells and culture 
medium. In Method 2, the amine groups were used instead for conjugating the 
alendronate to silane-modified Ti surface via a glutaraldehyde linker and the 
phosphate groups of the alendronate were thus free to interact with the cells 
and culture medium. The osteogenic differentiation of hMSCs on alendronate-
modified substrates was also studied since such cells have high proliferation 
capacity to self-replicate and ability to differentiate into different cell lineages 
such as osteoblasts. These distinctive advantages thus make them a good 
candidate in bone tissue engineering applications, as described in Chapter 2. 
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4.2 Materials and Methods 
4.2.1 Materials 
Glutaraldehyde was purchased from Sigma Aldrich. Alendronate sodium salt 
was purchased from Merck (Darmstadt, Germany). Poietics
TM
 human 
mesenchymal stem cells (hMSCs) were purchased from Lonza (Walkersville, 
US). The primers for human osterix (OSX), runt-related transcription factor 2 
(RUNX2), osteopontin (OPN), osteocalcin (OC) and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) were purchased from Qiagen (Hilden, 
Germany). All other chemicals were similar to those described in Section 3.2.1. 
 
4.2.2 Grafting of Alendronate on Plasma-Treated Ti (Method 1) 
Ti foils were cut into 1 cm × 1 cm coupons. The cleaning of Ti substrates was 
carried out as described in Section 3.2.3, and the cleaned Ti substrates were 
denoted as Pristine-Ti. The Pristine-Ti substrates were treated in a barrel 
plasma etcher (Anatech, Union City, US) using oxygen at 30 W for 1, 5 or 10 
min (denoted as Pls-Ti(t), where t=1, 5 or 10 depending on the duration of the 
plasma treatment). In each case, only one surface of Pristine-Ti was plasma-
treated. The surface of Pristine-Ti which was not to be plasma-treated was 
covered with adhesive tape prior to the plasma treatment. After plasma 
treatment, the substrates were immediately immersed in 0.5 mL of methanol-
water (60:40) solution containing alendronate of different concentrations (0.5, 
1 or 2.5 mg/mL of alendronate). The reaction medium was kept overnight 
(~12 h) at room temperature to facilitate conjugation of alendronate to the 
surface. Immobilization of alkyl phosphonates or bisphosphonates on metal 
surfaces has been carried out in anhydrous organic solvent such as 
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tetrahydrofuran or ethanol (Kaufmann et al., 2011, Kaufmann et al., 2010, 
Lecollinet et al., 2009, Mani et al., 2008), or in methanol-water solution 
(Guerrero et al., 2001, Lafond et al., 2003), or in pure aqueous medium under 
stringent reaction condition (Guerrero et al., 2001, Pop-Georgievski et al., 
2015). Methanol-water mixture was chosen as the solvent for alendronate 
because of its low solubility in organic solvents and stringent reaction 
conditions are required in pure aqueous medium. The substrates after 
treatment with the alendronate solution were then rinsed with distilled water 
and annealed in an oven at 100 °C for 2 h. In this work, different experimental 
conditions (i.e. duration of oxygen plasma treatment and concentration of 
alendronate solution during the immobilization process) for surface 
functionalization of Pristine-Ti were used. The as-prepared substrates were 
denoted as ALN-P-Ti-x(t), where x=0.5, 1 or 2.5 depending on the 
concentration of alendronate solution during the immobilization process and 
t=1, 5 or 10 depending on the duration of the plasma treatment. The surface 
modification steps are summarized in Figure 4-1(a) (Guerrero et al., 2001, 
Pop-Georgievski et al., 2015). 
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Figure 4-1 Schematic diagram illustrating the grafting of alendronate (a) on 
plasma-treated Ti surface and (b) on silane-modified Ti surface via a 
glutaraldehyde linker. 
 
4.2.3 Grafting of Alendronate on APTES-Modified Ti (Method 2) 
The Pristine-Ti substrates were treated on one side in a barrel plasma etcher 
with oxygen at 30 W for 1 min (Anatech) and then immediately immersed in 
2% APTES in toluene solution at 70 °C for 6 h with continuous stirring. After 
reaction, the substrates were sonicated in toluene for 15 min, washed with 
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toluene, isopropanol and distilled water in that order for 15 min each under 
continuous shaking (denoted as Silane-Ti). The Silane-Ti substrates were 
treated with 2% glutaraldehyde in 10 × PBS solution overnight (~12 h) at 
room temperature and then washed with copious amounts of distilled water 
under continuous shaking for 2 h (denoted as GA-Ti). To conjugate 
alendronate on GA-Ti, the substrates were immersed in 0.5 mL of alendronate 
aqueous solution (0.5 or 1 mg/mL) at room temperature overnight (~12 h). 
After the reaction, the substrates were washed with distilled water (denoted as 
ALN-S-Ti-x, x=0.5 or 1, depending on the concentration of the alendronate 
solution during the immobilization process). The surface modification steps 
are summarized in Figure 4-1(b). 
 
4.2.4 Characterization 
The methods for determination of surface composition and water contact angle 
were similar to those described in Section 3.2.7. The surface roughness (Ra) of 
pristine and alendronate-modified substrates was calculated from the 
roughness profile determined by atomic force microscopy (AFM, Dimension 
ICON, Bruker, Billerica, US) using the NanoScope Analysis 1.40 software. 
The AFM analyses were performed in tapping mode and areas of 30 μm × 30 
μm were scanned with a scan rate of 1.0 Hz. The zeta (ζ) potential of pristine 
and alendronate-modified substrates was determined using an electrokinetic 
analyzer (SurPass, Anton Paar, Graz, Austria) with an adjustable-gap cell 
module as described in a recent report (Guo et al., 2015). To determine the 
amount of immobilized alendronate on the substrates, the substrates were 
immersed in concentrated nitric acid (65%) in test tubes for at least 5 days 
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with shaking to dissolve the surface coating. The amount of phosphorous was 
determined by ICP-MS (Agilent Technologies). A calibration curve was 
generated using alendronate solutions of known concentrations. The surface 
density of the alendronate on each substrate was expressed as ng per cm
2
 of 
functionalized substrate surface. To evaluate the stability of the surface-
immobilized alendronate under prolonged immersion in water, the 
alendronate-modified substrates were immersed in 2 mL of ultrapure water in 
a 24-well microplate at room temperature under continuous shaking. At 
specific time points, the solution was collected and the amount of alendronate 
present in the solution was measured using ICP-MS.  
 
4.2.5 Cell Culture and Attachment Assay 
The cell culture protocol for osteoblasts was similar to that described in 
Section 3.2.9. The osteoblasts used were in passage 12-15. hMSCs were 
cultured in mesenchymal stem cell growth medium (Lonza) and the growth 
medium was changed every 3 to 4 days. The cells used in this study were in 
passage 5-8. The pristine and alendronate-modified substrates were placed into 
a 24-well microplate. To avoid cell adhesion on the microplate well during 
cell seeding, 0.05 mL of cell suspension containing ~5,000 cells was first 
carefully added to cover each substrate. After 6 h, another 0.95 mL of medium 
was added to each well. The metabolic activity of the cells at different time 
points was evaluated using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) assay. At specific time points, the medium was 
removed from each well and the substrates with attached cells were rinsed 
twice with PBS for 5 min each time. The substrates were transferred to a new 
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24-well microplate and 80 μL MTT reagent (5 mg/mL MTT in PBS) and 720 
μL fresh medium were added to each well. The plate was placed in a 5% CO2 
incubator at 37 °C for 4 h. After incubation, the medium was collected and 
centrifuged at 10,000 rpm for 5 min to collect the formazan crystals and the 
supernatant was discarded. The formazan on the substrate and in the medium 
was combined and dissolved in 400 μL dimethyl sulfoxide for 30 min with 
continuous shaking. An aliquot of 150 μL of this solution was transferred to a 
96-well plate, and its absorbance at 570 nm was measured using a microplate 
reader (Biotek, Winooski, US). The metabolic activity of the cells was 
normalized with respect to that of cells cultured on Pristine-Ti on Day 1. 
 
To evaluate the proliferation of osteoblasts and hMSCs cultured on Pristine-Ti 
over 7 days, the osteoblasts or hMSCs were seeded and cultured on the 
Pristine-Ti substrates as mentioned above. At specific time points, the culture 
medium was removed and the substrates were rinsed using PBS. The cells on 
the substrates were immersed in 4% glutaraldehyde in PBS for 30 min for 
fixation. After fixation, the substrates were rinsed again using PBS and then 
subjected to serial dehydration with 25, 50, 75, 95, 100% ethanol for 10 min 
each. The cells on the substrates were observed using a scanning electron 
microscope (JEOL 5600LV, Tokyo, Japan). 
 
4.2.6 ALP Activity and Calcium Deposition Assay 
For assays of osteoblast ALP activity and calcium deposition, the culture 
protocol was as described in Section 3.2.10. For experiments with hMSCs, the 
cells were seeded on the substrates at ~10,000 cells/cm
2
 and cultured in hMSC 
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osteogenic differentiation medium (Lonza). Since some alendronate on the 
modified substrates may be released into the medium, the effects of dissolved 
alendronate in the medium on osteoblast functions were also investigated. 
These experiments were carried out with osteoblasts cultured on Pristine-Ti in 
the differentiation medium as described in Section 3.2.10 containing dissolved 
alendronate. From the release profile of alendronate from ALN-P-Ti-2.5(5) 
immersed in water for 14 days, it was estimated that ~120 ng alendronate was 
released within the first two days, and on average ~24 ng alendronate was 
released per day from Day 3 onwards. Thus, 1 mL of differentiation medium 
containing 120 ng of dissolved alendronate was used per well for the first two 
days of culture. Then, the medium was refreshed with 1 mL of differentiation 
medium containing 72 ng of dissolved alendronate per well and the medium 
was changed every 3 days to mimic a 3-day cumulative release from the 
alendronate-modified substrate. The protocol for ALP activity assay was as 
described in Section 3.2.10. 
 
The amount of calcium deposited on the substrates by osteoblasts after 10 days 
was investigated using Alizarin Red staining. The staining solution was 
prepared by dissolving Alizarin Red S in water at a concentration of 2% (pH 
adjusted to 4.2 using 10% ammonium hydroxide). The solution was filtered 
through a 0.22 µm microfilter (Pall Corporation, Port Washington, US) prior 
to use. After 10 days of culture, the culture medium was removed and the 
substrates were rinsed with PBS. The osteoblasts on substrates were fixed 
using 4% glutaraldehyde for 30 min and rinsed with PBS at pH of 7.4 and 4.2 
sequentially. The osteoblasts were then stained using the freshly prepared 
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Alizarin Red solution for 2 min, and rinsed gently with water for 10 min 
before observation under an optical microscope. The amount of calcium 
deposited on the substrates by the cells after 10 and/or 21 days was quantified 
using ICP-MS as described in Section 3.2.10. 
 
4.2.7 Gene Expression Study by Real-Time Quantitative Reverse 
Transcriptase Polymerase Chain Reaction (qRT-PCR) 
hMSCs were seeded at 10,000 cells/cm
2
 and cultured in hMSC osteogenic 
differentiation medium (Lonza). The gene expressions of RUNX2, OSX, OPN 
and OC by the cells were investigated after 7 and 14 days of culture. After 
washing the substrates with PBS, the total RNA of the cultured cells was 
extracted using an RNeasy Mini Kit (Qiagen) and the amount of isolated total 
RNA was quantified using a Quant-iT RNA Assay Kit (Invitrogen, Carlsbad, 
US). qRT-PCR was conducted on a Bio-Rad iQ 5 multicolor qRT-PCR 
detection system using iScript One-Step RT-PCR Kit (Bio-Rad, Hercules, US) 
following the manufacturer’s instructions. The relative fold increase in 
expressions of the RUNX2, OSX, OPN and OC genes were normalized with 
respect to the reference gene, GAPDH, and all gene expression data was 
normalized by the respective data on Pristine-Ti on Day 7. 
 
4.2.8 Statistical Analysis 
The statistical analysis was as described in Section 3.2.11. 
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4.3 Results and Discussion  
4.3.1 Surface Characterization of Functionalized Ti  
In this work, alendronate was conjugated on Ti substrates via two methods. In 
Method 1, the phosphate groups of alendronate reacted with the hydroxyl 
groups on oxygen plasma-treated Ti while in Method 2, the amine group of 
alendronate reacted with the aldehyde group on GA-Ti. XPS was used to 
confirm the success of these surface reactions. From the wide scan spectrum 
of Pristine-Ti in Figure 4-2(a), the major peaks are Ti 2p (~460 eV), O 1s 
(~530 eV), and C 1s (284.6 eV). The presence of carbon is due to unavoidable 
hydrocarbon contamination and the presence of oxygen is due to the 
spontaneously formed oxide layer on Ti. The small amount of nitrogen on 
Pristine-Ti is likely due to the impurities of the substrate or adventitious 
contaminants. For Method 1, after plasma treatment (Figure 4-2(b)), the 
intensity of the C 1s peak was attenuated and the N 1s peak disappeared, 
suggesting plasma treatment decreases surface contaminants. In the wide scan 
spectrum for ALN-P-Ti-1(10) (Figure 4-2(c)), the P 2p peak is barely 
discernible, but from inset (c), the P 2p peak at ~133 eV (Ide et al., 2011) 
confirms the presence of alendronate on ALN-P-Ti-1(10). The wide scan 
spectra and P 2p core level spectra of the other ALN-P-Ti-x(t) surfaces 
(modified surfaces prepared with other concentrations of alendronate reagent 
or other conditions during the plasma treatment process) are similar to that of 
ALN-P-Ti-1(10). For Method 2, the Si 2s and Si 2p peaks appeared after 
silanization of Ti, accompanied by a decrease in the intensity of Ti 2p peak 
and an increase in the intensity of C 1s peak, indicating that APTES was 
successfully anchored on Pristine-Ti (Figure 4-2(d)). After grafting of 
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glutaraldehyde and alendronate, the intensity of the Ti 2p peak decreased 
further while the intensity of the N 1s and C 1s peaks increased (Figure 4-2(e)). 
The appearance of the peak in P 2p core level spectrum for ALN-S-Ti-1 
suggests alendronate was anchored on ALN-S-Ti-1 (Figure 4-2 inset (e)). The 
result obtained with ALN-S-Ti-0.5 is similar to that with ALN-S-Ti-1. 
 
Figure 4-2 XPS wide scan spectra of (a) Pristine-Ti, (b) Pls-Ti(10), (c) ALN-
P-Ti-1(10), (d) Silane-Ti and (e) ALN-S-Ti-1. The inset shows the P 2p core-
level spectrum of the respective substrate. 
 
Table 4-1 Amount of immobilized alendronate, water contact angle, surface 
roughness (Ra) and ζ potential (at pH~7.4) of pristine and functionalized Ti 
substrates. 
 
 
Substrate 
Amount of immobilized 
alendronate (ng/cm2) 
Contact 
angle (o) 
Ra       
(nm) 
ζ potential 
(mV) 
 Pristine-Ti -- 68±3 187±21 -86.4 
Method 1 
Pls-Ti(1) -- ~10
*   
ALN-P-Ti-0.5(1) 308 ± 36 ~10
* 176±20  
ALN-P-Ti-1(1) 557 ± 45 11±2 185±22  
ALN-P-Ti-1(5) 842 ± 39 12±3   
ALN-P-Ti-1(10) 867 ± 44 12±2   
ALN-P-Ti-2.5(5) 1186 ± 36 11±3 181±13 -86.3 
Method 2 
Silane-Ti -- 72±4   
ALN-S-Ti-0.5 1173 ± 26 47±2 171±16 -60.0 
ALN-S-Ti-1 1655 ± 32 47±3 175±12  
*
Due to the highly hydrophilic surface, an accurate measurement of the contact angle 
was not possible. 
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From Table 4-1, the amounts of alendronate immobilized directly on the 
plasma-treated Ti (Method 1) are 308 ± 36 ng/cm
2
 and 557 ± 45 ng/cm
2
 for 
ALN-P-Ti-0.5(1) and ALN-P-Ti-1(1). On the other hand, the alendronate 
anchored via silane anchor and glutaraldehyde linker on ALN-S-Ti-0.5 and 
ALN-S-Ti-1 (Method 2) amounted to 1173 ± 26 ng/cm
2
 and 1655 ± 32 ng/cm
2
, 
respectively. The conjugation of alendronate on Ti via Method 1 (Figure 4-
1(a)) may involve condensation between P-OH and Ti-OH groups to form 
monodentate binding, or coordination of the phosphoryl oxygen to Ti to form 
bidentate or tridentate binding. In addition, the remaining P-OH and P=O 
groups in the surface-immobilized alendronate may interact with adjacent 
monodentate or bidentate binding unit, or with hydroxyl or oxo groups on the 
substrate via hydrogen bonding (Brodard-Severac et al., 2008, Guerrero et al., 
2013, Mutin et al., 2005). As the relative contribution of each binding mode 
varies according to the phosphonate molecule anchored, the exact surface 
structure and distribution of the bonds is difficult to predict (Paz, 2011). In 
order to increase the amount of immobilized alendronate on the Ti substrate in 
Method 1, the duration of plasma treatment was extended. Plasma treatment of 
Pristine-Ti for 5 and 10 min resulted in a similar amount of immobilized 
alendronate, which is much higher than that on ALN-P-Ti-1(1) (Table 4-1). 
This increase in immobilized alendronate is likely due to the elimination of the 
surface contaminants and the introduction of more surface active hydroxyl 
groups with longer plasma treatment. Nevertheless, the surface density of 
alendronate on ALN-P-Ti-1(5) and ALN-P-Ti-1(10) is still less than that on 
ALN-S-Ti-1. In order to achieve a surface density of alendronate comparable 
to that on ALN-S-Ti-0.5 (1173 ± 26 ng/cm
2
) using Method 1, the experimental 
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conditions in Method 1 were adjusted. Pristine-Ti was treated with plasma for 
5 min and the initial concentration of alendronate solution during the 
conjugation reaction was increased to 2.5 mg/mL, resulting in 1186 ± 36 
ng/cm
2
 of immobilized alendronate on ALN-P-Ti-2.5(5). Thus, four times 
more reagent was required in Method 1 than in Method 2. In addition, in 
Method 1, it is not feasible to conjugate an amount of alendronate comparable 
to that on ALN-S-Ti-1 due to the solubility limitation of alendronate (~3.5 
mg/mL) in the methanol-water solution. Thus, even though Method 1 is 
simpler with fewer steps of reaction, it is not possible to prepare substrates 
with high surface densities of alendronate with this method.  
 
The change in surface wettability after surface modification via Methods 1 and 
2 can be seen from the contact angles in Table 4-1. The water contact angle of 
Pristine-Ti was 68°, indicating that the surface was rather hydrophobic. After 
plasma treatment for 1 min or more, the surface became extremely hydrophilic 
(water contact angle <10°). The water contact angle increased to ~10-12° after 
the substrates were modified with alendronate in Method 1. In Method 2, 
when APTES was coated on the plasma-treated substrate, the water contact 
angle increased to 72°. After treatment with glutaraldehyde and 
immobilization of alendronate, the surface became more hydrophilic (contact 
angle of 47°). These substrates are more hydrophobic than those prepared 
using Method 1, primarily due to the hydrophobicity of the silane coating.  
 
Surface roughness and surface charge have been widely reported to affect 
osteoblast adhesion, proliferation and differentiation (Gittens et al., 2013, 
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Shalabi et al., 2006, Wennerberg and Albrektsson, 2009, Wilson et al., 2005). 
Thus, the surface roughness and surface charge of pristine and functionalized 
substrates were investigated. From Table 4-1, the surface roughness of the 
alendronate-modified substrates is comparable to that of Pristine-Ti. Thus, 
both conjugation methods did not alter the surface topography of Ti 
significantly. The surface charge of alendronate-modified substrates with 
comparable surface density of alendronate (i.e. ALN-P-Ti-2.5(5) and ALN-S-
Ti-0.5) is compared in Table 4-1. The ζ potential of ALN-P-Ti-2.5(5) is 
similar to that of Pristine-Ti, and both are slightly lower than that of ALN-S-
Ti-0.5 at physiological condition (pH~7.4). Nevertheless, all substrates are 
negatively charged, and negatively charged surfaces are reported to be more 
favorable for proliferation and differentiation of osteoblasts than neutral or 
positively charged surfaces (Bodhak et al., 2009, Wilson et al., 2005). Since 
the surface roughness and surface charge of both types of alendronate-
modified substrates are not substantially different from those of Pristine-Ti, 
any observable differences in the behavior of cells on these substrates are 
likely due to the immobilized alendronate.  
 
4.3.2 Stability of Surface-Immobilized Alendronate 
The stability of the immobilized alendronate on the substrates after immersion 
in water was assessed from the amount of alendronate released into the water. 
For substrates prepared using Method 1, the Pristine-Ti substrates subjected to 
plasma treatment for 5 min and subsequent immersion in alendronate solution 
containing 1 and 2.5 mg/mL alendronate were tested (i.e. ALN-P-Ti-1(5) and 
ALN-P-Ti-2.5(5)). From Figure 4-3, the cumulative release of alendronate 
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from ALN-P-Ti-1(5) increased linearly with period of immersion, resulting in 
the release of 40% of the initial amount of the immobilized alendronate on the 
substrate. For ALN-P-Ti-2.5(5), the release of alendronate was more rapid in 
the first two days amounting to ~120 ng. From Day 3 onwards, the cumulative 
release of alendronate from ALN-P-Ti-2.5(5) increased linearly with period of 
immersion. This resulted in a release of 33% of the initial amount of 
immobilized alendronate on the substrate after 14 days. The phosphate groups 
of alendronate anchored on Ti via Method 1 may be in monodentate, bidentate 
and/or tridentate binding units. It has been reported that phosphonic acid can 
be bonded on Ti via monodentate, bidentate or tridentate binding modes, and 
the monodentate binding unit is the most stable (Brodard-Severac et al., 2008, 
Funar-Timofei and Ilia, 2007, Nilsing et al., 2005). Thus, alendronate 
immobilized via bidentate or tridentate binding units on the Ti surface may be 
similarly less stable than the monodentate binding unit and undergoes bond 
cleavage more readily during immersion in water.  
 
Figure 4-3 Cumulative amount of alendronate released from alendronate-
functionalized substrates after immersion in ultrapure water for different 
periods of time. 
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In contrast to the lack of stability of alendronate anchored on Ti via Method 1, 
the release of alendronate from the substrates prepared via Method 2 (ALN-S-
Ti-0.5 and ALN-S-Ti-1) is rather slow, resulting in < 10% release after 14 
days of immersion in water (Figure 4-3). It has been shown in Chapter 3 that 
bond cleavage between silane anchor and Ti is possible when silane-modified 
Ti was immersed for prolonged period in PBS. On the other hand, imine bond 
formed between aldehyde and amine groups has been reported to be stable 
under a wide range of pH and temperature in aqueous solution (Kuznetsova et 
al., 2013, Migneault et al., 2004). Since alendronate is immobilized on GA-Ti 
via imine bonds in Method 2, bond cleavage between GA-Ti and alendronate 
on ALN-S-Ti-0.5 or ALN-S-Ti-1 is less likely than the hydrolysis of the silane 
anchor in PBS. Similarly, the small amount of alendronate released from 
ALN-S-Ti-0.5 or ALN-S-Ti-1 as shown in Figure 4-3 is probably due to the 
latter.  
 
4.3.3 Assessment of Osteoblast Functions on Alendronate-Functionalized 
Substrates 
The biological responses of cells cultured on the pristine and modified 
substrates were investigated. Of particular interest is the comparison of cell 
behavior on substrates with comparable surface density of alendronate 
prepared by the two different methods, i.e. ALN-P-Ti-2.5(5) and ALN-S-Ti-
0.5. From Figure 4-4(a), it can be seen that for all substrates, the osteoblasts 
showed increasing metabolic activities with time. Over 7 days of cell culture, 
the metabolic activities of the osteoblasts on the modified substrates (i.e. 
plasma-treated, silane-treated, or with immobilized alendronate) are 
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comparable to that on Pristine-Ti. The increase in metabolic activity results 
from proliferation of the osteoblasts, as shown by the increasing number of 
cells on Pristine-Ti with time in the SEM images of Figure 4-5((a), (c) and (e)).  
 
Figure 4-4 (a) Metabolic activity of osteoblasts over 7 days. The metabolic 
activity was normalized by that obtained with the Pristine-Ti on Day 1. (b) 
ALP activity of osteoblasts over 18 days. (c) calcium mineral deposition of 
osteoblasts over 21 days. (* denotes significant difference (P<0.05) as 
compared with Pristine-Ti, # denotes significant difference (P<0.05) as 
compared with ALN-S-Ti-0.5 and $ denotes significant difference (P<0.05) as 
compared with ALN-P-Ti-2.5(5) at the same time point, respectively). (d-i) 
optical microscopy images of Alizarin Red stained osteoblasts on pristine and 
functionalized Ti substrates after culturing for 10 days. Scale bar = 200 µm. 
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Figure 4-5 SEM images of osteoblasts ((a), (c) and (e)) and hMSCs ((b), (d) 
and (f)) cultured on Pristine-Ti at different time points. (g) and (h) show the 
surfaces of Pristine-Ti (blank) immersed in osteoblast and hMSC growth 
medium without cells, respectively, after 7 days. Scale bar = 100 µm. 
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The ALP activity profiles of osteoblasts cultured on pristine and 
functionalized substrates are compared in Figure 4-4(b). Plasma treatment 
(Pls-Ti(5)) and the silane anchor (Silane-Ti) did not have any effect on the 
ALP activity of the osteoblasts but all the substrates with surface-immobilized 
alendronate resulted in an increase in ALP activity over those on Pristine-Ti. 
The osteoblasts cultured on ALN-P-Ti-2.5(5) and ALN-S-Ti-0.5 exhibited 
similar ALP activity profiles on Days 4, 7 and 10. Thus, it can be concluded 
that the manner in which the alendronate was conjugated to the surface did not 
play a significant role in stimulating the differentiation of osteoblasts during 
this period. However, by Day 14, a difference between ALP activity of the 
osteoblasts cultured on ALN-S-Ti-0.5 and ALN-P-Ti-2.5(5) can be observed. 
By Day 18, the ALP activity of osteoblasts cultured on ALN-P-Ti-2.5(5) is 
similar to that on Pristine-Ti, and significantly lower than that on ALN-S-Ti-
0.5. The decrease in the efficacy of ALN-P-Ti-2.5(5) in enhancing the 
differentiation of osteoblasts at this late stage is most likely due to the release 
of alendronate into the culture medium, which resulted in a decrease in the 
surface density of alendronate.  
 
Further investigations were carried out to determine the effect of the 
alendronate released into the medium on ALP activity of the osteoblasts on the 
substrates. Due to the high concentration of phosphate ions in the culture 
medium (1 mM), a release profile of alendronate in the culture medium cannot 
be accurately determined. Thus, the release profile of alendronate in water was 
used as an estimation of the amount of alendronate released in the culture 
medium, assuming no interference of dissolved ions in the culture medium on 
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the release of alendronate. To mimic the effect of the released alendronate in 
the culture medium, alendronate was added to the medium for culturing 
osteoblasts on Pristine-Ti (as described in Section 4.2.6). On Day 4, the ALP 
activity of osteoblasts cultured on Pristine-Ti under this condition is higher 
than that on Pristine-Ti without addition of alendronate (Figure 4-6). From 
Day 7 to Day 18, the ALP activity of osteoblasts cultured on Pristine-Ti in the 
presence of free alendronate is similar to that on Pristine-Ti without 
alendronate. This shows that alendronate released into the culture medium at 
the concentration (~120 ng/mL (0.37 µM) in the first two days and ~72 ng/mL 
(0.22 µM) in the subsequent days) observed in the current study did not 
significantly enhance osteoblast functions at all time points. This result is 
similar to earlier reports that the proliferation and expression of osteogenic 
gene markers of osteoblasts cultured in the presence of 0.1 µM or 1 µM of BP 
is indistinguishable from those cultured without BP (Idris et al., 2008, Koch et 
al., 2011). Hence, the osteogenic stimulating effect of ALN-P-Ti-2.5(5) 
substrate on the ALP activity of osteoblasts as shown in Figure 4-4(b) is likely 
due to the surface-immobilized alendronate.  
 
Chapter 4  
96 
 
  
Figure 4-6 ALP activity of osteoblasts cultured on Pristine-Ti over 18 days in 
culture medium without and with free alendronate of 120 ng/mL in the first 
two days and 72 ng/mL in the subsequent days. 
 
On the substrate with the highest surface density of alendronate, ALN-S-Ti-1, 
the ALP activity of the cultured osteoblasts peaked around Day 10, whereas 
for all the other substrates, the ALP activity peaked around Day 14 (Figure 4-
4(b)). ALP activity is a marker of early differentiation of osteoblasts. ALP 
plays a critical role in the release of inorganic phosphate from organic 
phosphate monoesters in the culture medium, which provides the major source 
of inorganic phosphate for mineralization in the calcium deposition phase. 
(Lian and Stein, 1992, Manolagas, 2000). Hence, with the osteoblasts on 
ALN-S-Ti-1 exhibiting significantly higher ALP activity and an earlier ALP 
activity peak, the progress to mineralization phase on this substrate is expected 
to occur earlier than those on the other substrates. 
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The substrates were stained for calcium on Day 10 as shown in Figure 4-4(d-i). 
The extent of calcium deposition by the osteoblasts cultured on Pristine-Ti 
(Figure 4-4(d)), Pls-Ti(5) (Figure 4-4(e)) and Silane-Ti (Figure 4-4(f)) was 
qualitatively similar, while the osteoblasts cultured on alendronate-
functionalized substrates deposited significantly more calcium minerals 
(Figure 4-4(g-i)). Quantification of calcium deposition by the osteoblasts on 
pristine and functionalized substrates over 21 days of culture was determined 
by ICP-MS and shown in Figure 4-4(c). On Day 10, the plasma treatment and 
silane anchor had no effects on the calcium deposition by osteoblasts. The 
amount of calcium deposited by the osteoblasts on ALN-P-TI-2.5(5), ALN-S-
Ti-0.5 and ALN-S-Ti-1 was comparable, which is on average ~23% more than 
that on Pristine-Ti. On Day 21, the osteoblasts cultured on ALN-P-Ti-2.5(5) 
showed 11% increase in calcium deposition over those cultured on Pristine-Ti, 
but this increase is not significant (P=0.06). On the other hand, ALN-S-Ti-0.5 
and ALN-S-Ti-1 increased calcium deposition by osteoblasts by 15% 
(P=0.035) and 30% (P=0.002), respectively, compared to Pristine-Ti. The 
results presented earlier in Section 4.3.2 indicate that alendronate anchored to 
Ti surface via Method 1 lacks stability in an aqueous environment, which 
accounts for the diminishing stimulating effect on cell functions over time. 
Thus, the more stable alendronate-modified substrates prepared using Method 
2 (ALN-S-Ti-0.5 and ALN-S-Ti-1) were chosen for the experiments with 
hMSCs.  
 
 
Chapter 4  
98 
 
4.3.4 Assessment of hMSC Functions on ALN-S-Ti-0.5 and ALN-S-Ti-1 
Substrates 
The metabolic activity of hMSCs cultured on pristine and functionalized 
substrates over the course of 7 days showed a similar increasing trend (Figure 
4-7(a)). Thus, similar to the results obtained with osteoblasts (Figure 4-4(a)), 
the immobilized alendronate has no effect on the metabolic activity of hMSCs. 
The increase in metabolic activity is again attributed to proliferation of the 
hMSCs (Figure 4-5(b), (d) and (f)). The ALP activity of the hMSCs on the 
various substrates is summarized in Figure 4-7(b). On Day 4, the ALP activity 
of hMSCs cultured on ALN-S-Ti-0.5 and ALN-S-Ti-1 is significantly higher 
than that on Pristine-Ti. This osteogenic stimulating effect was more evident 
on Day 7, where the hMSCs cultured on ALN-S-Ti-0.5 and ALN-S-Ti-1 
substrates showed an increase of 64% and 148% in ALP activity than those on 
Pristine-Ti, respectively. This percentage increase in hMSCs’ ALP activity 
due to the immobilized alendronate is much higher than the corresponding 
increase in osteoblasts’ ALP activity on Day 7 (42% and 81% more than on 
Pristine-Ti, Figure 4-4(b)). However, by Day 10, the hMSCs cultured on all 
substrates showed comparable ALP activity. This is likely because the ALP 
activity of hMSCs cultured on ALN-S-Ti-1 had already peaked around Day 7 
and started to decline by Day 10, whereas the ALP activity of hMSCs cultured 
on Pristine-Ti was just peaking. This acceleration of early differentiation of 
hMSCs by the immobilized alendronate is much desired in the regenerative 
medicine as the time required for osteogenesis of hMSCs would be 
significantly shortened. 
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Figure 4-7 (a) Metabolic activity of hMSCs over 7 days. The metabolic 
activity was normalized by that obtained with the Pristine-Ti on Day 1. (b) 
ALP activity of hMSCs over 14 days and (c) calcium mineral deposition of 
hMSCs after 21 days (* denotes significant difference (P<0.05) as compared 
with Pristine-Ti, # denotes significant difference (P<0.05) as compared with 
ALN-S-Ti-0.5 at the same time point, respectively). 
 
Figure 4-7(c) shows that on Day 21, the hMSCs cultured on ALN-S-Ti-0.5 
and ALN-S-Ti-1 deposited 24% and 69% more calcium minerals than those 
on Pristine-Ti, respectively. It has been reported that calcium deposition by 
hMSCs is modulated by free alendronate in the culture medium at a 
concentration of 5 µM at the early stage of osteogenic differentiation (Days 1-
5), but not at later stages (Days 5-15) (Chang et al., 2014). On the other hand, 
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the amount of alendronate immobilized on ALN-S-Ti-1 (~5.1 nmol/cm
2
) per 1 
mL of medium used in each well is equivalent to ~5.1 µM, and yet this 
substrate enhanced hMSCs’ ALP activity (Figure 4-7(b)) and calcium 
deposition (Figure 4-7(c)) over 14 and 21 days, respectively. The surface-
immobilized alendronate has the advantage over free alendronate in that it is 
not internalized by the cells, and hence it is available for interaction with the 
hMSCs over the assay period. Comparing Figure 4-7(c) and Figure 4-4(c), 
hMSCs deposit less calcium on both Pristine-Ti and alendronate-modified Ti 
than osteoblasts. However, the percentage increase in calcium mineral 
deposition by hMSCs due to the surface-immobilized alendronate is higher 
than that by osteoblasts.  
 
The effects of the surface-immobilized alendronate on gene expression of the 
osteogenic markers, RUNX2, OSX, OPN and OC, in hMSCs are shown in 
Figure 4-8. Many genes are related to osteogenic differentiation and bone 
formation, and these four markers were chosen as they are the important gene 
markers that characterize the early (RUNX2), middle (OSX) and late stages 
(OPN, OC) of osteogenic differentiation of hMSCs (Graneli et al., 2014). On 
Day 7, significantly higher expression of OPN and OC in hMSCs cultured on 
alendronate-modified substrates (i.e. ALN-S-Ti-0.5 and ALN-S-Ti-1) was 
observed, compared with that on Pristine-Ti (Figure 4-8(c-d)). On the other 
hand, only the hMSCs cultured on ALN-S-Ti-1 exhibited higher expression of 
RUNX2 and OSX over those on Pristine-Ti (Figure 4-8(a-b)). This suggests 
that surface density of alendronate higher than that on ALN-S-Ti-0.5 is needed 
to achieve enhanced expression of RUNX2 and OSX on Day 7. RUNX2 is 
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often referred to as the master regulator of the osteogenic differentiation of 
hMSCs, and its expression is usually up-regulated at early stage of the 
osteogenic differentiation and down-regulated at the late stage of the 
osteogenic differentiation (Deng et al., 2008, Ducy et al., 2000). Figure 4-7(b) 
shows that only ALN-S-Ti-1 accelerated the early differentiation of hMSCs, 
which is consistent with the RUNX2 expression profile on Day 7 (Figure 4-
8(a)). Since OSX acts downstream of RUNX2 (Nakashima et al., 2002), the 
expression of OSX in hMSCs on ALN-S-Ti-0.5 and ALN-S-Ti-1 (Figure 4-
8(b)) is expected to follow a similar trend as that of RUNX2 on Day 7 (Figure 
4-8(a)). On Day 10, the expressions of all gene markers are slightly up-
regulated compared to those on Day 7. On Day 14, the expressions of all gene 
markers are up-regulated compared to those on Day 10. The alendronate-
modified substrates (ALN-S-Ti-0.5 and ALN-S-Ti-1) resulted in significant 
higher expressions of RUNX2, OSX, OPN and OC in hMSCs, compared to 
those in hMSCs on Pristine-Ti. On Day 18, the expressions of early-mid 
osteogenic differentiation markers, RUNX2 and OSX, in hMSCs cultured on 
Pristine-Ti are down-regulated. However, the expressions of mid-late 
osteogenic differentiation markers, OPN and OC in hMSCs cultured on 
Pristine-Ti are slightly up-regulated. This suggests the hMSCs have 
progressed to mid-late stages of osteogenic differentiation by Day 18. For 
alendronate-modified substrates, all gene markers in hMSCs cultured on ALN-
S-Ti-0.5 and ALN-S-Ti-1 are down-regulated from Day 18 onwards. This 
suggests that the hMSCs on these two substrates may have progressed to mid-
late stages of osteogenic differentiation earlier than those on Pristine-Ti. On 
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Day 21, the expressions of all gene markers in hMSCs on Pristine-Ti and 
Silane-Ti are down-regulated. 
 
Figure 4-8 mRNA expression of (a) RUNX2, (b) OSX, (c) OPN, and (d) OC 
by hMSCs cultured on pristine and functionalized Ti substrates over 21 days 
as determined by qPCR. All data is presented as fold difference in gene 
expression after normalization by the result obtained with Pristine-Ti on Day 7 
(* and # denote significant difference (P< 0.05) compared to Pristine-Ti and 
ALN-S-Ti-0.5 at the same time point, respectively). 
 
Free alendronate is reported to increase the expression of osteogenic gene 
markers in stem cells (Fu et al., 2008, Kim et al., 2009, Ribeiro et al., 2014). 
From Figure 4-8(c), the expression of OPN in hMSCs cultured on ALN-S-Ti-1 
(~5.1 nmol/cm
2
 of immobilized alendronate, equivalent to 5.1 µM of 
alendronate per 1 mL of medium used in each well) was ~1.6 fold of that on 
Chapter 4  
103 
 
Pristine-Ti after 14 days. Investigations carried out with free alendronate 
showed that 0.01 µM of free alendronate in the culture medium had no effect 
on the expression of OPN in rat MSCs. When the concentration of free 
alendronate was increased to 0.1 or 1 µM, the expression of OPN was ~1.35 
fold that without alendronate. A further increase of alendronate concentration 
to 10 µM resulted in the expression of OPN increasing to ~1.7 fold that 
without alendronate (Fu et al., 2008). If it is assumed that the effects of 
alendronate on hMSCs and rat MSCs are similar, it would appear that 
immobilized alendronate has similar efficacy as free alendronate. Inorganic 
phosphates have also been shown to increase the expression of osteogenic 
gene markers in hMSCs (Danoux et al., 2015, Phadke et al., 2012, Schack et 
al., 2013). It has been reported that 4 mM of inorganic phosphates in the 
culture medium did not increase the expression of OC in hMSCs but with 8 
mM of inorganic phosphates, the expression of OC after 7 days increased to 
~2.2 fold of that cultured without inorganic phosphates (Danoux et al., 2015). 
In the current study, the expression of OC in hMSCs cultured on ALN-S-Ti-1 
which has the equivalent of ~10.2 µM phosphate functional groups in the 1 
mL of culture medium used per well was ~2.5 fold of that on Pristine-Ti on 
Day 7 (Figure 4-8(d)). This comparison indicates that alendronate 
immobilized on the Ti surface is much more effective in increasing the 
expression of OC in hMSCs than free inorganic phosphates in the culture 
medium. 
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4.4 Conclusion 
In this study, alendronate was immobilized on Ti via either its phosphate or 
amine groups (Method 1 or Method 2, respectively). The surface roughness 
and surface charge of these alendronate-modified substrates are not 
substantially different from those of the unmodified Ti substrate. With a 
similar amount of alendronate immobilized, ALN-P-Ti-2.5(5) prepared by 
Method 1 and ALN-S-Ti-0.5 prepared by Method 2 showed comparable 
effects in enhancing osteoblast ALP activity and calcium deposition up to Day 
10. However, the osteogenic stimulating effects of ALN-P-Ti-2.5(5) 
diminished towards the later stages (Days 14 to 21) due to the lower degree of 
stability of the immobilized alendronate on this substrate compared to ALN-S-
Ti-0.5. Our study suggests that the surface density and degree of stability of 
the immobilized alendronate play critical roles in modulating osteoblast 
differentiation. hMSCs cultured on ALN-S-Ti-1 also exhibited enhanced 
osteogenic differentiation, with 148% increase in ALP activity on Day 7 and 
69% increase in calcium deposition on Day 21 compared to those on Pristine-
Ti. The surface-immobilized alendronate is also more effective than free 
inorganic phosphates in the culture medium in promoting the up-regulation of 
osteogenic gene markers in hMSCs. In addition, the immobilized alendronate 
stimulated osteogenic differentiation of hMSCs to a greater extent than 
osteoblasts. Taking the surface property and cell responses into consideration, 
Ti substrates with alendronate anchored via its amine groups are potentially 
useful for clinical applications.  
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CHAPTER 5 BIFUNCTIONAL COATING BASED 
ON CARBOXYMETHYL CHITOSAN WITH 
STABLE CONJUGATED ALKALINE 
PHOSPHATASE FOR INHIBITING BACTERIAL 
ADHESION AND PROMOTING OSTEOGENIC 
DIFFERENTIATION ON TITANIUM  
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5.1 Introduction 
As highlighted in Chapter 2, the main reasons for implant failure are aseptic 
loosening and implant-associated infection. Chapter 4 illustrates how the 
surface chemistry of Ti can be modified with alendronate to enhance 
osteoblast and hMSC functions. Nevertheless, an implant surface which can 
enhance osteoblast functions and concomitantly resist bacterial adhesion and 
colonization would be more advantageous than one which only achieved the 
former. In this Chapter the development of a bifunctional coating on Ti that 
enhances cell functions and inhibits bacterial adhesion is described. 
 
In Chapter 3 and 4, the therapeutic molecules used for surface modification of 
Ti were BMP-2 and alendronate, respectively. BMP-2 is a growth factor and 
alendronate is a drug, and both of them are relatively expensive. In this 
Chapter, a cheaper therapeutic agent, ALP, was utilized for surface 
modification of Ti. The functions of ALP on bone formation have been 
reviewed in Section 2.5.1.1. It has been reported that ALP can be immobilized 
on surfaces such as Ti, alumina, bioactive glass, glass ceramics, collagen 
membrane, polymer sheets and fibrin scaffold via adsorption and covalent 
conjugation. These surface-active ALPs are able to promote the osteogenic 
differentiation of osteoblasts and osteoblast-like cells in vitro and in vivo 
(Aminian et al., 2015, de Jonge et al., 2009, Nijhuis et al., 2013, Oortgiesen et 
al., 2012, Osathanon et al., 2009, Schouten et al., 2009, Verne et al., 2010). In 
this Chapter, covalent conjugation of ALP on Ti was used due to its multiple 
advantages as discussed in Chapter 2.  
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Currently, reported methods for covalent anchoring of ALP on Ti are via 
amine groups of ALP reacting with surface activated hydroxyl groups on Ti 
(Ferraris et al., 2012, Ferraris et al., 2011), or via the dopamine-quinone 
groups of polydopamine (PDA)-coated Ti (Nijhuis et al., 2013). In the former 
method, ALP was released from the substrate upon repeated rinsing and 
ultrasonic washing, whereas ALP was retained for prolonged periods using the 
latter method. To date, no work has reported the co-immobilization of ALP 
with other molecules to achieve a bifunctional substrate. CMCS coating has 
been shown to possess antibacterial properties in Chapter 3. In this Chapter, 
ALP was covalently immobilized on CMCS-coated PDA-functionalized Ti via 
reaction between its amine group and the carboxyl group in CMCS.  
 
As indicated in Chapter 2 and 3, it is of great importance to ensure the stability 
of the functional coatings and surface anchors on Ti. The stability of the 
bifunctional coating developed in this Chapter was assessed after being 
subjected to physiological conditions (with and without lysozyme), 
disinfection and sterilization procedure. As CMCS and PDA are stable as 
shown in Chapter 3, the stability of the bifunctional coating after being 
subjected to these procedures would provide information on the stability of the 
surface-immobilized ALP.  
 
In this Chapter, the osteogenic differentiation of osteoblasts, hMSCs and 
human adipose derived stem cells (hADSCs) on Ti with surface-immobilized 
ALP was investigated. Although MSCs are currently the best characterized 
stem cell population, the limited number of available MSCs and the invasive 
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nature of tissue harvesting compromise their applicability in tissue engineering 
(Gao et al., 2014, Ruetze and Richter, 2014). Stem cells are also found in 
other sources, such as in adipose tissue. The greater accessibility and 
abundance of hADSCs make them a highly attractive alternative (Diederichs 
et al., 2013). hADSCs express comparable cell surface marker profile as 
hMSCs, and with proper osteogenic induction and culture protocol, hADSCs 
can achieve osteogenic differentiation with high potency (Ruetze and Richter, 
2014).  
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5.2 Materials and Methods 
5.2.1 Materials 
ALP from bovine intestinal mucosa (P7640) was obtained from Sigma Aldrich. 
Poietics
TM
 human adipose-derived stem cells (hADSCs) were purchased from 
Lonza. All other chemicals were similar to those described in Section 3.2.1 
and Section 4.2.1. 
 
5.2.2 Grafting of CMCS on Ti and Subsequent ALP Immobilization  
The synthesis of CMCS was carried out as described in Section 3.2.2. Ti foils 
were cut into 1 cm × 1 cm pieces. The cleaning of Ti substrates was as 
described in Section 3.2.3, and the cleaned Ti substrates were denoted as 
Pristine-Ti. All surface modification procedures in this work were carried out 
in a sterile environment in a biosafety cabinet. The coating of PDA on 
Pristine-Ti was carried out as described in Section 3.2.5 and the modified 
substrates were denoted as PDA-Ti. The grafting of CMCS on PDA-Ti was 
carried out as described in Section 3.2.3, and the modified substrates were 
denoted as CMCS-Ti. CMCS was conjugated to PDA-Ti by means of Michael 
addition and/or Schiff base reaction between the -NH2 groups of CMCS and 
the quinone groups of PDA-Ti (Lee et al., 2009), as well as the reaction of the 
-COOH groups of CMCS with the -NH2 groups of PDA-Ti via carbodiimide 
chemistry. Reaction between the -NH2 and -COOH groups of CMCS chains 
also resulted in crosslinking of the CMCS. Before conjugating ALP on 
CMCS-Ti, the -COOH groups of CMCS-Ti were activated in 0.1 M MES 
buffer (pH=6.0) containing NHS (313 mM) and EDC (125 mM) for 1 h. The 
substrates were washed with MES, and the conjugation of ALP was carried 
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out by adding 0.05 mL of ALP solution (with concentration of 0.012, 0.05, 0.1, 
0.5 or 1 mg/mL ALP) in MES (pH=6.0) to cover the surfaces of the substrates 
and then left to react overnight (~12 h). After the reaction, the substrates were 
rinsed four times with copious amount of distilled water and washed for at 
least 30 min under continuous shaking to remove adsorbed ALP and then air-
dried (denoted as ALP-Ti-x, where x=0.012, 0.05, 0.1, 0.5 and 1, depending 
on the initial concentration of the ALP solution used in the immobilization 
process). The surface modification steps are summarized in Figure 5-1. An 
earlier work reported on the immobilization of ALP directly on PDA-
functionalized Ti (Nijhuis et al., 2013). To compare the ALP-Ti-1 substrate in 
this study with the reported method, some ALP-functionalized substrates were 
prepared following the reported method. Briefly, Pristine-Ti was placed in 
dopamine (2 mg/mL) in 10 mM Tris buffered (pH=8.5) solution with 
continuous shaking for 16 h, followed by washing with copious amount of 
distilled water. After that, 0.05 mL of ALP solution (1 mg/mL in 10 mM Tris) 
was introduced on the surface for 16 h. The as-prepared substrates were 
washed and dried in a similar manner as described above for the ALP-Ti-x 
substrates and denoted as ALP-PDA-Ti-1. 
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Figure 5-1 Schematic diagram illustrating the sequential immobilization of 
PDA, CMCS and ALP on Pristine-Ti surface. 
 
5.2.3 Characterization 
The determination of surface composition and water contact angle were 
similar to those described in Section 3.2.7. The amount of surface active ALP 
was assessed by measuring the enzymatic activity of the substrates. Briefly, 
substrates were placed in a 24-well microplate and immersed in a mixture of 
200 μL distilled water, 250 μL of 0.5 mM p-nitrophenyl phosphate and 50 μL 
of 0.5 mM 2-amino-2-methyl-1-propanol buffered (pH=10.3) solution. After 
incubation at 37 °C for 1 h, the substrates were carefully removed and 50 μL 
of 0.3 M NaOH was added to each well. The absorbance of the resultant 
solution at 405 nm was measured using a microplate reader (Biotek) and 
compared to a standard curve obtained with known concentrations of p-
nitrophenol. The enzymatic activity of the surface bound ALP on each 
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substrate was expressed as activity unit, in which 1 unit is defined as the 
amount of ALP that converts 1 μmol of p-nitrophenyl phosphate per min to p-
nitrophenol at 37 °C and pH of 10.3. To quantify the phosphorous content on 
ALP-modified substrates, ALP-Ti-0.5 and ALP-Ti-1 were immersed in either 
sterile 1 × PBS solution (pH=7.4), or sterile 1 × PBS solution containing 10 
µg/mL lysozyme for 14 days. The solution was changed every 2 days. After 
14 days, the substrates were taken out and rinsed using ultrapure water (>18.2 
MΩ cm, Millipore Milli-Q system) and immersed in concentrated nitric acid 
(65%) overnight with vigorous shaking to dissolve the surface coating. The 
phosphorous content on ALP-Ti-0.5, ALP-Ti-1, ALP-Ti-x-LY, and ALP-Ti-x-
PBS (x=0.5 or 1) was quantified by ICP-MS (Agilent Technologies). The 
phosphorous content of each substrate was expressed as the phosphorous 
concentration in the nitric acid solution (2 mL) used to dissolve the coating on 
1 cm
2
 of the substrate. 
 
5.2.4 Bacterial Adhesion 
The protocol for bacteria culture and bacterial adhesion assay was as described 
in Section 3.2.8. 
 
5.2.5 Stability Test  
The ALP-Ti-0.5, ALP-Ti-1 and ALP-PDA-Ti-1 substrates were subjected to 
four different treatment procedures: immersion in 70% ethanol solution for 1 h 
(samples denoted with ET suffix), autoclaving (using a Hirayama HVE50 
autoclave, Japan) at 121 °C for 20 min (samples denoted with AC suffix), 
immersion in sterile 1 × PBS solution (pH=7.4) for 14 days (samples denoted 
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with PBS suffix), or immersion in sterile 1 × PBS solution containing 10 
µg/mL lysozyme for 14 days (samples denoted with LY suffix), respectively. 
After the treatment procedure, the substrates were rinsed three times with 
sterile distilled water and air-dried in a sterile environment. The enzymatic 
activity assay and cellular ALP activity assay (described in Section 5.2.7) 
were then carried out to evaluate the effects of the treatment procedures on the 
immobilized ALP. 
 
5.2.6 Cell Culture, Cell Attachment and Proliferation Assay 
The cell culture protocol for osteoblasts and hMSCs was similar to those 
described in Section 3.2.9 and Section 4.2.5. hADSCs were cultured in 
adipose-derived stem cell growth medium (Lonza). The osteoblasts used were 
in passage 12-15, and both types of stem cells used were in passage 4-8. The 
protocol for cell attachment assay was as described in Section 4.2.5. For the 
assessment of cell proliferation, the osteoblasts, hMSCs and hADSCs were 
detached using trypsin and counted using a hemocytometer after 1, 4, and 7 
days of culture, respectively. In addition, to verify the down-regulation of 
osteoblast proliferation is due to osteogenic differentiation, osteoblasts were 
cultured on the pristine and functionalized Ti substrates in osteogenic 
differentiation medium. The osteogenic differentiation medium used was 
similar to that described in Section 3.2.10. The cell proliferation assay was 
carried out after 1, 4 and 7 days of culture. 
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5.2.7 Cellular ALP Activity and Calcium Deposition Assay 
For assays of cellular ALP activity and calcium deposition, the culture 
protocol for osteoblasts was as described in Section 3.2.10. The hMSCs and 
hADSCs were seeded at 10,000 cells/cm
2
 and cultured in mesenchymal stem 
cell osteogenic differentiation medium (Lonza). The protocol for cellular ALP 
activity assay was as described in Section 3.2.10. To confirm if ALP 
conjugated on the substrates contributed to the measured cellular ALP activity, 
ALP-modified substrates without seeded cells were subjected to same 
treatment procedure as described in Section 3.2.10 to serve as the negative 
control.  
 
The calcium deposition assay was carried out as described in Section 3.2.10. 
Similar to the cellular ALP activity assay, the equivalent ALP-Ti-x substrates 
without seeded cells were used as negative controls. In addition, Alizarin Red 
S was used to stain the calcium deposited by the hADSCs after 21 days of 
culture. The preparation of staining solution and the staining protocol were as 
described in Section 4.2.6. 
 
5.2.8 Gene Expression Study by qRT-PCR 
hMSCs and hADSCs were seeded at 10,000 cells/cm
2
 and cultured in 
mesenchymal stem cell osteogenic differentiation medium (Lonza). Gene 
expressions of RUNX2, OSX, and OC were investigated after 7 and 14 days 
following the protocol as described in Section 4.2.7. 
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5.2.9 Statistical Analysis 
The statistical analysis was as described in Section 3.2.11. 
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5.3 Results and Discussion 
5.3.1 Surface Characterization 
The XPS wide scan spectra and the surface elemental composition of Pristine-
Ti, PDA-Ti and CMCS-Ti are shown in Figure 5-2((a)-(c)) and Table 5-1(a). 
After Pristine-Ti has been treated with PDA and CMCS, the Ti 2p peak 
disappeared and the N 1s peak intensity increased, confirming the success of 
the coating process. The C 1s core-level spectra of PDA-Ti, CMCS-Ti and 
ALP-Ti-1 are shown in Figure 5-2(d)-(f). The C 1s core-level spectrum of 
PDA-Ti (Figure 5-2(d)) can be fitted with four peaks at 284.6 eV, 285.6 eV, 
286.2 eV and 287.7 eV, attributable to C-H, C-N, C-O and C=O groups of the 
PDA coating (Dreyer et al., 2013, Jiang et al., 2010, Liu et al., 2014, Moulder 
and Chastain, 1992) The C 1s core-level spectra of CMCS-Ti and ALP-Ti-1 
(Figure 5-2(e) and (f)) can be fitted with five peaks at 284.6 eV, 285.6 eV, 
286.2 eV, 287.7 eV and 288.5 eV, which are attributed to C-H, C-N, C-O, 
C=O/N-C=O, and O-C=O groups (Moulder and Chastain, 1992, Yang et al., 
2011). In the C 1s core-level spectrum of CMCS-Ti (Figure 5-2(e)), the 
increase in the C-O peak intensity compared to that of PDA-Ti (Figure 5-2(d)) 
and the appearance of the O-C=O peak are consistent with the structure of 
CMCS. The N-C=O groups are attributable to amide bonds formed between 
PDA-Ti and CMCS and between CMCS chains as a result of crosslinking. 
Due to the small amount of ALP immobilized on the surface, the C 1s core-
level spectra for CMCS-Ti (Figure 5-2(e)) and ALP-Ti-1 (Figure 5-2(f)) are 
not substantially different. Thus, enzymatic activity assay was used to confirm 
the success of the functionalization of the CMCS-Ti substrate with ALP 
(described below). Table 5-1(b) shows that the PDA coating did not alter the 
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surface wettability of Ti significantly, whereas functionalization with CMCS 
resulted in an extremely hydrophilic surface (contact angle <10°). In addition, 
the water angle contact angles of 16 different areas on CMCS-Ti were tested 
per 1 cm
2
 of CMCS-Ti substrate, and the surfaces were consistently 
hydrophilic with water contact angles measured to be <10°. Thus, the CMCS 
coating on the PDA-Ti is uniform. 
 
Figure 5-2 XPS wide scan spectra of (a) Pristine-Ti, (b) PDA-Ti and (c) 
CMCS-Ti and C 1s core-level spectra of (d) PDA-Ti, (e) CMCS-Ti and (f) 
ALP-Ti-1. 
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Table 5-1 (a) Elemental composition
*
 (determined using XPS) and (b) water 
contact angle of Pristine-Ti and functionalized Ti substrates. 
(a) 
 
Pristine-Ti PDA-Ti CMCS-Ti 
Ti 34.4±4.2 -- -- 
N 1.1±1.1 9.8±0.4 11.7±1.1 
C 64.5±4.3 90.2±0.4 88.3±1.1 
(b) 
Substrates Water contact angle 
Pristine-Ti 68°±3° 
PDA-Ti 64°±3° 
CMCS-Ti <10°
#
 
ALP-Ti-0.012 17°±2° 
ALP-Ti-0.05 17°±4° 
ALP-Ti-0.1 18°±3° 
ALP-Ti-0.5 19°±3° 
ALP-Ti-1 20°±3° 
ALP-PDA-Ti-1 57°±4° 
*
Percentages computed based on the C, N, and Ti contents only. 
#
Due to the highly hydrophilic surface, a precise measurement of the contact angle 
was not possible. 
 
Figure 5-3 shows that all the ALP-modified substrates exhibit enzymatic 
activity, indicating successful immobilization of ALP. The amount of 
bioactive ALP on the surface is dose-dependent, with the surface density of 
immobilized bioactive ALP increasing linearly with the concentration of ALP 
solution used in the immobilization process over the range tested. An equal 
amount of ALP loading solution of 50 μg/cm2 was used to prepare ALP-Ti-1 
and ALP-PDA-Ti-1. However, ALP-Ti-1 has an enzymatic activity of 49.7 ± 
6.2 μU/cm2, which is approximately 26% more than that of ALP-PDA-Ti-1 
prepared using the method reported in an earlier publication (39.5 ± 5.1 
μU/cm2, P=0.043). This increase in enzymatic activity is possibly due to a 
higher surface density of immobilized ALP and/or a more favorable 
conformation of the immobilized ALP on ALP-Ti-1 due to the presence of the 
CMCS layer. Another difference between the ALP-Ti-1 and ALP-PDA-Ti-1 
Chapter 5  
119 
 
substrates is hydrophilicity as shown in Table 5-1(b). The surfaces of ALP-Ti-
x became slightly more hydrophobic (contact angle increased from <10° to 
between 17-20°) after the immobilization of ALP on CMCS-Ti, whereas the 
direct immobilization of ALP on PDA-coated Ti resulted in a much more 
hydrophobic (water contact angle of 57°) surface compared to ALP-Ti-x, due 
to the hydrophobicity of the PDA layer. 
 
Figure 5-3 Enzymatic activity of surface-immobilized ALP as a function of 
amount of ALP used in the reaction medium. The enzymatic activity assay 
was carried out after the preparation of substrates. The dotted line represents 
the best fit line for ALP-Ti-x samples (x=0.012, 0.05, 0.1, 0.5 and 1). 
 
The antibacterial property of CMCS on the Ti substrate was assessed using S. 
epidermidis, which has been identified as one of the two leading etiologic 
agents of orthopedic implant infection (Montanaro et al., 2011). Figure 5-4 
and Figure 5-5 show the fluorescence microscopy images of viable adherent 
bacterial cells on different substrates after incubation in S. epidermidis 
suspension of 1×10
7
 cells/mL in PBS for 4 h. The anti-adhesive and 
bactericidal effects of CMCS coating resulted in a significant decrease in 
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viable adherent bacterial cells on CMCS-Ti (Figure 5-4(b)) compared to that 
on Pristine-Ti (Figure 5-4(a)). Since all the ALP-Ti-x substrates demonstrated 
the same extent of inhibition of bacterial adhesion as CMCS-Ti (Figure 5-
5(b)-(f)), the antibacterial property of CMCS on these substrates was not 
compromised by the immobilized ALP. On the other hand, the extent of 
bacterial colonization on ALP-PDA-Ti-1 (Figure 5-5(g)) appeared similar to 
that on PDA-Ti (Figure 5-5(a)). The spread plate results in Figure 5-4(c) are in 
agreement with the fluorescence microscopy images. The CMCS coating 
resulted in ~89% reduction in adherent bacterial cells compared to Pristine-Ti. 
In the presence of ALP on CMCS-Ti, the number of adherent bacterial cells 
was also reduced by ~89% compared to Pristine-Ti, whereas no reduction was 
observed on ALP-PDA-Ti-1. This confirms that surface-immobilized ALP, in 
the range of the surface density tested, did not affect the antibacterial 
properties of the CMCS layer. 
 
Figure 5-4 Fluorescence microscopy images of (a) Pristine-Ti and (b) CMCS-
Ti surfaces after exposure to a PBS suspension of S. epidermidis of 1×10
7
 
cells/mL for 4 h ((a) and (b) were viewed under a green filter. Scale bar = 
50µm), (c) number of viable adherent S. epidermidis per cm
2
 of substrate after 
exposure to bacterial suspension in PBS (1×10
7
 cells/mL) for 4 h (* denotes 
significant difference (P<0.05) compared with Pristine-Ti). 
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Figure 5-5 Fluorescence microscopy images of (a) PDA-Ti, (b) ALP-Ti-0.012, 
(c) ALP-Ti-0.05, (d) ALP-Ti-0.1 (e) ALP-Ti-0.5, (f) ALP-Ti-1 and (g) ALP-
PDA-Ti-1 surfaces after exposure to a PBS suspension of S. epidermidis of 
1×10
7
 cells/mL for 4 h. (a)-(g) were viewed under a green filter. Scale bar = 
50µm. 
 
5.3.2 Assessment of Osteoblast Functions  
The bioactivity of the immobilized ALP was investigated by examining the 
cellular responses of different cell lines cultured on the substrates. Figure 5-6 
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illustrates the responses of osteoblasts cultured on the pristine and modified 
substrates. From Figure 5-6(a), the number of attached osteoblasts cultured on 
all substrates in growth medium shows an increasing trend over the 7-day 
period. On Days 1 and 4, the number of osteoblasts on the ALP-modified 
substrates was comparable to that on Pristine-Ti, but on Day 7, the numbers of 
osteoblasts cultured on ALP-Ti-1 and ALP-PDA-Ti-1 were less than that on 
Pristine-Ti. It has been reported that as osteoblasts progress to differentiation, 
the rate of proliferation declines (Lian and Stein, 1992). Figure 5-6(b) shows 
the proliferation of osteoblasts cultured in osteogenic differentiation medium 
over 7 days. It can be seen from Figure 5-6(a) and Figure 5-6(b) that the trend 
of increasing osteoblast numbers on the different substrates in growth medium 
and in osteogenic differentiation medium was similar from Day 1 to Day 4. 
However, on Day 7, the number of osteoblasts on Pristine-Ti and ALP-
modified substrates cultured in osteogenic differentiation medium (Figure 5-
6(b)) was significantly lower than that on the corresponding substrates 
cultured in growth medium (Figure 5-6(a)). This result shows the proliferation 
of osteoblasts is down-regulated when the cells progress to differentiation. 
Since ALP is reported to promote early osteogenic differentiation of 
osteoblasts and osteoblast-like cell lines (Bosco et al., 2014, Verne et al., 
2014), and ALP-Ti-1 and ALP-PDA-Ti-1 have the two highest surface density 
of bioactive ALP, it is possible that the osteoblasts on these substrates may 
have progressed to the early differentiation phase by Day 7. This would then 
result in a slower proliferation rate of the cells compared to the cells on the 
other substrates, as shown in Figure 5-6(a).  
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Figure 5-6 (a) Osteoblast proliferation in growth medium over 7 days, (b) 
osteoblast proliferation in osteogenic differentiation medium over 7 days, (c) 
cellular ALP activity over 14 days and (d) calcium mineral deposition after 21 
days (* denotes significant difference (P<0.05) as compared with Pristine-Ti, 
# denotes significant difference (P<0.05) as compared with ALP-Ti-0.05, ^ 
denotes significant difference (P<0.05) as compared with ALP-Ti-0.1, and & 
denotes significant difference (P<0.05) as compared with ALP-Ti-1 at the 
same time point, respectively). 
 
The cellular ALP activities of osteoblasts on ALP-modified substrates at Day 
7 and Day 14 (Figure 5-6(c)) show different degrees of increase compared to 
that on Pristine-Ti at the same time point. On Day 7, the highest cellular ALP 
activity was exhibited by osteoblasts on ALP-Ti-0.5, ALP-Ti-1 and ALP-
PDA-Ti-1. On Day 14, the increase in cellular ALP activity is much more 
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pronounced on ALP-Ti-0.5 and ALP-Ti-1, resulting in ~103% and ~108% 
increase in cellular ALP activities as compared to that on Pristine-Ti, 
respectively. Cellular ALP activity of osteoblasts is well documented as an 
important marker of osteogenesis. The up-regulation of cellular ALP activity 
is accompanied by the down-regulation of proliferation, and the cellular ALP 
activity peaks before the up-regulation of the matrix mineralization (Balcerzak 
et al., 2003, Quarles et al., 1992). In the current study, the significant increase 
in cellular ALP activity of osteoblasts on ALP-Ti-1 and ALP-PDA-Ti-1 over 
that on Pristine-Ti on Day 7 implies that the cells may have progressed to 
early differentiation, which would be consistent with the lower number of cells 
on these substrates as shown in Figure 5-6(a). As highlighted in Section 
2.5.1.1, ALP is responsible for catalysis of ROP such as sodium 
glycerophosphate in the culture medium to release Pi for physiological 
mineralization (Anderson, 1995, de Jonge et al., 2009). Pi has been reported to 
induce osteopontin expression in osteoblasts, which increases synthesis and 
activity of cellular ALP (Beck et al., 2003, Beck et al., 1998, Beck et al., 
2000). Thus, the observed increase in cellular ALP activity of osteoblasts on 
ALP-Ti-0.5, ALP-Ti-1 and ALP-PDA-Ti-1 over that on Pristine-Ti (Figure 5-
6(c)) is probably due to the release of Pi resulting from the catalytic reaction 
of the immobilized ALP. 
 
In the above analysis, it was assumed that the measured ALP activity is due to 
that produced by the cells. Since there is a possibility that the surface-
immobilized ALP may detach and contribute to the measured ALP activity 
values, the same experimental procedures were carried out with the ALP-
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modified substrates in the absence of cells as described in Section 5.2.7. These 
experiments showed that there was no detachment of ALP in its bioactive 
form from the substrates during the cell lysis process, and hence the measured 
ALP in Figure 5-6(c) reflects the ALP produced by the cells. 
 
The amount of calcium deposited on the substrates was measured after 21 days. 
A recent work has reported that surface-anchored ALP induces mineralization 
when placed in cell culture medium in the absence of cells (referred to as 
ALP-induced mineralization in the later discussion) (de Jonge et al., 2009). To 
distinguish between ALP-induced mineralization due to the surface-
immobilized ALP and minerals deposited by cells, acellular ALP-modified Ti 
substrates were treated under the same experimental procedures as ALP-
modified Ti as described in Section 5.2.7. The calcium deposited on the 
acellular ALP-modified Ti was then subtracted from that of the respective 
cell-containing substrate to obtain the cellular calcium deposition shown in 
Figure 5-6(d). The average amount of calcium deposited on acellular ALP-
modified Ti was ~12 µg/cm
2
, which is ~14-18% of the total calcium 
deposition obtained with ALP-modified substrates incubated with osteoblasts. 
As can be seen from Figure 5-6(d), osteoblasts cultured on all ALP-modified 
Ti substrates (except ALP-Ti-0.012) deposited significantly more calcium than 
those on Pristine-Ti, with increasing surface density of ALP resulting in higher 
calcium deposition. The low surface density of bioactive ALP on ALP-Ti-
0.012 is the likely reason for the absence of increased mineralization. An 
earlier study had reported that ALP-PDA-Ti-1 failed to enhance the functions 
of rat bone marrow derived primary osteoblast-like cells in vitro (Nijhuis et al., 
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2014). The enhanced osteoblast functions obtained on ALP-PDA-Ti-1 in the 
current study is most likely due to the differences in the cell lines used.  
 
Comparing ALP-PDA-Ti-1 and ALP-Ti-1, the amount of calcium deposited 
on the former is 11% less than that on the latter. This result in combination 
with the cellular ALP activity profiles in Figure 5-6(c) indicates that ALP-
PDA-Ti-1 enhances osteoblast differentiation to a similar degree as ALP-Ti-1 
at an early stage (Day 7), but it is less effective compared to ALP-Ti-1 in 
modulating osteoblast differentiation at late stages (Day 14 and Day 21). The 
enhanced osteoblast function on ALP-Ti-1 over those on ALP-PDA-Ti-1 is 
possibly due to a higher surface density of immobilized bioactive ALP on the 
substrate (as shown in Figure 5-3). According to recent works, prolonged 
immersion of ALP-modified substrates (prepared by different surface 
modification methods) in water, Tris buffered solution, PBS or cell culture 
medium resulted in different degrees of reduction in enzymatic activity of the 
immobilized protein (Aminian et al., 2015, Ball, 2014, Osathanon et al., 2009). 
Thus, another possible reason for the differences in osteoblast behavior on 
ALP-Ti-1 and ALP-PDA-Ti-1 is the difference in stability of the surface-
immobilized ALP on these substrates. In the current study, ALP was 
immobilized on ALP-Ti-1 via carbodiimide reaction with carboxyl groups 
from CMCS-Ti while ALP was immobilized on ALP-PDA-Ti-1 via reaction 
with dopamine-quinone on PDA-Ti. The different conjugation chemistry of 
ALP on ALP-Ti-1 and ALP-PDA-Ti-1 substrates may affect the stability of 
the immobilized protein and result in a decreasing effect on osteoblast 
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differentiation on ALP-PDA-Ti-1 with increasing time. This postulate will be 
verified in Section 5.3.6. 
 
5.3.3 Assessment of hMSC Functions 
The proliferation of hMSCs on the different substrates over 7 days (Figure 5-
7(a)) is similar to the trend observed with osteoblasts (Figure 5-6(a)). Similar 
to osteoblasts, the rate of proliferation of hMSCs cultured on ALP-Ti-1 and 
ALP-PDA-Ti-1 was lower that on Pristine-Ti on Day 7. This is probably 
because the hMSCs cultured on these substrates may have progressed to the 
early differentiation phase by Day 7, and this postulate would be further 
verified with the gene expression results in Section 5.3.5. Figure 5-7(b) shows 
that the ALP activity of hMSCs cultured on ALP-modified substrates 
increased compared to those on Pristine-Ti at Day 7, and a higher amount of 
surface-immobilized ALP resulted in a higher increase. However, unlike 
osteoblasts, the ALP activity of hMSCs on ALP-Ti-1 on Day 14 appears 
similar to that of Day 7. The results on Day 10 showed that the ALP activity 
of hMSCs on ALP-Ti-1 has reached its peak around this period and has 
declined by Day 14 (Figure 5-8). In terms of calcium deposition (Figure 5-
7(c)), only substrates with higher surface density of ALP, namely, ALP-Ti-0.5, 
ALP-Ti-1 and ALP-PDA-Ti-1, resulted in enhanced calcium deposition (36%, 
54% and 26% more calcium than on Pristine-Ti, respectively). From the ALP 
activity and calcium deposition results, it is evident that only these substrates 
enhanced the osteogenic differentiation of hMSCs and hence, they were used 
for experiments with hADSCs. 
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Figure 5-7 (a) Proliferation of hMSCs over 7 days, (b) cellular ALP activity 
over 14 days and (c) calcium mineral deposition after 21 days (* denotes 
significant difference (P<0.05) as compared with Pristine-Ti, $ denotes 
significant difference (P<0.05) as compared with ALP-Ti-0.012, # denotes 
significant difference (P<0.05) as compared with ALP-Ti-0.05, ^ denotes 
significant difference (P<0.05) as compared with ALP-Ti-0.1, and & denotes 
significant difference (P<0.05) as compared with ALP-Ti-1 at the same time 
point, respectively).  
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Figure 5-8 Cellular ALP activity of hMSCs over 14 days (* denotes 
significant difference (P<0.05) as compared with Pristine-Ti, # denotes 
significant difference (P<0.05) as compared with ALP-Ti-0.5 and & denotes 
significant difference (P<0.05) as compared with ALP-Ti-1 at the same time 
point, respectively). 
 
5.3.4 Assessment of hADSC Functions 
The proliferation of hADSCs on the different substrates over 7 days is shown 
in Figure 5-9(a), and the trend is similar to that of osteoblasts (Figure 5-6(a)) 
and hMSCs (Figure 5-7(a)). It should be noted that with the same initial 
seeding density of 5,000 cells/cm
2
, the number of hADSCs increases to 
~29,500 cells/cm
2
 in 7 days whereas hMSCs only increases to ~6,500 
cells/cm
2
 (Figure 5-7(a)). This highlights the different rates of proliferation for 
different types of stem cells (Diederichs et al., 2013). On Day 7, the ALP 
activity of hADSCs cultured on ALP-Ti-0.5, ALP-Ti-1 and ALP-PDA-Ti-1 
are comparable, and significantly higher than that on Pristine-Ti (Figure 5-
9(b)). Similar to hMSCs, the ALP activity of hADSCs on ALP-Ti-1 peaks on 
~Day 10, and is significantly higher than that on Pristine-Ti and ALP-Ti-0.5. 
By Day 14, the ALP activity of hADSCs on ALP-Ti-1 has declined to a 
comparable level as that on Pristine-Ti, which has just reached its peak. After 
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21 days of culture, the hADSCs on ALP-Ti-0.5 and ALP-PDA-Ti-1 deposited 
42% and 35% more calcium compared with those on Pristine-Ti, and hADSCs 
on ALP-Ti-1 deposited 129% more calcium compared to those on Pristine-Ti 
(Figure 5-9(c)). These results are consistent with the images of stained calcium 
deposits on the substrates (Figure 5-9(d)-(h)). Comparing Figure 5-9(c) with 
Figure 5-7(c), the hADSCs deposit less calcium on both Pristine-Ti and ALP-
modified Ti than hMSCS with same number of initially seeded cells. However, 
the percentage increase in calcium mineral deposition due to the surface-
immobilized ALP as compared with Pristine-Ti is more pronounced in 
hADSCs than that in hMSCs.  
 
In Figure 5-9((d)-(h)), the degree of calcium staining is lower compared to that 
in Figure 4-4 ((d)-(i)) in Chapter 4. In Figure 5-9((d)-(h)), the stained calcium 
nodules were deposited by hADSCs seeded at a density of 10,000 cells/cm
2
 
and cultured in human mesenchymal stem cell osteogenic differentiation 
medium for 21 days. In Figure 4-4((d)-(i)), the stained calcium nodules were 
deposited by mouse osteoblasts seeded at a density of 30,000 cells/cm
2
 and 
cultured in osteoblast osteogenic differentiation medium for 10 days. The 
differences in source of origin of cells and experimental conditions are likely 
to be the reasons for the observed differences in the stained calcium nodules. 
For instance, it has been reported that the stained calcium nodules deposited 
by hMSCs are more than those deposited by hADSCs, when both cell lines 
were cultured under the same condition for three weeks (Ardeshirylajimi et al., 
2015). 
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Figure 5-9 (a) Proliferation of hADSCs over 7 days, (b) cellular ALP activity 
over 14 days, (c) calcium mineral deposition after 21 days, (d)-(h) optical 
microscopy images of Alizarin Red-stained hADSCs on the different 
substrates after culturing for 21 days. Scale bar = 200 µm. (* denotes 
significant difference (P<0.05) as compared with Pristine-Ti, # denotes 
significant difference (P<0.05) as compared with ALP-Ti-0.5, and & denotes 
significant difference (P<0.05) as compared with ALP-Ti-1 at the same time 
point, respectively). 
 
5.3.5 Assessment of Gene Expression by hMSCs and hADSCs 
The osteogenic differentiation of stem cells involves complex signaling 
pathways and regulations of multiple gene markers. Among the markers that 
are associated with osteogenic differentiation, three osteogenic markers, 
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RUNX2, OSX and OC were investigated over a 2-week period. RUNX2 was 
selected as it has been identified as the master regulator in the early stage of 
osteogenic differentiation (Deng et al., 2008). OSX acts downstream of 
RUNX2, and OC is a common marker for the late stage of osteogenic 
differentiation (Deng et al., 2008, Marie, 2008). For hMSCs (Figure 5-10(a), 
(c) and (e)), the CMCS coating did not have an impact on gene marker 
expression on Day 7, whereas the expressions of all three markers in hMSCs 
cultured on ALP-Ti-1 are significantly higher than those on the other 
substrates. In Figure 5-10(a), the significant increase in expression of RUNX2 
in hMSCs on ALP-Ti-1 and ALP-PDA-Ti-1 over those on the other substrates 
indicates these cells are in osteogenic differentiation phase by Day 7, which is 
consistent with the slower proliferation rate of hMSCs on ALP-Ti-1 and ALP-
PDA-Ti-1 shown in Figure 5-7(a). On Day 14, the increase in the expressions 
of RUNX2, OSX and OC in hMSCs on the ALP-modified substrates 
compared to those on Pristine-Ti shows a similar trend as Day 7. However, 
from Day 7 to Day 14, the extent of up-regulation of OSX and OC genes in 
hMSCs on ALP-Ti-0.5 is greater than that on ALP-Ti-1 (Figure 5-10(c) and 
Figure 5-10(e)), suggesting enhanced osteogenic differentiation of hMSCs on 
ALP-Ti-0.5 compared to ALP-Ti-1. This may be because the up-regulation of 
genes in hMSCs on ALP-Ti-1 has occurred earlier than that on ALP-Ti-0.5 as 
indicated in Figure 5-10(a). The higher expression of RUNX2 in hMSCs on 
ALP-Ti-1 compared to ALP-Ti-0.5 on Day 7 suggests the hMSCs on ALP-Ti-
1 may have progressed to osteogenic differentiation earlier. As OSX and OC 
are mid and late stage markers for osteogenic differentiation, the up-regulation 
of these two markers in hMSCs on ALP-Ti-1 would thus have occurred earlier 
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than those on ALP-Ti-0.5, as mentioned above. It can be seen from Figure 5-
10(a), (c) and (e) that the expressions of all three markers in hMSCs cultured 
on ALP-PDA-Ti-1 are comparable or less than that on ALP-Ti-1 at the 
respective time points, suggesting a lower osteogenic potential of the hMSCs 
on ALP-PDA-Ti-1. This result is in agreement with the lower ALP activity 
and calcium deposition of hMSCs on ALP-PDA-Ti-1 compared to that on 
ALP-Ti-1 on Day 14 and Day 21 (Figure 5-7(b) and Figure 5-7(c), 
respectively). 
 
For hADSCs, the general gene expression trends of the three markers (Figure 
5-10(b), (d) and (f)) are similar to those observed with hMSCs. At the same 
time point, the fold difference in expression of RUNX2 and OC in hADSCs is 
comparable to those of hMSCs on the same ALP-modified substrates, but the 
fold difference in expression of OSX in hADSCs appears to be slightly lower 
than that in hMSCs. Thus, the gene expression results show that the 
immobilized ALP enhances the osteogenic differentiations of hMSCs and 
hADSCs by up-regulating the RUNX2, OSX and OC osteogenic markers. 
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Figure 5-10 mRNA expression of RUNX2, OSX and OC by hMSCs ((a), (c) 
and (e)) and hADSCs ((b), (d) and (f)) cultured on different substrates for 7 
and 14 days as determined by qPCR. Data is presented as fold difference in 
gene expression after normalization with respect to Pristine-Ti on Day 7 (* 
and # denote significant difference (P<0.05) compared to Pristine-Ti and 
ALP-Ti-0.5, and & denotes significant difference (P<0.05) as compared with 
ALP-Ti-1 at the same time point, respectively). 
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Combining the results on gene expression, ALP activity profile and calcium 
deposition of these two types of stem cells, it appears that hADSCs have 
comparable potency in osteogenic differentiation as hMSCs when cultured on 
ALP-modified substrates. hMSCs on these substrates exhibit significantly 
higher calcium deposition, but for hADSCs, the percentage increase in 
calcium deposition resulting from the surface-immobilized ALP is higher. 
Earlier studies on the osteogenic potential of hADSCs and hMSCs reported 
that hMSCs either possess superior or similar osteogenic potential as hADSCs 
in in vitro studies using tissue culture polystyrene (Ardeshirylajimi et al., 2015, 
De Ugarte et al., 2003, Shafiee et al., 2011, Tognarini et al., 2008, 
Vishnubalaji et al., 2012), Ti (Tognarini et al., 2008) or poly(l-lactide) 
nanofibers (Ardeshirylajimi et al., 2015), and in in vivo studies where the cells 
were cultured on collagen sponge (Miyazaki et al., 2008), hydroxyapatite-β 
tricalcium phosphate scaffold (Jo et al., 2013) or atelocollagen scaffold 
(Hattori et al., 2004) and implanted in rat models. In the current study, our 
conclusion that hMSCs and hADSCs exhibit similar ostegenic differentiation 
potential is in agreement with some of these earlier in vitro studies (De Ugarte 
et al., 2003, Tognarini et al., 2008), despite differences in the source of origin 
of cells, cell culture protocol and duration of the assay. It is worth noting that 
the slower proliferation rate of hMSCs compared to hADSCs (comparing 
Figure 5-7(a) to Figure 5-9(a)) would be a disadvantage in potential 
applications which require large quantities of cells. 
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5.3.6 Assessment of Stability of ALP-Functionalized Substrates 
The enzymatic activities of ALP-Ti-1 and ALP-PDA-Ti-1 and the responses 
of osteoblasts cultured on ALP-Ti-1 and ALP-PDA-Ti-1 were evaluated after 
the substrates were subjected to 70% ethanol, autoclaving and prolonged 
immersion in PBS or PBS containing lysozyme. Figure 5-11 shows that 
treatment with 70% ethanol (ALP-Ti-1-ET) and autoclaving (ALP-Ti-1-AC) 
did not affect the enzymatic activities of the surface-anchored ALP, i.e. 
comparable enzymatic activity as that of ALP-Ti-1 was observed. On the other 
hand, prolonged immersion in PBS (ALP-Ti-1-PBS) and in PBS containing 10 
µg/mL lysozyme (ALP-Ti-1-LY) resulted in approximately 52-55% decrease 
in the enzymatic activity compared to ALP-Ti-1. For ALP-PDA-Ti-1, 70% 
ethanol treatment (ALP-PDA-Ti-1-ET) and autoclaving (ALP-PDA-Ti-1-AC) 
resulted in 37% and 96% decrease in the enzymatic activity compared to ALP-
PDA-Ti-1, respectively. Similar to ALP-Ti-1, prolonged immersion in PBS 
(ALP-PDA-Ti-1-PBS) and in PBS containing 10 µg/mL lysozyme (ALP-
PDA-Ti-1-LY) resulted in approximately 54-65% decrease in the enzymatic 
activity compared to ALP-PDA-Ti-1.  
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Figure 5-11 Enzymatic activity of as-prepared ALP-Ti-1 and ALP-PDA-Ti-1 
substrates and ALP-Ti-1 and ALP-PDA-Ti-1 substrates after different stability 
tests (* denotes significant difference (P<0.05) compared with the as-prepared 
ALP-Ti-1 and # denotes significant difference (P<0.05) compared with the as-
prepared ALP-PDA-Ti-1, respectively). 
 
From Figure 5-12(a), the ALP activities of osteoblasts cultured on ALP-Ti-1-
ET and ALP-Ti-1-AC are comparable to that on ALP-Ti-1 on both Day 7 and 
Day 14, indicating that the covalently bonded ALP was stable and retained its 
bioactivity after 70% ethanol treatment and autoclaving, consistent with the 
surface enzymatic activity results (Figure 5-11). Although an earlier study 
showed that ALP immobilized on Ti or glass surfaces via surface-activated 
hydroxyl groups on Ti is stable when subjected to gamma irradiation, e-beam 
irradiation and ethylene oxide (Ferraris et al., 2012), the effects of 70% 
ethanol treatment or autoclaving on the stability of immobilized ALP have not 
been reported before. ALP in aqueous medium is heat stable up to only 40 °C, 
and it loses 50% of its activity after heat treatment at 64 °C for 5 min, and is 
completely denatured after heating at 80 °C for 15 min (Bortolato et al., 2002, 
Craig et al., 1996, Delafourniere et al., 1995). This suggests ALP is a rather 
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heat liable enzyme. During thermal denaturation, ALP undergoes catastrophic 
loss of activity with chemical denaturation taking place at or near the active 
center of the enzyme (Craig et al., 1996, Delafourniere et al., 1995). The 
results in Figure 5-12(a) suggests that the covalent bonds formed between 
ALP and the CMCS coating inhibit the unfolding of the protein when 
subjected to autoclaving at 121 °C and to 70% ethanol. Although it is not 
possible to conclude that there was absolutely no denaturation of the 
immobilized ALP, the extent of denaturation, if any, is likely to be low since 
there was no adverse impact on the immobilized ALP’s enhancement of 
osteoblast functions. For ALP-PDA-Ti-1 (Figure 5-12(b)), the ALP activity of 
osteoblasts cultured on ALP-PDA-Ti-1-ET on Day 14 (but not Day 7) shows a 
decrease compared to that on ALP-PDA-Ti-1. Moreover, the ALP activity of 
osteoblasts cultured on ALP-PDA-Ti-1-AC is similar to that on Pristine-Ti, 
and is significantly lower than that on ALP-PDA-Ti-1 on both Day 7 and Day 
14. These results are in agreement with the enzymatic activity results of the 
substrates (Figure 5-11). Thus, the enzymatic activity assay and the cellular 
ALP activity assay confirm the lower stability of the surface-immobilized 
ALP on ALP-PDA-Ti-1 compared to that on ALP-Ti-1. 
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Figure 5-12 ALP activity of osteoblasts cultured for 14 days on (a) ALP-Ti-1 
substrates and (b) ALP-PDA-Ti-1 substrates subjected to 70% ethanol (-ET), 
autoclaving (-AC), 14 days immersion in PBS (-PBS) or PBS containing 10 
µg/mL of lysozyme (-LY) (* denotes significant differences (P<0.05) 
compared with Pristine-Ti and # denotes significant difference (P<0.05) 
compared with ALP-Ti-1 at the same time point, respectively). 
 
From Figure 5-12(a), the ALP activity of osteoblasts cultured on ALP-Ti-1 
after prolonged immersion in PBS or PBS containing lysozyme (ALP-Ti-1-
PBS and ALP-Ti-1-LY) on Day 14 (but not Day 7) shows a decrease 
compared to ALP-Ti-1 (P<0.05). Similar results were obtained with ALP-
PDA-Ti-1 substrates (Figure 5-12(b)). This decrease in the bioactivity of these 
ALP-modified substrates is in agreement with the results from the enzymatic 
activity assay (Figure 5-11). It has been previously shown that the CMCS 
coating on PDA-Ti is stable upon prolonged immersion in PBS (Zheng et al., 
2013). Thus, any loss in ALP bioactivity is likely due to changes in the ALP. 
It is known that inorganic phosphate ions cause inactivation of ALP dissolved 
in aqueous medium due to competitive inhibition (Coleman, 1992). When 
ALP-modified substrates are immersed in a fluid rich in inorganic phosphate 
ions, these ions are likely to be attracted to and bind to the active sites of the 
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immobilized ALP (Ferraris et al., 2011, Verne et al., 2010). With the blockage 
of the active sites by inorganic phosphate ions, it is expected that the 
enzymatic activity of the surface-immobilized ALP will decrease. In the 
current study, the decrease in the osteoblast functions on ALP-Ti-1-PBS and 
ALP-Ti-1-LY compared to that on ALP-Ti-1 is thus attributed to this effect of 
the phosphate ions (10 mM) in the PBS buffer. In order to confirm this 
postulate, we determined the phosphorous content on ALP-Ti-0.5 and ALP-
Ti-1 before and after prolonged immersion in PBS and in PBS containing 10 
µg/mL lysozyme using ICP-MS. From Table 5-2, it can be seen that the 
phosphorous content on ALP-Ti-1-LY and ALP-Ti-1-PBS increased 
compared to that on ALP-Ti-1 (P<0.05). A similar result was obtained with 
ALP-Ti-0.5 substrate.  
 
Table 5-2 Phosphorous content (nM) on different substrates (per cm
2
) as 
measured by ICP-MS. 
 
 ALP-Ti-x ALP-Ti-x-LY ALP-Ti-x-PBS 
x=0.5 2.1±0.1 2.7±0.2* 2.8±0.2* 
x=1 2.4±0.1 3.1±0.2* 3.2±0.1* 
*
denotes significant difference (P<0.05) compared with the corresponding ALP-Ti-x 
substrate. 
 
The concentration of lysozyme in human serum is reported to range between 7 
and 13 µg/mL. In this study, a concentration of 10 µg/mL was used to mimic 
the physiological conditions (Hankiewi.J and Swiercze.E, 1974). Lysozyme 
has been reported to degrade chitosan-based materials in vivo and in vitro via 
hydrolysis of the glycosidic bonds present in the polysaccharide backbone 
(Tomihata and Ikada, 1997). Bacterial adhesion assays on CMCS-Ti substrates 
after prolonged immersion in PBS containing lysozyme (10 µg/mL) show that 
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the antibacterial property of CMCS is well preserved (reduction of ~89% and 
~91% in adherent bacterial cells on CMCS-Ti, before and after prolonged 
immersion in PBS containing lysozyme, respectively), and hence the CMCS 
coating is stable. The similarity in the ALP activity of osteoblasts cultured on 
ALP-Ti-1-LY and ALP-Ti-1-PBS (Figure 5-12(a)) and on ALP-PDA-Ti-1-LY 
and ALP-PDA-Ti-1-PBS (Figure 5-12(b)) also suggests that the bioactivity of 
the immobilized ALP was not affected by the lysozyme in PBS. Although the 
ALP activities of osteoblasts on ALP-Ti-1-PBS and ALP-Ti-1-LY showed a 
moderate decrease compared to that on ALP-Ti-1, they are still significantly 
higher than that on Pristine-Ti (Figure 5-12(a)), which indicates that these 
ALP-modified substrates may be suitable for long-term use under 
physiological conditions. 
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5.4 Conclusion 
In this Chapter, ALP was covalently immobilized on CMCS-modified Ti to 
achieve a bifunctional coating. The coating retained the antibacterial property 
of CMCS and resulted in ~89% reduction in S. epidermidis adhesion. The 
ALP immobilized in this manner achieved a higher enzymatic activity 
compared to that immobilized on PDA-coated Ti, possibly due to a higher 
surface density of immobilized ALP and/or a more favorable conformation in 
the former. The bifunctional coating prepared using an ALP solution of 50 
μg/cm2 resulted in 108% higher cellular ALP activity and 44% more calcium 
deposition by osteoblasts after 14 and 21 days, respectively, compared to those 
on Pristine-Ti. Similarly, significant enhancement in osteogenic differentiation 
of hMSCs and hADSCs in terms of cellular ALP activity, calcium deposition 
and expression of osteogenic gene markers of RUNX2, OSX and OC was 
achieved. Lastly, the stability of ALP immobilized on the CMCS coating is 
significantly improved over its free form. The surface-anchored ALP was 
stable when subjected to 70% ethanol and autoclaving, but lost ~50% of its 
enzymatic bioactivity after immersion in PBS or PBS containing lysozyme for 
14 days. The results in this Chapter show that the bifunctional coating based 
on CMCS and conjugated ALP on Ti has good potential in future applications 
in bone tissue engineering. 
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CHAPTER 6 EFFECTS OF SURFACE 
TOPOGRAPHY AND SURFACE CHEMISTRY OF 
TITANIUM ON OSTEOBLAST FUNCTIONS 
Chapter 6  
144 
 
6.1 Introduction 
The strategies described in Chapters 3 to 5 focused on the modification of the 
surface chemistry of Ti. Since surface topography of Ti also plays a critical 
role in modulating cell responses, modification of the surface topography of Ti 
for enhancement of cell functions were carried out and discussed in this 
Chapter. Furthermore, comparisons were made between the effects of surface 
topography and surface chemistry on osteoblast functions. As highlighted in 
Chapter 2, nanotubular features on Ti enhance the osteoblast functions. Thus, 
in this Chapter, the surface topography of Ti was altered by formation of a 
layer of NTs on the surface of Ti. The surface chemistry of Ti was modified 
with the therapeutic molecules investigated in Chapters 3 to 5 (i.e. BMP-2, 
alendronate and ALP). The modification of both surface topography and 
surface chemistry of Ti was also carried out by covalent immobilization of 
BMP-2, alendronate and ALP on TiNT, respectively. The enhancement of 
osteoblasts’ ALP activity and calcium deposition due to the surface-
immobilized molecules, surface NTs and combination of surface-immobilized 
molecules and surface NTs was investigated and compared.  
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6.2 Materials and Methods 
6.2.1 Materials 
Ethylene glycol and ammonium fluoride were purchased from Sigma Aldrich. 
All other chemicals were similar to those described in Section 3.2.1, Section 
4.2.1 and Section 5.2.1.  
 
6.2.2 Preparation of TiNT 
Ti foils were cut into 3 cm × 1 cm pieces. The cleaning of Ti substrates was as 
described in Section 3.2.3, and the cleaned Ti substrates were denoted as 
Pristine-Ti. To prepare TiNT substrates, a platinum foil (as cathode) and a 
Pristine-Ti substrate (as anode) were connected with copper wires to a DC 
power source (3645A DC power supply, Circuit Specialists, Mesa, US). A 
constant voltage of 20 V was applied for 0.5 h, 1.5 h or 4.5 h following the 
procedure of an earlier study (Kowalski and Schmuki, 2010). The different 
durations of the anodization resulted in TiNT substrates with different tube 
lengths. The distance between the Ti anode and the platinum cathode was kept 
constant at about 2 cm. The electrolyte solution used was ethylene glycol-
water electrolyte (55:45 v/v) containing ammonium fluoride (0.27 M) and the 
anodization of Pristine-Ti was carried out inside a plastic beaker. After the 
reaction, the substrates were washed with 70% ethanol and cleaned in an 
ultrasonic bath using distilled water for 15 min. The substrates were then 
rinsed with copious amounts of distilled water, dried under reduced pressure 
and autoclaved (denoted as TiNT-0.5h, TiNT-1.5h or TiNT-4.5h, depending 
on the duration of the anodization process). 
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6.2.3 Coating of PDA on Pristine-Ti and TiNT and Subsequent BMP-2 
Conjugation 
Pristine-Ti and TiNT-1.5h were coated with PDA as described in Section 
3.2.5. After the coating process, the substrates were immersed in 70% ethanol 
for 1 h, rinsed with copious amounts of sterile distilled water and left to air-
dry in the sterile environment of a biosafety cabinet (denoted as PDA-Ti and 
PDA-TiNT, respectively). To conjugate BMP-2 on the substrate, an area of 1 
cm × 1 cm on PDA-Ti and PDA-TiNT was marked. The marked areas of the 
PDA-Ti and PDA-TiNT substrates were then covered with 0.05 mL of 10 mM 
Tris buffered (pH=8.5) solution containing 45 and 50 ng of BMP-2 overnight 
(~12 h), respectively. Different amounts of BMP-2 were used during the 
conjugation reaction for the two substrates in order to prepare the BMP-2-
modified Ti and the BMP-2-modified TiNT with comparable amount of 
surface-immobilized BMP-2. After conjugation, the substrates were rinsed 
with sterile PBS to remove physically adsorbed BMP-2 and left to air-dry 
(denoted as BMP-PDA-Ti and BMP-PDA-TiNT, respectively). 
 
6.2.4 Coating of APTES on Pristine-Ti and TiNT and Subsequent 
Alendronate Conjugation 
Pristine-Ti and TiNT-1.5h were coated with APTES as described in Section 
4.2.3 and the as-prepared substrates were denoted as Silane-Ti and Silane-
TiNT, respectively. To introduce glutaraldehyde linker, an area of 1 cm × 1 
cm on Silane-Ti and Silane-TiNT was first marked. The marked areas of the 
Silane-Ti and Silane-TiNT substrates were treated with glutaraldehyde 
solution as described in Section 4.2.3 and the substrates after the treatment 
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were denoted as GA-Ti and GA-TiNT, respectively. To conjugate alendronate, 
the marked areas of GA-Ti and GA-TiNT were treated with 0.5 mL of 
alendronate aqueous solution containing 1 and 0.5 mg/mL alendronate 
overnight (~12 h), respectively. Different amounts of alendronate were used 
during the conjugation reaction for the two substrates in order to prepare the 
alendronate-modified Ti and the alendronate-modified TiNT with comparable 
amount of surface-immobilized alendronate. After the reaction, substrates 
were immersed in 70% ethanol for 1 h, rinsed with copious amounts of sterile 
distilled water and left to air-dry in the sterile environment of a biosafety 
cabinet (denoted as ALN-S-Ti and ALN-S-TiNT, respectively). 
 
6.2.5 Coating of PDA on Pristine-Ti and TiNT and Subsequent ALP 
Conjugation 
Surface modification of Pristine-Ti and TiNT-1.5h with PDA was carried out 
as described in Section 6.2.3. After that, the substrates were immersed in 70% 
ethanol for 1 h, rinsed with copious amounts of sterile distilled water and left 
to air-dry in the sterile environment of a biosafety cabinet. To conjugate ALP, 
an area of 1 cm × 1 cm on PDA-Ti and PDA-TiNT was first marked. Then, 
the marked areas of the PDA-Ti and PDA-TiNT substrates were covered with 
0.05 mL of 10 mM Tris buffered (pH=8.5) solution containing 5 and 50 µg of 
ALP overnight (~12 h), respectively. Different amounts of ALP were used 
during the conjugation reaction for the two substrates in order to prepare the 
ALP-modified Ti and the ALP-modified TiNT with comparable enzymatic 
bioactivity. After reaction, the substrates were rinsed four times with copious 
amounts of distilled water and washed for at least 30 min under continuous 
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shaking to remove adsorbed ALP and left to air-dry (denoted as ALP-PDA-Ti 
and ALP-PDA-TiNT, respectively). 
 
6.2.6 Characterization 
The methods for determining surface composition and water contact angle 
were similar to those described in Section 3.2.7. In order to estimate the 
lengths of the NTs formed on the TiNT substrates, the surfaces of TiNT-0.5h, 
TiNT-1.5h and TiNT-4.5h were scratched using a thin blade. The scratched-
off debris containing NTs and the surfaces of different Ti and TiNT based 
substrates were viewed using field emission scanning electron microscopy 
(FESEM, JEOL JSM-6700, Tokyo, Japan). The surface density of 
immobilized BMP-2 on BMP-PDA-Ti or BMP-PDA-TiNT was determined as 
described in Section 3.2.4. The surface density of immobilized alendronate on 
ALN-S-Ti and ALN-S-TiNT was determined as described in Section 4.2.4. 
The enzymatic bioactivity of ALP-PDA-Ti and ALP-PDA-TiNT substrates 
was determined as described in Section 5.2.3. 
 
6.2.7 Osteoblast Culture and Cell Attachment Assay  
The cell culture protocol for osteoblasts was similar to that described in 
Section 3.2.9. For cell seeding, 0.05 mL of osteoblast suspension containing 
~5,000 cells was added to the marked area of 1 cm × 1 cm on each substrate 
(placed in a Petri dish). After 6 h, the substrates were placed in a cell culture 
assembly and 1.95 mL of growth medium was added to each culture well as 
shown in Figure 6-1. Cell culture was carried out on a vertical substrate in the 
assembly shown in Figure 6-1 since this configuration was needed for ES 
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experiments described in Chapter 7. The protocol for assessment of cell 
proliferation was as described in Section 5.2.6. 
 
Figure 6-1 Diagram illustrating (a) osteoblast seeding and (b) cell culture 
assembly. 
 
6.2.8 ALP Activity and Calcium Deposition Assay 
The culture protocol for osteoblasts and the protocol for ALP activity assay 
and calcium deposition assay were as described in Section 3.2.10.  
 
6.2.9 Statistical Analysis 
The statistical analysis was carried out as described in Section 3.2.11. 
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6.3 Results and Discussion 
6.3.1 Surface Characterization 
The FESEM images of pristine and modified Ti substrates are shown in Figure 
6-2. The surface of Pristine-Ti does not have nanofeatures (Figure 6-2(a)) 
while highly ordered NTs were formed on the surface of the TiNT substrate 
(Figure 6-2(b)). Figure 6-2(c) shows that the inner diameter of the NTs is ~80-
100 nm. The wall thickness of the NTs is < 10 nm and the interspace between 
neighboring NTs is mostly between 10 and 25 nm. The lengths of the NTs 
formed on TiNT substrates are dependent on the duration of the anodization. 
From Figure 6-3, the lengths of the NTs on TiNT-0.5h, TiNT-1.5h and TiNT-
4.5h are ~350-400 nm (Figure 6-3(a)), ~600-650 nm (Figure 6-3(b)) and ~800-
850 nm (Figure 6-3(c)), respectively. The diameters of these NTs on TiNT-
0.5h, TiNT-1.5h and TiNT-4.5h are similar (~80-100 nm), as shown in the 
insets in Figure 6-3((a)-(c)). The water contact angle of Pristine-Ti was 68° 
whereas the water contact angle of TiNT-1.5h was ~10° (Table 6-1). The NTs 
formed on the surface of TiNT have been reported to be partially hydroxylated 
and of polar nature (Balaur et al., 2005). The water droplets spread and fill up 
the pores of the NTs and form an air-free contact on the TiNT substrate, 
resulting in a highly hydrophilic surface (Macak et al., 2007). Thus, the drastic 
difference in the water contact angle between TiNT-1.5h and Pristine-Ti is 
attributed to the polar nature and the nanotopography of the surface of TiNT. 
The hydrophilic TiNT surface in the current study is consistent with other 
reported works (Das et al., 2009, Hu et al., 2012). 
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Figure 6-2 FESEM images of (a) Pristine-Ti, (b-c) TiNT, (d) PDA-TiNT, (e) 
Silane-TiNT, (f) BMP-PDA-TiNT, (g) ALN-S-TiNT and (h) ALP-PDA-TiNT 
substrates. Scale bars in (a-b) and (d-h) represent 400 nm and scale bar in (c) 
represents 200 nm. 
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Figure 6-3 FESEM images of the scratched-off NTs from (a) TiNT-0.5h, (b) 
TiNT-1.5h and (c) TiNT-4.5h. The insets show the surface morphologies of 
different as-prepared substrates. Scale bars in (a-c) and the insets represent 
200 nm 
 
Since only TiNT-1.5h and TiNT-4.5h resulted in enhanced biological response 
(results shown in Section 6.3.2) and the time for preparing TiNT-1.5h was one 
third of that for TiNT-4.5h, TiNT-1.5h was chosen for further surface 
modifications. Since surface modification of Pristine-Ti with PDA and APTES 
has been discussed in Chapter 3 and 4, this section focuses on the surface 
characterization of the TiNT-based substrates. The success of coating TiNT 
with PDA and silane anchor was confirmed using XPS. The XPS wide scan 
spectra for TiNT and functionalized TiNT are as shown in Figure 6-4. The 
decrease in intensity of the Ti 2p peak and increase in intensity of the N 1s 
peak after PDA was coated on TiNT confirmed the success of the coating 
process (Figure 6-4(b)). The appearance of Si 2s and Si 2p peaks after 
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silanization of TiNT, accompanied by a decrease in the intensity of Ti 2p peak 
and an increase in the intensity of C 1s peak, indicates the silane anchor was 
successfully coated on TiNT (Figure 6-4(c)). From Figure 6-2, the 
functionalization of TiNT with PDA and silane anchor did not alter the surface 
topography significantly (comparing Figure 6-2(d-e) with Figure 6-2(b)). 
However, the PDA and silane coatings decreased the wettability of the 
surfaces due to the hydrophobicity of these anchors, and the water contact 
angles of PDA-TiNT and Silane-TiNT were 35° and 63°, respectively (Table 
6-1).  
 
Table 6-1 Water contact angle of pristine and functionalized Ti substrates. 
 
Substrate Contact angle (°) 
Pristine-Ti 68±3 
TiNT-1.5h ~10* 
PDA-TiNT 35±3 
Silane-TiNT 63±3 
BMP-PDA-TiNT 28±4 
ALP-PDA-TiNT 32±2 
ALN-S-TiNT 44±3 
*
Due to the highly hydrophilic surface, a precise measurement of the contact angle 
was not possible. 
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Figure 6-4 XPS wide scan spectra of (a) TiNT (b) PDA-TiNT and (c) Silane-
TiNT. 
 
The amount of immobilized BMP-2 on BMP-PDA-Ti and BMP-PDA-TiNT 
was determined to be 35.1 ± 3.9 ng/cm
2
 and 31.4 ± 3.4 ng/cm
2
, respectively. 
About 11% more BMP-2 was required to conjugate a comparable amount of 
BMP-2 on PDA-TiNT compared to PDA-Ti. This may be due to the steric 
hindrance for protein conjugation resulting from the surface NTs of PDA-
TiNT. From the FESEM image (Figure 6-2(f)), surface modification of PDA-
TiNT with BMP-2 did not cause substantial changes in the surface topography 
(comparing Figure 6-2(f) with Figure 6-2(d)). From Table 6-1, it can be seen 
that the immobilized BMP-2 did not alter the surface wettability significantly.  
 
The amount of surface-immobilized alendronate on ALN-S-Ti and ALN-S-
TiNT was determined to be 1631 ± 41 ng/cm
2 
and 1609 ± 52 ng/cm
2
, 
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respectively. The amount of alendronate reagent used to achieve a similar 
amount of surface-immobilized alendronate on ALN-S-TiNT is half of that for 
ALN-S-Ti. Since alendronate is a small molecule, steric hindrance from the 
NTs is unlikely. The lesser amount of reagent required is likely due to the 
increased surface area of Silane-TiNT due to the surface NTs, which 
facilitated the conjugation of alendronate. Surface modification of Silane-
TiNT with alendronate also did not alter the surface topography significantly 
(comparing Figure 6-2(g) with Figure 6-2(e)). From Table 6-1, the water 
contact angle of ALN-S-TiNT decreased to 44° after alendronate was 
immobilized on Silane-TiNT.  
 
Unlike immobilized BMP-2 or alendronate, surface modification of PDA-
TiNT with ALP caused significant changes in the surface topography 
(comparing Figure 6-2(h) with Figure 6-2(d)). In Figure 6-2(h), the surface-
immobilized ALP covered some of the openings of the NTs and filled the 
interspace between neighboring NTs. ALP and BMP-2 were immobilized on 
PDA-TiNT via the same reaction chemistry. The visible difference in the 
surface morphologies (comparing Figure 6-2 (h) with Figure 6-2(f)) is 
probably due to the higher amount of ALP reagent used (50 µg of ALP 
compared to 50 ng of BMP-2 used during conjugation process). The 
enzymatic bioactivity of ALP-PDA-Ti and ALP-PDA-TiNT was determined 
to be 9.2 ± 2.5 μU/cm2 and 8.1 ± 2.3 μU/cm2, respectively. To achieve similar 
enzymatic activity of the immobilized ALP, the amount of ALP reagent used 
for ALP-PDA-TiNT is ten times that used for ALP-PDA-Ti. The amount of 
the ALP immobilized on ALP-PDA-TiNT is likely to be higher than that on 
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ALP-PDA-Ti, due to the much higher amount of ALP reagent used. However, 
much of the immobilized ALP in the former is buried in the interspace 
between the neighboring NTs, and the enzymatic bioactivity of these ALP 
molecules will be drastically reduced. From Table 6-1, it can be seen that the 
immobilized ALP did not alter the surface wettability. 
 
6.3.2 Assessment of Osteoblast Functions on TiNT and TiNT 
Functionalized with Surface Anchors 
The ALP activity of osteoblasts cultured on Pristine-Ti and TiNT substrates 
with different tube lengths over 14 days is as shown in Figure 6-5(a). On Day 
7, the ALP activity of osteoblasts cultured on TiNT-0.5h is similar to that on 
Pristine-Ti. On the other hand, the ALP activity of osteoblasts cultured on 
TiNT-1.5h is significantly higher than that on Pristine-Ti. The ALP activity of 
osteoblasts cultured on TiNT-4.5h is comparable to that on TiNT-1.5h, and is 
also significantly higher than that on Pristine-Ti. The ALP activity of 
osteoblasts cultured on Pristine-Ti and TiNT substrates with different tube 
lengths on Day 14 is similar to those on Day 7. Thus, the shorter NTs (~350-
400 nm) formed on TiNT have no effect on the osteogenic differentiation of 
osteoblasts whereas the longer tube lengths (~600-650 and ~800-850 nm) 
formed on TiNT enhance the osteogenic differentiation of osteoblasts. From 
Figure 6-5(b), it can be seen that over 7 days of cell culture, the cell number 
on TiNT-1.5h, PDA-TiNT and Silane-TiNT is comparable to that on Pristine-
Ti. This indicates the surface NTs and the immobilized PDA and silane on 
TiNT do not affect osteoblast proliferation. The ALP activity profiles of 
osteoblasts on pristine and functionalized substrates over 14 days are 
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compared in Figure 6-5(c). On Day 7, the ALP activity of osteoblasts cultured 
on TiNT-1.5h, PDA-TiNT and Silane-TiNT is comparable, and on average, 
~26% higher than that on Pristine-Ti. This osteogenic stimulating effect of the 
surface NTs is similar to some earlier studies (Brammer et al., 2009, Wang et 
al., 2014). On Day 14, the ALP activity of osteoblasts on all substrate 
increased compared to that on Day 7. Similar to Day 7, the surface NTs 
enhanced the osteoblasts’ ALP activity, resulting in ~22% increase in 
osteoblasts’ ALP activity on TiNT-1.5h, PDA-TiNT and Silane-TiNT 
substrates over that on Pristine-Ti. 
 
Figure 6-5 (a) ALP activity of osteoblasts over 14 days (b) osteoblast 
proliferation over 7 days, (c) ALP activity over 14 days and (d) calcium 
mineral deposition after 21 days (* denotes significant difference (P<0.05) as 
compared with Pristine-Ti at the same time point, respectively).  
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Figure 6-5(d) shows that the surface NTs increased calcium mineral deposition 
by osteoblasts by ~25% after 21 days compared to that on Pristine-Ti. The 
PDA and silane anchor immobilized on TiNT did not affect the mineral 
deposition by osteoblasts. The results in Figure 6-5(c) and Figure 6-5(d) show 
the osteogenic stimulating effects of the surface NTs. The PDA and silane 
anchors on TiNT-1.5h, on the other hand, did not affect osteoblast 
differentiation, similar to the results obtained with these surface anchors on 
Pristine-Ti, as shown in Chapters 3 to 5. 
 
6.3.3 Assessment of Osteoblast Functions on TiNT Functionalized with 
Immobilized Therapeutic Molecules 
ALP activity and calcium deposition were tested to compare the effects of 
surface NTs and surface-immobilized therapeutic molecules on osteoblast 
functions. Osteoblast proliferation was not tested as it has been shown in 
Section 6.3.2 and Chapter 4 and 5 that the surface NTs and surface-
immobilized alendronate and ALP do not affect osteoblast proliferation. 
Figure 6-6(a) shows the ALP activity of osteoblasts cultured on Ti-based and 
TiNT-based substrates over 14 days. On Day 7, the surface-immobilized 
BMP-2, alendronate and ALP resulted in ~31%, ~86% and ~112% increase in 
the ALP activity of osteoblasts on BMP-PDA-Ti, ALN-S-Ti and ALP-PDA-Ti 
compared to that on Pristine-Ti, respectively. On the other hand, the surface 
NTs resulted in ~24% increase in the ALP activity of osteoblasts on TiNT-
1.5h compared to that on Pristine-Ti. From the percentage increase in the 
osteoblasts’ ALP activity, the surface-immobilized BMP-2, alendronate and 
ALP are more effective than the surface NTs. With the combination of surface 
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NTs and surface-immobilized BMP-2, the ALP activity of osteoblasts cultured 
on BMP-PDA-TiNT was ~54% higher over that on Pristine-Ti. Thus, the 
combination of these two surface cues resulted in an additive effect in 
stimulating the ALP activity of osteoblasts. Unlike BMP-2 which has a more 
stimulating effect on the ALP activity of osteoblasts when immobilized on the 
TiNT-1.5h substrate than on Pristine-Ti, alendronate and ALP immobilized on 
these two substrates have comparable effects. 
 
Figure 6-6 (a) ALP activity of osteoblasts over 14 days and (b) calcium 
mineral deposition of osteoblasts after 21 days (* denotes significant 
difference (P<0.05) as compared with Pristine-Ti, # denotes significant 
difference (P<0.05) as compared with BMP-PDA-Ti, ^ denotes significant 
difference (P<0.05) as compared with ALN-S-Ti, & denotes significant 
difference (P<0.05) as compared with BMP-PDA-TiNT at the same time point, 
respectively). 
 
On Day 14, the ALP activity of osteoblasts cultured on BMP-PDA-Ti, ALN-
S-Ti and ALP-PDA-Ti was comparable, which is on average ~63% higher 
than that on Pristine-Ti. On the other hand, the surface NTs resulted in ~21% 
increase in the osteoblasts’ ALP activity over that on Pristine-Ti. Similar to 
Day 7, the surface-immobilized therapeutic molecules have a greater 
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osteogenic stimulating effect than that of surface NTs. With the combination 
of surface-immobilized BMP-2 and surface NTs, the osteoblasts on BMP-
PDA-TiNT exhibited ~82% higher ALP activity over those on Pristine-Ti. 
Similarly, the combination of surface-immobilized alendronate and surface 
NTs also resulted in ~84% increase in the ALP activity of osteoblasts on 
ALN-S-TiNT compared to that on Pristine-Ti. These two pairs of surface cues 
thus resulted in an additive effect on the osteoblast functions.  
 
On the other hand, the combination of surface-immobilized ALP and surface 
NTs resulted in ~59% increase in osteoblasts’ ALP activity on ALP-PDA-
TiNT compared to that on Pristine-Ti. This extent of increase is similar to that 
obtained with just the surface-immobilized ALP. Thus, the NTs on ALP-PDA-
TiNT appeared to have little effect on the ALP activity of osteoblasts. It has 
been proposed that NTs enhance the differentiation of stem cells by causing 
elongation of the cells, which induces cytoskeletal stress and thus osteogenic 
differentiation (Oh et al., 2009). The interspace between neighboring NTs is 
also reported to possibly facilitate the continuous fluid flow of culture medium, 
which increases the exchange for gas, nutrients and cell signaling molecules 
for overall enhancement of cell functions (Brammer et al., 2012). On ALP-
PDA-TiNT, the openings of the NTs were partially covered and the interspace 
of the NTs was filled with the immobilized ALP (Figure 6-2(h)). These 
changes in surface topography may compromise the osteogenic stimulating 
effects of the surface NTs, and rendered them ineffective for enhancing the 
ALP activity of the osteoblasts. 
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On Day 21, the osteoblasts cultured on BMP-PDA-Ti, ALN-S-Ti and ALP-
PDA-Ti substrates deposited ~37%, ~30% and ~23% more calcium minerals, 
compared to those on Pristine-Ti (Figure 6-6(b)). The surface NTs on TiNT-
1.5h resulted in ~23% more calcium deposition by osteoblasts, compared to 
that on Pristine-Ti. The combination of the surface-immobilized BMP-2 and 
surface NTs resulted in ~63% more calcium deposition by the osteoblasts on 
BMP-PDA-TiNT compared to that on Pristine-Ti. Thus, the combination of 
the surface-immobilized BMP-2 and surface NTs again resulted in an additive 
effect. The combination of the surface-immobilized alendronate and surface 
NTs resulted in ~42% more calcium deposition by the osteoblasts on ALN-S-
TiNT compared to that on Pristine-Ti. This extent of increase is slightly lower 
than the sum of the effects due to the surface-immobilized alendronate and 
surface NTs separately. In addition, the osteoblasts on ALP-PDA-TiNT 
deposited ~19% more calcium compared to those on Pristine-Ti, and this 
amount is comparable to that on ALP-PDA-Ti. Thus, the surface NTs on the 
ALP-PDA-TiNT also appeared to have no effects on mineral deposition by 
osteoblasts for the same reason as the lack of effect on ALP activity. 
Comparing the combinations of surface cues, the combination of surface-
immobilized BMP-2 and surface NTs resulted in the highest increase in 
calcium deposition by osteoblasts. 
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6.4 Conclusion 
In this Chapter, the effects of surface topography and surface chemistry of Ti 
on osteoblast functions were investigated and compared. The surface 
topography of Ti was altered by formation of NTs, while the surface chemistry 
was modified with BMP-2, alendronate or ALP. The surface NTs were shown 
to enhance the differentiation of osteoblasts, resulting in ~21% and ~23% 
increase in osteoblasts’ ALP activity on Day 14 and calcium deposition on 
Day 21, respectively. The surface-immobilized BMP-2, alendronate and ALP 
were more effective than the surface NTs in enhancing the osteoblasts’ ALP 
activity. Surface NTs act in concert with either surface-immobilized BMP-2 or 
surface-immobilized alendronate in an additive manner on osteoblast functions. 
On the other hand, the effect of surface NTs on ALP-PDA-TiNT was minimal 
due to the blockage of the NTs’ openings and interspaces by the immobilized 
ALP. The combination of surface-immobilized BMP-2 and surface NTs was 
the most effective in stimulating osteoblast differentiation, resulting in 63% 
increase in calcium deposition compared to that on Pristine-Ti. 
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CHAPTER 7 EFFCTS OF SURFACE CUES IN 
COMBINATION WITH ELECTRICAL 
STIMULATION ON OSTEOBLAST 
PROLIFERATION AND FUNCTIONS 
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7.1 Introduction 
As shown in Chapter 6, the combination of surface-immobilized BMP-2 and 
surface NTs on Ti significantly enhances osteoblast differentiation. In this 
Chapter, the possibility of utilizing these surface cues in combination with ES 
to further enhance osteoblast functions was explored. As highlighted in 
Chapter 2, biopotential is the natural electric property that controls the growth 
and development of bone tissue. As endogenous electric fields modulate bone 
cell activities, it can be assumed that exogenous ES can also be applied to 
enhance bone cell functions (Gittens et al., 2011).  
 
ES can be applied via DC, IC or CC stimulation in clinical applications. The 
advantages of DC stimulation over IC and CC stimulation have been reviewed 
in Chapter 2. DC stimulation at 25 µA applied for 15 min for three times a day 
has been reported to stimulate the proliferation of human fetal osteoblast cells 
(hFOBs) cultured on Ti in vitro (Bodhak et al., 2012). Recently, biphasic 
electric current (BEC) stimulation, which is generally used in neural prosthetic 
devices, has been reported to enhance osteoblast and stem cell functions 
(Ercan and Webster, 2010, 2008, Kim et al., 2009, Kim et al., 2006). With 
BEC stimulation, there is no accumulation of charged proteins on electrodes, 
and charge balance and constant pH of the culture medium can be maintained 
(Ercan and Webster, 2010, Kim et al., 2009). It has been reported that biphasic 
pulsed current applied for 1 h/day at 4.2 A/cm
2
 or 195 µA results in enhanced 
osteoblast proliferation and differentiation on pristine Ti and on TiNT 
compared to those without ES in vitro (Ercan and Webster, 2010, 2008). 
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Despite the reported positive effects of DC or BEC stimulation on 
osteogenesis, there is little knowledge of how different combinations of ES 
parameters will affect osteoblast functions. The manner in which the current is 
applied to the osteoblasts (e.g. DC or BEC and direction of current with 
respect to the surface of the substrate) may affect their proliferation 
differently. In this Chapter, the effects of DC and BEC applied via different 
methods on osteoblasts cultured on pristine Ti or on TiNT were first 
investigated. The ES parameters that resulted in the highest proliferation rate 
were used to study the effects of surface-immobilized BMP-2, surface-NTs 
and ES on osteoblast functions. BMP-2 was conjugated to the TiNT substrate 
via either PDA or polypyrrole-1-propionic acid (PPYC) linker. Since the PDA 
coating is semi-conductive (Meredith and Sarna, 2006) while the PPYC 
coating is conductive (Lee et al., 2006), the effect of electrical property of the 
surface coating on osteoblast functions when subjected to ES was also 
investigated. 
 
Chapter 7  
166 
 
7.2 Materials and Methods 
7.2.1 Materials 
Pyrrole-1-propionic acid (PYC) was purchased from Accela (San Diego, US). 
Sodium dodecyl sulfate was purchased from Sigma Aldrich. All other 
chemicals were similar to those described in Section 3.2.1, Section 4.2.1, 
Section 5.2.1 and Section 6.2.1.  
 
7.2.2 Preparation of TiNT 
Ti foils were cut into 3 cm × 1.3 cm pieces for experiments conducted in the 
horizontal assembly (described in Section 7.2.5) and 3.9 cm × 1 cm pieces for 
experiments conducted in the vertical assembly (described in Section 7.2.5). 
The cleaning of Ti substrates was as described in Section 3.2.3, and the 
cleaned Ti substrates were denoted as Pristine-Ti. The preparation of TiNT 
substrates was as described in Section 6.2.2, and the TiNT-1.5h substrate 
(nanotubular Ti formed after anodization for 1.5 h) prepared in Chapter 6 was 
used and denoted as TiNT in this Chapter. 
 
7.2.3 Coating of PDA on TiNT and Subsequent BMP-2 Conjugation 
ES experiments (described in Section 7.2.5) showed that higher osteoblast 
proliferation on the TiNT substrate was achieved in the vertical assembly 
compared to the horizontal assembly. Thus, surface modification of TiNT with 
PDA and BMP-2 was only carried out on the substrates for use in the vertical 
assembly. TiNT (3.9 cm × 1 cm) were coated with PDA and BMP-2 
sequentially as described in Section 6.2.3. The surface density of BMP-2 
immobilized on the substrate was calculated as described in Section 3.2.4. 
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7.2.4 Coating of PPYC on TiNT and Subsequent BMP-2 Conjugation 
Similarly, surface modification of TiNT with PPYC and BMP-2 was only 
carried out on the substrates for the vertical assembly. The 
electropolymerization of PYC was carried out at room temperature using an 
Autolab electrochemical workstation PGSTAT302N (EcoChemie, Utrecht, 
Netherlands) with the installed software (General Purpose Electrochemical 
System v4.9, EcoChemie). A three-electrode cell containing 10 mL of PYC 
(0.1 M) and sodium dodecyl sulfate (25 mM) in aqueous solution was used 
with a saturated calomel reference electrode, a platinum counter electrode and 
a TiNT (3.9 cm × 1 cm) working electrode (Kowalski and Schmuki, 2010, 
Kowalski et al., 2011). The solution was deaerated by bubbling nitrogen for 
20 min before the experiment and the cell was kept under nitrogen atmosphere 
during electropolymerization. A linear sweep voltammetry protocol based on 
an earlier study (Xie and Du, 2012) was applied with a scan rate of 0.004 V/s 
and potential increase from 0.7 to 1.1 V in steps of 0.004 V. After completion 
of electropolymerization, the substrates were rinsed with copious amounts of 
distilled water, immersed in 70% ethanol for 1 h, rinsed with copious amounts 
of sterile distilled water and left to air-dry in the sterile environment of a 
biosafety cabinet (denoted as PPYC-TiNT). Before conjugation with BMP-2, 
the carboxyl groups on PPYC-TiNT were activated by reaction with freshly 
prepared NHS (313 mM) and EDC (125 mM) in 0.1 M MES buffer (pH=6.0) 
for 1 h. The substrates were rinsed with MES buffer, and then 0.05 mL of 
MES buffer containing 50 ng of BMP-2 was added to a marked area of 1 cm × 
1 cm on PPYC-TiNT for overnight reaction. After reaction, the substrates 
were rinsed with sterile PBS to remove unreacted or surface-adsorbed BMP-2 
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and left to air-dry (denoted as BMP-PPYC-TiNT). The amount of 
immobilized BMP-2 on PPYC-TiNT was calculated as described in Section 
3.2.4. 
 
7.2.5 ES Experiment 
The assembly for cell culture and application of ES was labeled “horizontal” 
or “vertical” to denote how the Ti or TiNT substrates were positioned with 
respect to the applied current (Figure 7-1). In the horizontal assembly, the 
direction of the applied current was parallel to the surface of the substrate, 
whereas in the case of the vertical assembly, the direction of the applied 
current was perpendicular to the surface of the substrate. 
 
The cell culture assemblies were first cleaned in an ultrasonic bath using 
distilled water and 70% ethanol for 15 min each, and then immersed in 70% 
ethanol for overnight, followed by irradiation under UV light in a biosafety 
cabinet for 1 h prior to use. Cell seeding (described in Section 7.2.7) was 
carried out directly on the Ti or TiNT substrate in the horizontal assembly 
(Figure 7-1(a)). For the vertical assembly, cell seeding was first carried out on 
the substrates placed in a Petri dish, and two substrates with attached 
osteoblasts were positioned face-to-face in the vertical assembly to act as the 
anode and cathode (Figure 7-1(b)). Copper tape was used to fix the substrates 
to the cover of the vertical assembly. For both assemblies, DC or BEC 
stimulation was applied to osteoblasts 8 h after cell seeding. For the ES 
experiments, two alligator clips were attached to the substrates and then 
connected to a Keithley 6221 current source (Keithley Instruments Inc., 
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Boston, US). The entire assembly was placed in an incubator maintained at 
37 °C in 5% CO2 and 95% air. For DC stimulation, different ES periods (1-6 
h/day) and current (50-250 µA) were tested. For BEC stimulation, a square 
wave function with current of 200 µA and -200 µA per cycle was applied at a 
frequency of 20 Hz. Different ES periods (1-6 h/day) were tested.  
 
7.2.6 Characterization  
The methods for determining surface composition and water contact angle 
were similar to those described in Section 3.2.7. The surface morphologies of 
the substrates were viewed using FESEM as described in Section 6.2.6. The 
electrical resistivity of the substrates was determined using a four point 
resistivity system (Signatone Pro4, Lucas Labs, Gilroy, US) at 20 °C and 60% 
relative humidity. Briefly, Ti foils were cut into 2 cm × 2 cm pieces and the 
cleaning procedure and surface functionalization of Ti were similar to those 
described in Sections 7.2.2 to 7.2.4. The Ti or TiNT based tested substrate was 
placed on the resistivity platform. Then, a four point probe with 1.59 mm 
spacing between neighboring probes was placed in direct contact with the top 
surface of the center of the tested substrate. After the four point probe was 
connected to a multimeter and a current source (Keithley Instruments Inc., 
Boston, US), the current across the outer probes was set at 100 mA and the 
voltage across the inner probes was measured. The thickness of the substrate 
was measured using a vernier scale. As the thickness of the tested substrates 
was less than half of the probe spacing (results shown in Section 7.3.1), the 
resistivity of the tested substrate was determined according to the following 
equation (Schroder, 2006, Smits, 1958): 
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Resistivity = π / ln2 × t × (V/I) × f1 × f2 
Where 
t = thickness of the tested substrate 
V = voltage across the inner probes 
I = current across the outer probes 
f1 = finite thickness correction factor = 1  
f2 = finite geometry correction factor = 0.95 
f1 and f2 were obtained from the correlation charts reported in the literature 
(Smits, 1958, Uhlir, 1955). 
 
7.2.7 Cell Culture and Attachment Assay 
The cell culture protocol for osteoblasts was similar to that described in 
Section 3.2.9. For experiments conducted in the horizontal assembly, 0.05 mL 
of cell suspension containing ~5,000 cells was added onto 1 cm
2
 of the 
substrate in each well. After 6 h, another 0.95 mL of growth medium was 
added to each well. For experiments conducted in the vertical assembly, 0.05 
mL of cell suspension containing ~5,000 cells was added to a marked area of 1 
cm
2
 on each substrate. After 6 h, the substrates were placed in the vertical 
assembly and 1.95 mL of growth medium was added to each well. The 
protocol for assessment of cell proliferation was as described in Section 5.2.6. 
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Figure 7-1 Diagram illustrating (a) horizontal and (b) vertical assembly for ES 
experiment. In the horizontal assembly, the direction of the applied current 
was parallel to the surface of the substrate. In the vertical assembly, the 
direction of the applied current was perpendicular to the surface of the 
substrate. 
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7.2.8 ALP Activity and Calcium Deposition Assay  
The culture protocol for osteoblasts and the protocol for ALP activity assay 
and calcium deposition assay were as described in Section 3.2.10. The 
protocol for calcium staining assay after 21 days using Alizarin Red S was as 
described in Section 4.2.6. 
 
7.2.9 Statistical Analysis 
The statistical analysis was carried out as described in Section 3.2.11. 
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7.3 Results and Discussion 
7.3.1 Surface Characterization of Functionalized Ti 
The surface morphology and water contact angle of TiNT have been discussed 
in Section 6.3.1. The thickness of the Ti and TiNT based substrates was 
measured to be 0.39-0.44 mm. The resistivity of Pristine-Ti was calculated to 
be 185 ± 2 µΩ-cm and the presence of NTs on the TiNT substrate resulted in a 
small but significant increase in the electrical resistivity to 192 ± 2 µΩ-cm 
(Table 7-1). 
 
Table 7-1 Water contact angle and electrical resistivity of pristine and 
functionalized Ti substrates. 
 
Substrate Contact angle (°) Resistivity (µΩ-cm) 
Pristine-Ti 68±3 185±2 
TiNT ~10* 192±2 
PDA-TiNT 35±3 201±8 
BMP-PDA-TiNT 28±4 212±6 
PPYC-TiNT 38±5 195±4 
BMP-PPYC-TiNT 32±2 205±9 
*
Due to the highly hydrophilic surface, a precise measurement of the contact angle 
was not possible. 
 
The success of coating TiNT with PDA was confirmed using XPS as shown in 
Section 6.3.1. The XPS wide scan spectra for TiNT and PPYC-TiNT are as 
shown in Figure 7-2. The decrease in intensity of the Ti 2p peak and increase 
in intensity of the N 1s peak after PPYC was coated on TiNT confirmed the 
success of the coating process (Figure 7-2(b)). From FESEM image (Figure 7-
3(a)), the functionalization of TiNT with PPYC did not alter the surface 
topography significantly (comparing Figure 7-3(a) with Figure 6-2(b)). 
However, similar to PDA coating, the PPYC coating decreased the wettability 
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of the surfaces due to the hydrophobicity of PPYC, and the water contact 
angle of PPYC-TiNT substrate was measured to be 38° (Table 7-1). 
 
It has been reported that PDA is semi-conductive due to its melanin-like 
structure, and the conductivity of melanin film is estimated to be ~1 × 10
-7
 
S/cm at 60% relative humidity (Jastrzebska et al., 1995). On the other hand, 
the conductivity of PPYC film was reported to be 4.65 × 10
-4
 S/cm (Lee et al., 
2006). It can be seen from Table 7-1 that despite the substantial differences in 
the conductivities of PDA and PPYC, PDA-TiNT and PPYC-TiNT exhibited 
rather similar electrical resistivity. This is because the PDA and PPYC 
coatings were very thin (less than the probing depth of XPS, which has been 
reported to be ~2-10 nm (Smentkowski, 2014)) as indicated by the Ti 2p 
signal in the wide scan spectra of PDA-TiNT (Figure 6-4(b)) and PPYC-TiNT 
(Figure 7-2(b)). As such, the resistivities of both PDA-TiNT and PPYC-TiNT 
were similar to that of TiNT.  
 
Figure 7-2 XPS wide scan spectra of (a) TiNT (b) PPYC-TiNT. 
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Figure 7-3 FESEM images of (a) PPYC-TiNT and (b) BMP-PPYC-TiNT. 
Scale bar = 400 nm. 
 
The amount of BMP-2 immobilized on the PDA-TiNT and PPYC-TiNT 
surfaces was determined to be 31.4 ± 3.4 ng/cm
2
 and 36.5 ± 5.8 ng/cm
2
, 
respectively, when a BMP-2 loading solution of 50 ng/cm
2
 was used. Surface 
modification of PDA-TiNT with BMP-2 has been shown not to cause 
substantial changes in the surface topography in Chapter 6. From the FESEM 
images (Figure 7-3), surface modification of PPYC-TiNT with BMP-2 also 
did not cause substantial changes in the surface topography (comparing Figure 
7-3(b) with Figure 7-3(a)). From Table 7-1, it can be seen that the 
immobilized BMP-2 did not alter the surface wettability and electrical 
resistivity of the substrates. 
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7.3.2 Assessment of Tolerance of Osteoblasts to ES 
Osteoblasts cultured on Pristine-Ti in the horizontal and vertical assemblies 
were subjected to DC stimulation of 50, 100, 150, 200 and 250 µA for 4 h/day 
for 7 days, respectively. From Figure 7-4(a), DC stimulation in the range of 
50-250 µA did not affect the proliferation of osteoblasts cultured in the 
horizontal assembly on Day 1 or Day 4. However, on Day 7, significant 
increase in number of osteoblasts compared to that without ES was observed 
when the osteoblasts were subjected to DC stimulation of 100, 150 and 200 
µA. An earlier study similarly showed that the metabolic activity of 
osteoblasts cultured on polypyrrole/chitosan film was significantly increased 
when subjected to DC stimulation of 100-200 µA for 4 h/day although this 
increase was observed after 4 days (Zhang et al., 2013). The most number of 
osteoblasts was observed with 200 µA stimulation, resulting in 37% more 
osteoblasts than without ES and 24% more osteoblasts than with 100 µA. 
When the current was increased to 250 µA, significantly lower osteoblast 
proliferation was observed. This decrease in osteoblast proliferation when the 
current increased beyond 200 µA was also reported in the earlier study with 
polypyrrole/chitosan film as substrate (Zhang et al., 2013). Another reported 
work showed the optimal proliferation of rat’s mandibular osteoblasts on a 
poly-DL-lactide nanofiber scaffold with embedded multiwalled carbon NTs 
occurred at DC stimulation of 100 µA and cell proliferation decreased at 200 
µA (Shao et al., 2011). Differences in cell origin, and the form and electrical 
property of the substrates may give rise to some differences in the level of 
tolerance to DC stimulation.  
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Figure 7-4 Osteoblast proliferation on Pristine-Ti in (a) horizontal and (b) 
vertical assembly and subjected to DC stimulation for 4 h/day over 7 days. 
Suffix of CA or AN refers to osteoblasts cultured on Pristine-Ti cathode or 
anode in the vertical assembly, respectively (* denotes significant difference 
(P<0.05) as compared with Pristine-Ti without ES (0 µA) at the same time 
point, # denotes significant difference (P<0.05) as compared with 100 µA on 
Day 7). 
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The response of the osteoblasts cultured on the cathode and anode of the 
vertical assembly was also investigated. Figure 7-4(b) shows that DC 
stimulation in the range of 50-250 µA did not affect the proliferation of 
osteoblasts cultured on either electrode on Day 1. On Day 4, DC stimulation 
of 150 and 200 µA resulted in significantly increased number of osteoblasts on 
both electrodes. On Day 7, only DC stimulation of 200 µA resulted in an 
increase in the number of the osteoblasts. Increasing the current to 250 µA 
resulted in a significant decrease in proliferation of osteoblasts, similar to the 
result obtained with the horizontal assembly (Figure 7-4(a)). Figure 7-4(b) 
shows that the number of osteoblasts on the cathode and anode is comparable 
over the range of current tested. No previous work has reported on the 
comparison of osteoblast proliferation on the two opposing electrodes when 
subjected to DC stimulation. It has been reported that osteoblasts subjected to 
DC electric fields generated by two electrodes placed between the cultured 
cells in vitro undergo reorganization of their cytoskeleton and may 
preferentially migrate towards one of the electrodes. Rat calvarial osteoblasts 
(RCOs) when subjected to 10 V/cm of DC electric field migrated towards the 
cathode but human SAOS-2 cells migrated towards the anode (Ozkucur et al., 
2009). In another work, DC electric field of 2 V/cm applied for 2 h resulted in 
actins of hFOBs accumulated towards the cathode side and actin 
depolymerization at the anode side, and cells migrated towards the cathode 
(Titushkin and Cho, 2009). In the current study, the comparable number of 
osteoblasts on both electrodes after 7 days of culture implies that either the 
cathode or anode would be suitable for use as substrates for osteoblast 
adhesion and proliferation in potential ES treatments. From Figure 7-4(a) and 
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Figure 7-4(b), since 200 µA resulted in the most number of osteoblasts in both 
assemblies, it was selected as the optimal current and used in the subsequent 
experiments. 
 
7.3.3 Assessment of Proliferation of Osteoblasts Subjected to ES 
Figure 7-5 shows the proliferation of osteoblasts cultured on Pristine-Ti and 
subjected to different forms of ES. Osteoblasts cultured in the horizontal 
assembly and subjected to DC or BEC stimulation of 200 µA were referred to 
as “Horizontal-DC(Ti)” and “Horizontal-BEC(Ti)” groups, respectively. 
Osteoblasts cultured in the vertical assembly and subjected to similar 
treatment were referred to as “Vertical-DC(Ti)” and “Vertical-BEC(Ti)” 
groups. Osteoblasts cultured in the horizontal or vertical assembly without ES 
(0 h/day) served as controls. 
 
From Figure 7-5(a), there was no significant difference in the number of 
osteoblasts in the Horizontal-DC(Ti) and the Horizontal-BEC(Ti) groups when 
ES was applied for 1, 2, or 4 h/day. Increasing period of ES resulted in 
increasing number of osteoblasts in both groups compared to the 
corresponding controls. Similarly, the cell number of the Vertical-DC(Ti) and 
the Vertical-BEC(Ti) groups increased compared to the corresponding 
controls, when ES was increased from 1 to 4 h/day. The highest cell number 
was observed with the Horizontal-DC(Ti) and the Vertical-BEC(Ti) groups 
under application of ES for 6 h/day, resulting in ~66% more osteoblasts 
compared to that of the corresponding controls. 
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DC stimulation carried out in a configuration similar to the vertical assembly 
generated electrochemical products including hydrogen peroxide, hydroxyl, 
oxygen ions and free radicals at the cathode. A decrease in oxygen 
concentration and an increase in pH of the culture medium resulting from 
these electrochemical products are reported to enhance osteoblast functions 
(Bushinsky, 1996, Gittens et al., 2013). However, prolonged periods of DC 
stimulation may result in accumulation of reactive oxygen species (ROS) such 
as hydrogen peroxide and uncontrolled elevation of pH in the culture medium, 
which adversely affect cell functions (Kim et al., 2006). Thus, the higher cell 
proliferation in the Vertical-BEC(Ti) group compared to the Vertical-DC(Ti) 
group when ES was applied for 4 or 6 h/day (Figure 7-5(a)) is probably 
because the alternating current during BEC stimulation reduces the risks of 
ROS accumulation and increase in pH of the culture medium (Ercan and 
Webster, 2010). Similarly, when ES was applied for 6 h/day, the cell number 
in the Horizontal-DC(Ti) group was much higher than in the Vertical-DC(Ti) 
group because generation of electrochemical products is not expected when 
ES is carried out in the former. 
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Figure 7-5 Osteoblast proliferation on (a) Pristine-Ti and (b) TiNT subjected 
to different current and duration of ES (200 µA) in horizontal and vertical 
assemblies after 7 days. The type of ES and substrate used are as indicated in 
the suffix and bracket, respectively. 0 h/day refers to cell culture without ES (*, 
#, & and + denote significant difference (P<0.05) as compared with 0, 1, 2 and 
4 h/day cultured in the same assembly and subjected to the same type of ES, 
@, ^ and $ denote significant difference (P<0.05) as compared with 
Horizontal-DC, Horizontal-BEC, and Vertical-DC subjected to the same 
duration of ES and on the same type of substrate). 
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Figure 7-5(b) shows the proliferation of osteoblasts cultured on TiNT and 
subjected to different forms of ES. Similar to the experiments conducted with 
Pristine-Ti, the experimental groups were divided into Horizontal-DC(TiNT), 
Horizontal-BEC(TiNT), Vertical-DC(TiNT), Vertical-BEC(TiNT) and control 
groups. The increasing number of osteoblasts in all four groups with 
increasing duration of ES is similar to the results obtained with Pristine-Ti 
subjected to the same form of ES. With ES was applied for 6 h/day, the cell 
number of the Vertical-BEC(TiNT) group was the highest, with ~79% more 
osteoblasts compared to that of the TiNT control. 
 
The cell number of the Horizontal-DC(TiNT) group was ~14% less than that 
of the Vertical-BEC(TiNT) group, when subjected to ES for 6 h/day. This is 
different from the comparable cell number of the Horizontal-DC(Ti) and the 
Vertical-BEC(Ti) groups when subjected to the same duration of ES in Figure 
7-5(a). For the Pristine-Ti substrate, the cells are in contact with the flat 
surface while on TiNT the cells are on top of the NTs. As shown in Table 7-1, 
the electrical resistivity of TiNT is higher than that of Pristine-Ti. Thus, the 
cells on TiNT are more insulated from the underlying conducting substrate, 
and when the same current is applied, the effect on the cells may be different.  
 
Figure 7-5(a) and Figure 7-5(b) show that the increase in the number of 
osteoblasts resulting from ES is indeed dependent on the manner in which ES 
was applied. Among the combinations of ES parameters, the highest number 
of osteoblasts was found in the vertical assembly with application of BEC for 
4 or 6 h/day for both Pristine-Ti and TiNT. The number of osteoblasts of the 
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Vertical-BEC(Ti) or the Vertical-BEC(TiNT) group did not increase 
significantly when the ES was increased from 4 to 6 h/day. Thus, 4 h/day was 
selected for the experiments on the effects of ES in combination with surface-
immobilized BMP-2 and surface NTs on osteoblast functions described in 
Section 7.3.4. 
 
The molecular mechanism by which BEC stimulation enhances cell 
proliferation is not fully understood. A recent work reported enhanced 
proliferation of osteoblasts with increased number of microfilaments and 
pseudopodia formation on TiNT when subjected to PEMFs. The authors 
proposed that under PEMF stimulation, the electric potential gradient on TiNT 
surface was amplified due to the different magnetic susceptibility of the 
underlying Ti substrate and the NTs (Wang et al., 2014). In the current study, 
BEC stimulation generates an alternating electric field. The different 
resistivity of pure Ti and NT may also cause similar amplification in the 
electric potential gradient on the TiNT surface when subjected to BEC 
stimulation. Thus, the increased osteoblast proliferation may be due to a 
similar mechanism as in PEMFs. 
 
7.3.4 Assessment of Combination of Surface and Biophysical Cues on 
Osteoblast Functions 
The effects of combinations of surface NT, surface-immobilized BMP-2 and 
BEC stimulation of 200 µA for 4 h/day on osteoblast functions are shown in 
Figure 7-6 and Figure 7-7. After 7 days, the osteoblasts cultured on all 
substrates showed similar number of cells without ES, suggesting surface NTs, 
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PDA coating, PPYC coating and surface-immobilized BMP-2 in the current 
study did not affect osteoblast proliferation. With ES, 60-67% more 
osteoblasts were found on all substrates. Thus, the promotion of osteoblast 
proliferation due to ES is not affected by the presence of NTs or immobilized 
BMP-2. 
 
Figure 7-6 (a) Osteoblast proliferation after 7 days (b) ALP activity of 
osteoblasts over 14 days and (c) calcium deposition of osteoblasts after 21 
days in vertical assembly with and without ES. ES refers to BEC stimulation 
of 200 µA for 4 h/day (* denotes significant difference (P<0.05) comparing 
substrate subjected to ES with the corresponding substrate without ES at the 
same time point). 
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Figure 7-7 (a) Osteoblast proliferation after 7 days (b) ALP activity of 
osteoblasts over 14 days and (c) calcium deposition by osteoblasts after 21 
days in the vertical assembly with and without ES. ES refers to BEC 
stimulation of 200 µA for 4 h/day (* denotes significant difference (P<0.05) 
comparing substrate subjected to ES with the corresponding substrate without 
ES, # and & denote significant difference (P<0.05) comparing substrate with 
Pristine-Ti or TiNT, all in the absence of ES, ^ and @ denote significant 
difference (P<0.05) comparing substrate with Pristine-Ti or TiNT, all 
subjected to ES. Comparison was made between substrates at the same time 
point). 
 
ALP activity is widely used as a marker for the early differentiation of 
osteoblast-like cells (Vo et al., 2012). From Figure 7-7(b), without ES, the 
ALP activity of osteoblasts cultured on TiNT is ~24% higher than that on 
Pristine-Ti on Day 7. This result is consistent with the results as shown in 
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Figure 6-6(a). The surface coating of PDA and PPYC does not affect the ALP 
activity of osteoblasts, as shown by the comparable ALP activity of 
osteoblasts cultured on TiNT, PDA-TiNT and PPYC-TiNT in Figure 7-6(b). 
The immobilized BMP-2 resulted in ~25% increase in the ALP activity of 
osteoblasts cultured on BMP-PDA-TiNT and BMP-PPYC-TiNT compared to 
that on TiNT (Figure 7-7(b)), similar to results obtained in Figure 6-6(a). The 
ALP activity of osteoblasts cultured on BMP-PDA-TiNT and BMP-PPYC-
TiNT is comparable, which is not surprising since the amount of BMP-2 
conjugated to these coatings is similar. With administration of ES, the ALP 
activity of osteoblasts cultured on all substrates is significantly increased by 
~34% on average, over that without ES. Comparing the effects of surface NTs, 
surface-immobilized BMP-2 and ES, the latter resulted in greatest increase in 
the ALP activity of osteoblasts. The stimulating effects of the combination of 
surface NTs, surface-immobilized BMP-2 and ES on the ALP activity of 
osteoblasts cultured on pristine and functionalized Ti substrates on Day 14 is 
similar is to those on Day 7. The combination of surface NTs, surface-
immobilized BMP-2 and ES resulted in 100% and 132% increase in the ALP 
activity of osteoblasts on Day 7 and Day 14, compared with that on Pristine-Ti 
without ES, respectively. ALP is responsible for catalyzing the organic 
phosphate monoesters in the culture medium to release inorganic phosphate 
for physiological mineralization (de Jonge et al., 2009). Thus, it is expected 
that with significantly higher ALP activity of osteoblasts, more inorganic 
phosphate will be released, and this in turn will result in higher calcium 
deposition by the osteoblasts, as shown below. 
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The calcium minerals deposited by osteoblasts cultured on pristine and 
functionalized Ti substrates after 21 days with or without ES were stained as 
shown in Figure 7-8. The quantification of calcium deposition by osteoblasts 
was as shown in Figure 7-7(c). Comparing Figure 7-8(a) with Figure 7-8(c), 
the osteoblasts cultured on TiNT deposited more calcium minerals than those 
on Pristine-Ti. These staining results were confirmed by ~23% increase in 
calcium deposition by osteoblasts compared to that on Pristine-Ti as shown in 
Figure 7-7(c) and Figure 6-6(b). The TiNT substrates with surface-
immobilized BMP-2 resulted in more calcium deposition by osteoblasts as 
compared to that on TiNT (comparing Figure 7-8(e) and (g) with Figure 7-
8(c)). This was quantitatively confirmed by ~28% increase on average in 
calcium deposition by osteoblasts on BMP-PDA-TiNT and BMP-PPYC-TiNT 
compared to that on TiNT in Figure 7-7(c). With ES, the osteoblasts cultured 
on all substrates deposited more calcium minerals than those without ES 
(comparting Figure 7-8(b), (d), (f) and (h) with Figure 7-8(a), (c), (e) and (g), 
respectively). This was again confirmed by Figure 7-7(c), where oteoblasts 
deposited ~33% more calcium minerals on average across all substrates when 
subjected to ES, compared to those without ES.  
 
Chapter 7  
188 
 
 
Figure 7-8 Optical microscopy images of Alizarin Red-stained osteoblasts 
cultured on pristine and functionalized Ti substrates in the vertical assembly 
without ES ((a), (c), (e) and (g)) with ES (BEC stimulation of 200 µA for 4 
h/day) ((b), (d), (f) and (h)) after 21 days. Scale bar = 200 μm. 
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The above results show that ES has a more pronounced effect on promoting 
calcium deposition than surface NTs or surface-immobilized BMP-2. In 
combination with surface NTs and surface-immobilized BMP-2, application of 
BEC (i.e. BMP-PDA-TiNT and BMP-PPYC-TiNT substrates) resulted in 
~91% more calcium deposition by osteoblasts than Pristine-Ti without ES. 
Earlier studies reported that DC stimulation combined with BMP-2 resulted in 
synergistic effects on osteoblasts (Zhang et al., 2013) while a combination of 
surface NTs and BEC or PEMF stimulation resulted in an additive effect on 
the functions of hFOB and RCOs, respectively (Ercan and Webster, 2010, 
Wang et al., 2014). In the current study, comparing the effect of the 
combination of BEC, surface NTs and surface-immobilized BMP-2 on 
calcium deposition with the effect of each factor evaluated independently, it is 
likely that the increase in calcium deposition resulting from the combination 
of the three factors is an additive effect. 
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7.4 Conclusion 
In this Chapter, the effect of ES applied in different manner to osteoblasts, and 
the effect of a combination of surface-immobilized BMP-2, surface NTs and 
ES on cell functions were evaluated. The optimal current for osteoblast 
proliferation cultured on Pristine-Ti was 200 µA, when subjected to DC 
stimulation for 4 h/day. This optimal current was independent of whether the 
current was applied along the surface of the substrate or perpendicular to it 
and whether the substrate served as the cathode or anode in the latter. DC and 
BEC stimulation at 200 µA applied for 1, 2 or 4 h/day in the horizontal 
assembly resulted in comparable increase in cell number. On the other hand, 
BEC stimulation at 200 µA applied for 4 and 6 h/day in the vertical assembly 
resulted in significantly higher cell number than that in the horizontal 
assembly. Among the different forms of ES tested (type of current and the 
manner it was applied to the cells), BEC at 200 µA applied perpendicularly to 
the cells on the electrode (in the vertical assembly) for 4 or 6 h/day resulted in 
the greatest increase in cell number. Comparing the effects of surface-
immobilized BMP-2, surface NTs and BEC applied independently, the latter is 
the most effective in enhancing osteoblasts’ ALP activity and calcium 
deposition, resulting in ~34% more calcium deposition compared to that 
without ES. With a combination of these three factors, ~98% more calcium 
was deposited by osteoblasts compared to Pristine-Ti without BMP-2 and ES. 
Thus, the surface modification strategy developed in this Chapter is highly 
desirable for ES treatment in clinical applications.  
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CHAPTER 8 CONCLUSIONS AND 
RECOMMENDATIONS FOR FUTURE WORK 
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8.1 Conclusions 
The present research study has attempted to develop surface modification 
strategies on Ti substrate with the aim of enhancing osteoblast and stem cell 
functions in vitro. Different therapeutic molecules were used for modification 
of the surface chemistry of Ti. The surface topography of Ti was modified by 
formation of NTs on Ti. The biological responses of osteoblasts and stem cells 
cultured on the functionalized substrates were investigated. 
 
In the first part of the work, the stability of silane, DA and PDA as surface 
anchor, and surface coatings of CMCS and BMP-2 immobilized on Ti via 
these anchors after being subjected to 70% ethanol, autoclaving and prolonged 
immersion in PBS was assessed. The immobilized CMCS and BMP-2 on the 
DA- and PDA-modified Ti retained a high degree of their respective 
bioactivity after the above-mentioned stability assays. The silane anchor, 
while not as stable as DA or PDA, still retained a substantial degree of 
stability after the above-mentioned stability assays. This work was the first to 
report the assessment of stability of covalently immobilized surface anchors 
and coatings by evaluating the biological responses of the substrates after 
different stability tests. The covalently immobilized BMP-2 in this work 
exhibited improved thermal stability over the adsorbed BMP-2, with at least 
78% of the former remaining active compared to complete denaturation of the 
latter after the substrates were autoclaved (Yano et al., 2009). Thus, silane, 
DA, PDA, CMCS and BMP-2 would be suitable for surface modification of Ti 
in the subsequent parts of the thesis. 
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In the second part of the work, the effect of immobilized alendronate via its 
different functional groups on osteoblast function was investigated to elucidate 
how immobilized alendronate affects osteoblasts. Two strategies were 
developed for immobilizing alendronate on Ti via either its phosphate or 
amine group. With similar amounts of immobilized alendronate, these two 
types of modified substrates have comparable stimulating effects on osteoblast 
differentiation up to Day 10. Alendronate immobilized via its phosphate 
groups was less stable and its stimulating effect on osteoblast differentiation 
diminished from Day 14 to 21. On the other hand, alendronate immobilized 
via its amine group continued to stimulate osteoblast differentiation over 21 
days. The surface density of the immobilized alendronate is another critical 
factor in modulating the osteoblast differentiation. Alendronate immobilized 
via its amine group also significantly enhanced the osteogenic differentiation 
of hMSCs. The immobilized alendronate had similar efficacy as free 
alendronate in increasing the expression of osteopontin in hMSCs (Fu et al., 
2008), and had much higher efficacy than free inorganic phosphate in 
increasing the expression of osteocalcin in hMSCs (Danoux et al., 2015). Thus, 
alendronate immobilized via its amine group would be potentially useful for 
regenerative medicine therapy. 
 
In the third part of the work, a stable bifunctional coating was developed by 
sequential covalent immobilization of CMCS and ALP on PDA-modified Ti to 
resist bacterial adhesion and to enhance osteoblast and stem cell functions. 
The ALP immobilized in this manner achieved 26% higher enzymatic activity 
compared to a previously reported method (Nijhuis et al., 2013). The ALP-
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modified substrate prepared using an ALP solution of 50 μg/cm2 resulted in 
89% reduction in S. epidermidis adhesion. At the same time, this substrate also 
enhanced calcium deposition by osteoblasts, hMSCs and hADSCs by 44%, 
54% and 129%, respectively, compared to pristine Ti after 21 days. In addition, 
the thermal stability of the immobilized ALP was significantly improved over 
that of free ALP (Craig et al., 1996) and ALP immobilized directly on PDA-
modified Ti (Nijhuis et al., 2013). 
 
The work carried out in the first three parts in the thesis focused on the 
modification of the surface chemistry of Ti. The next two parts of the work 
focused on the modification of both surface chemistry and surface topography 
of Ti. In the fourth part of the work, the effects of surface-immobilized BMP-2, 
alendronate, ALP, and surface nanotubes on Ti on osteoblast functions were 
compared in order to screen for the best combination of surface modification 
strategy. The surface-immobilized BMP-2, alendronate and ALP were more 
effective than the surface nanotubes in enhancing the ALP activity of 
osteoblasts. The substrate with the combination of surface nanotubes and 
surface-immobilized BMP-2 was the most effective in stimulating osteoblast 
differentiation, resulting in 63% increase in calcium deposition by osteoblasts 
compared to pristine Ti.  
 
In the fifth part of the work, DC or BEC was applied to osteoblasts either 
along the substrate or perpendicular to it, and the effects on osteoblasts 
differentiation were investigated. Osteoblast proliferation on these substrates 
was dependent on the type of current, the manner and duration of application 
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to the osteoblasts. BEC at 200 µA applied perpendicularly to the osteoblasts 
on the electrode for 4 or 6 h/day resulted in the greatest increase in cell 
number. Comparing the effects of surface nanotubes, surface-immobilized 
BMP-2 and BEC applied independently, BEC was the most effective in 
enhancing osteoblasts’ ALP activity and calcium deposition, resulting in 
~34% increase in calcium deposition compared to that without electrical 
stimulation. A combination of these three factors resulted in ~98% increase in 
calcium deposition by osteoblasts compared to pristine Ti without electrical 
stimulation and BMP-2. 
 
In summary, this thesis has shown that surface modification of Ti by covalent 
immobilization of therapeutic molecules and formation of nanotopographical 
features can significantly enhance osteoblast and stem cell functions in vitro. 
Thus, the functionalized substrates developed in this thesis exhibit good 
potential in orthopedic applications. However, further improvements are 
needed before these substrates can be utilized in clinical applications. Some 
recommended future works are described in the following section. 
  
8.2 Recommendations for Future Work 
Based on the investigations carried out in this study, the following related 
research projects are recommended for future work.  
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8.2.1 Stability of Nanotubular Ti Functionalized with Immobilized BMP-
2 
In Chapter 3 and 5, autoclaving of substrates was carried out to assess the 
stability of the surface coatings. It is also important to ensure the stability of 
the surface coatings after they are subjected to other sterilization techniques, 
long term storage and friction forces during implant insertion. Nanotubular Ti 
substrates functionalized with immobilized BMP-2 are the most promising in 
enhancing osteoblast functions as shown in Chapter 7. Thus, it is 
recommended that the stability of these substrates after being subjected to 
gamma irradiation or ethylene oxide sterilization, long term storage and 
friction forces be assessed. The substrates should be sterilized via gamma 
irradiation or ethylene oxide sterilization. Gamma irradiation and ethylene 
oxide sterilization are recommended as they are standard procedures utilized 
in sterilization of medical implants. After this treatment, the substrates should 
be stored at 4°C or -20°C for 1 to 3 months. For assessment of stability of the 
substrates after being subjected to friction forces, a friction test is proposed. A 
piece of bone tissue (attached to a counterpart) should be placed on the surface 
of a functionalized nanotubular Ti substrate (attached to another counterpart). 
The two counterparts should be loaded with an axial force, and move against 
each other to mimic the friction during the insertion of an implant as shown in 
Figure 8-1 After the stability tests, the physicochemical properties of the 
substrates and the biological responses of osteoblasts/stem cells to these 
substrates should be investigated. 
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Figure 8-1 Proposed friction test for assessment of stability of nanotubular Ti 
functionalized with BMP-2. 
 
8.2.2 Optimization of Surface Topography of Ti and Electrical 
Stimulation Parameters for Enhancing Osteoblast Function and 
Inhibiting Biofilm Formation  
Since the two major problems associated with current orthopedic implants are 
infection and lack of tissue integration, a modified surface that can solve these 
two problems would be highly desired. Thus, it is recommended that further 
research be carried out on BMP-2-functionalized nanotubular Ti described in 
Chapter 7 to optimize the dimensions of the surface nanotubes (e.g. diameter 
and length of the nanotubes, and the interspace of neighboring nanotubes) and 
the electrical stimulation parameters to achieve simultaneous enhancement of 
osteoblast functions and inhibition of biofilm formation. As highlighted in 
Chapter 2, there is no firm evidence from the literature regarding the 
dimension of nanotubes which would be most effective in reducing biofilm 
formation. This underscores the necessity for this research. The optimization 
of the substrate and electrical stimulation parameters can be carried out using 
in vitro experiments with osteoblasts and S. epidermidis. Both monoculture 
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and co-culture of osteoblasts and bacterial cells should be investigated. S. 
epidermidis is recommended as it is one of the two leading etiologic agents of 
orthopedic implant infection (Montanaro et al., 2011). 
 
8.2.3 Surface Modification of Three-dimensional Ti Based Substrate and 
In Vivo Experiment for Assessment of Osseointegration 
The current study is based on two-dimensional Ti based substrates. 
Modifications of surface chemistry and surface topography of three-
dimensional Ti based substrates (such as cylindrical Ti and Ti screws) should 
be carried out to simulate actual implants. Moreover, the current study is based 
on in vitro investigations, which cannot reflect the complex biological 
environment in the human body. Thus, in vivo experiments should be carried 
out. The substrate with highest degree of stability and optimal surface 
topography for enhancement of osteogenesis and reduction of biofilm 
formation should be implanted into a model animal for in vivo tests. After 
implantation, electrical stimulation using the optimized parameters should be 
applied. The efficacy of the substrate in improving the implant fixation with 
the host tissue can be evaluated by measuring the pull-out force of the 
implanted substrate from the bone cavity. The effects of the substrate on 
osseointegration can be studied using histological analysis. 
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